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Summary 
The Norwegian Scientific Committee for Food Safety (Vitenskapskomiteen for mattrygghet, 
VKM) has on request of The Norwegian Food Safety Authority performed a risk assessment 
of furan intake in the Norwegian population based on the most recent national food 
consumption surveys. National occurrence data of furan concentrations in food were 
preferentially used in the risk assessment. When national data were lacking, VKM has used 
occurrence data of furan from other countries. The assessment has been performed by the 
VKM Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food 
and Cosmetics and the VKM Panel on Contaminants. 
Furan is a volatile and lipophilic compound formed in a variety of heat-treated commercial 
foods and contributes to the sensory properties of the product. The substance has been found 
in a number of foods such as coffee, canned and jarred foods including baby food containing 
meat and various vegetables. High concentrations of furan have been found in coffee and the 
presence of furan in jarred baby food and infant formulae has received much attention since 
such products may be the sole diet for many infants. The occurrence of furan in a variety of 
foods suggests that there are multiple routes of furan formation rather than a single 
mechanism. 
The Norwegian Food Safety Authority has in 2008 and 2009 collected data on furan 
concentrations in different food products sold on the Norwegian market (Norwegian Food 
Safety Authority, 2008). In 2011, the Norwegian Food Safety Authority also decided to 
analyse commercial porridges for infants and children sold on the Norwegian market, to see if 
furan could be detected in such products. 
The calculated furan exposures from food and beverages are based on data from the nationally 
representative food consumption surveys; Spedkost, Småbarnskost, Ungkost and Norkost. 
The consumption for each relevant food or food category in the dietary surveys were 
multiplied with the corresponding mean furan concentrations and totalled for each individual. 
The liver is the main target organ for furan toxicity both in mice and rats, but the rat is the 
most sensitive species. A dose-dependent increase in hepatocellular adenomas and 
carcinomas was observed in mice and rats, and an increase in the incidence of 
cholangiocarcinomas was observed in rat liver. Cholangiocarcinomas in male and female rats 
were the most sensitive toxicological end point observed in rodents. On the basis of the 
available data, VKM considers that rat cholangiocarcinomas may be relevant for assessing 
human risk from furan. 
Available in vivo data with furan indicate that a reactive metabolite, most likely cis-2-butene-
1,4-dial (BDA), is formed and that this metabolite can react with DNA and induce mutations. 
To VKM’s knowledge, no in vivo studies on genotoxicity of BDA have been performed, but 
BDA was found to be genotoxic in several in vitro tests. VKM therefore considers that a 
genotoxic mechanism in furan-induced carcinogenesis cannot be excluded and the substance 
was assessed as a genotoxic carcinogen. 
VKM used the Margin of Exposure (MOE) approach in this risk assessment. The suitability 
of different studies on cholangiocarcinomas for dose-response modelling was considered. The 
9-month interim evaluation of a 2-year study from NTP (1993) was chosen because it 
demonstrates a dose-response relationship. From this study, a point of departure of 0.02 
mg/kg bw/day was chosen, based on a benchmark dose lower bound (BMDL10) of 0.14 mg 
furan/kg bw/day and a correction factor of 7 for shorter than full life-time (2 years) study 
duration.  
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For 6-, 12- and 24-month-old children, the main source of furan exposure is jarred baby food. 
For 4-, 9- and 13-year-old children, the major food source to the furan exposure is breakfast 
cereals. In adults, the major contribution to the furan exposure is coffee. The highest furan 
exposure was calculated for 12-month-old infants and ranged from 0.62-1.51 µg/kg bw/day. 
In adults the furan exposure ranged from 0.27-0.82 µg/kg bw/day.  
For mean exposure among infants, children and adolescents, the MOE-values ranged from 29 
in 12-month-infants to 2000 in the 13-year-old adolescents. Among high consumers in these 
groups, the MOE-values ranged from 13 to 400. In adults, the corresponding MOE-values 
ranged from 59 to 74 for mean furan exposure and from 24 to 26 for high exposure. 
It should be noted that this risk assessment of furan contains notable uncertainties and 
limitations. The use of the 9-month interim study in rats including a correction factor of 7 to 
derive a point of departure, instead of a full life-time study (2-year) study, likely 
overestimates the hazard of furan. A possible over-diagnosis of the cholangiocarcinomas, due 
to the similarities in histopathology between cholangiofibrosis and cholangiocarcinomas in 
rats, may overestimate the hazard. There are also limitations in assessing food consumption 
and furan content in foods, leading to uncertainties in estimation of furan exposure.  
VKM considers that the current exposure to furan in all age groups, particularly among 
infants and children, is of health concern. 
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Norsk sammendrag 
Vitenskapskomiteen for mattrygghet (VKM) har på oppdrag fra Mattilsynet utført en 
risikovurdering av furaninntak i den norske befolkningen basert på de nyeste nasjonale 
kostholdsundersøkelsene. I risikovurderingen er det fortrinnsvis brukt nasjonale 
forekomstdata av furan i mat. VKM har brukt forekomstdata fra andre land der nasjonale data 
har manglet. Vurderingen er utarbeidet av Faggruppen for tilsetningsstoffer, aroma, 
matemballasje og kosmetikk og Faggruppen for forurensninger, naturlige toksiner og 
medisinrester.  
Furan er et lettfordamplig og fettløselig stoff som dannes i en rekke varmebehandlede 
kommersielle matvarer og bidrar til produktenes sensoriske egenskaper. Furan er påvist i 
mange typer mat, f.eks. kaffe, hermetikk og forseglede matvarer på glass inkludert barnemat 
som inneholder kjøtt og ulike grønnsaker. Høye konsentrasjoner av furan er funnet i kaffe. 
Funn av furan i barnemat på glass og i morsmelkerstatning har fått mye oppmerksomhet fordi 
slike produkter kan være den eneste dietten for mange spedbarn. Furan er påvist i en rekke 
matvarer og derfor er sannsynligvis flere enn en mekanisme involvert i dannelsen av stoffet. 
I 2008 og 2009 foretok Mattilsynet en begrenset kartlegging av furannivå i matvarer på det 
norske markedet. Mattilsynet bestemte seg i 2011 for også å undersøke kommersielle 
barnegrøter på det norske markedet, for å se om furan kunne påvises i slike produkter. 
Konsumdata fra de nasjonale kostholdsundersøkelsene Spedkost, Småbarnskost, Ungkost og 
Norkost er brukt til å beregne furaneksponering fra mat og drikke. Konsum av hver relevant 
matvare eller matkategori i kostholdsundersøkelser ble multiplisert med gjennomsnittlig 
furankonsentrasjon i matvaren og summert for hvert individ. 
Leveren er det viktigste organet for furantoksisitet både hos mus og rotter, men rotte er den 
mest sensitive arten. En doseavhengig økning av hepatocellulært adenom og karsinom 
(leverkreft) ble sett hos mus og rotter, og en økning i forekomsten av kolangiokarsinom 
(gallegangskreft) ble sett i rottelever. Det mest sensitive toksikologiske endepunktet hos 
gnagere var kolangiokarsinom hos hann- og hunnrotter. Ut i fra tilgjengelige data, mener 
VKM at kolangiokarsinom hos rotte kan være relevant for å vurdere human risiko av furan. 
Tilgjengelige in vivo data indikerer at furan danner en reaktiv metabolitt, mest sannsynlig cis-
2-buten-1,4-dial (BDA), og at denne metabolitten kan reagere med DNA og indusere 
mutasjoner. VKM kjenner ikke til at det er utført in vivo studier av gentoksisitet av BDA, men 
BDA er funnet å være gentoksisk i flere in vitro tester. VKM mener derfor at en gentoksisk 
mekanisme ikke kan utelukkes i furanindusert kreft og stoffet er derfor blitt vurdert som et 
gentoksisk karsinogen. 
VKM har brukt metoden ”eksponeringsmargin” (Margin of exposure, MOE) i denne 
risikovurderingen. Flere studier ble vurdert for å finne den best egnede for dose-
responsmodelleringen av kolangiokarsinom. En 9-måneders interimevaluering av NTPs 2-
årige rottestudie (1993) ble valgt, fordi den viste en dose-responssammenheng med 
furaneksponering. Fra denne studien ble 0,02 mg furan/kg kroppsvekt/dag valgt som 
referansedose (point of departure, POD), basert på det nedre konfidensintervallet av 
benchmarkdosen (BMDL10) på 0,14 mg furan/kg kroppsvekt/dag og en korreksjonsfaktor på 7 
for kortere enn full livstids varighet (2 år) på studien. 
Hovedkilden for furaneksponering hos 6, 12 og 24 måneder gamle barn er barnemat på glass. 
For 4, 9 og 13 år gamle barn er frokostblandinger den viktigste matkilde for 
furaneksponering. Hos voksne er det kaffe som gir det største bidraget til furaneksponering. 
Høyeste furaneksponering ble beregnet for 12 måneder gamle spedbarn og varierte fra 0,62 til 
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1,51 mikrogram/kg kroppsvekt/dag. Hos voksne varierte furaneksponeringen fra 0,27 til 0,82 
mikrogram/kg kroppsvekt/dag. 
Den gjennomsnittlig furan eksponering blant spedbarn, barn og ungdom ga MOE-verdier som 
varierte fra 29 hos 12 måneder gamle spedbarn til 2000 hos 13-årige ungdommer. Blant 
høykonsumenter i alle aldersgrupper varierte MOE-verdier fra 13 til 400. Hos voksne varierte 
MOE-verdiene fra 59 til 74 ved gjennomsnittlig furaneksponering, og fra 24 til 26 ved høy 
eksponering. 
Det bemerkes at denne risikovurdering av furan inneholder vesentlige usikkerheter og 
begrensninger. Bruken av 9-måneders interrimstudie i rotte og en korreksjonsfaktor på 7 til å 
utlede en referansedose i stedet for en fullstendig livstidsstudie (2 år), overvurderer 
sannsynligvis faren ved furaneksponering. En mulig overdiagnostisering av kolangiokarsinom 
hos rotte på grunn av likheter i histopatologi mellom kolangiofibrose og kolangiokarsinom, 
kan også overvurdere faren. Det er begrensninger både i beregningene av matinntak i ulike 
aldersgrupper og av furaninnhold i ulike matvarer som igjen fører til usikkerhet i 
estimeringene av furaneksponeringene. 
VKM anser at dagens eksponering for furan i alle aldersgrupper, særlig blant spedbarn og 
barn, er av bekymring for helsen. 
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Background 
In 2004, the United States Food and Drug Administration (U.S. FDA) reported the presence 
of low furan concentrations in a wide variety of commonly consumed food, especially in 
foods that undergo thermal treatment such as canning and jarring. This discovery raised for 
the first time, concern about potential risk of furan to human health, even if furan had 
previously been identified in food such as coffee, canned food etc. 
Knowledge on the toxicity of furan is rather limited, but at a meeting in February 2010 the 
Joint FAO/WHO Expert Committee on Food Additives (JECFA) concluded that dietary 
exposure to furan resulted in hepatocellular adenomas and carcinomas in female mice 
(JECFA 2010, Summary report). The calculated Margin of Exposures (MOEs) representing 
average and high dietary human exposure to furan were considered by the Committee to 
indicate a human health concern. Furan is considered a possible carcinogen to humans (Group 
2B) by the International Agency for Research on Cancer (IARC, 1995) and its carcinogenicity 
is probably attributable to a genotoxic mechanism (EFSA, 2004). 
Risk assessments of furan have previously been performed by the European Food Safety 
Authority (EFSA) (2004) and by the Joint FAO/WHO Expert Committee on Food Additives 
(2011). Furan has also been evaluated by U.S. FDA (2004), and National Toxicology 
Program (NTP) (1993). Data on furan in food was reported by FDA (2004) and EFSA (2009; 
2010; 2011), and in 2008 a small survey was performed by the Norwegian Food Safety 
Authority (Furan i næringsmidler, 2008). There are no Norwegian or European regulations 
that cover furan content in food. 
 
Terms of reference 
The Norwegian Food Safety Authority requests the Norwegian Scientific Committee for Food 
Safety (VKM) to assess the significance of exposure to furan for the Norwegian population’s 
health based on the concentrations found in food on the Norwegian market and on the most 
recent food consumption surveys for infants, small children, youths and adults (Spedkost, 
Småbarnskost, Ungkost, Norkost 3), and existing toxicological assessments of the substance. 
 
• VKM is requested to assess the significance of exposure levels of furan for infants, 
children and youths based on data from Spedkost, Småbarnskost and Ungkost. The 
exposure assessment for adults should be based on data from the new food 
consumption survey Norkost 3. 
• Where relevant, VKM should take into consideration occurrence data for 
concentrations of furan in foodstuffs from other countries in addition to the Norwegian 
data, where the foodstuffs in question (such as coffee) may contribute considerably to 
the exposure in the Norwegian population.  
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Assessment 
 
1 Introduction 
1.1 Previous risk assessments of furan  
1.1.1 Initial Report of the EFSA Scientific Panel on Contaminants in the Food Chain 
(CONTAM) on provisional findings on furan in food (EFSA, 2004) 
This report provided the current knowledge on exposure and adverse effects of furan and on 
gaps in the knowledge and possible research needs for future comprehensive risk assessments. 
The EFSA CONTAM Panel concluded, based on presently available data, that furan-induced 
carcinogenicity is probably attributable to a genotoxic mechanism, and that chronic toxicity 
with secondary cell proliferation may indirectly amplify the tumour response. There are 
limited sets of data on the occurrence of furan in various food categories, as well as available 
consumption data. Thus, EFSA chose to present the range of the estimated exposure rather 
than the average exposure. The exposure range of <0.03 – 3.5 µg/kg bw per day was based on 
furan concentrations from non-detectable to 112 µg/kg in baby food and an assumed 
consumption of 234 g/day of canned baby food of a 6 months old baby weighing 7.5 kg. 
However, the limited data revealed that there was relatively small difference between possible 
human exposure and the doses in experimental animals that produce carcinogenic effects. The 
EFSA CONTAM Panel also concluded that a reliable risk assessment would require further 
data on both toxicity and exposure.  
 
1.1.2 72nd Joint FAO/WHO Expert Committee on Food Additives (2011) – Technical Report 
At its 72nd meeting (2010), the Joint FAO/WHO Expert Committee on Food Additives 
(JECFA) conducted a full evaluation of furan, as requested by the Codex Alimentarius 
Commission at its Thirty-first Session (2008). Results of studies on the genotoxic and 
carcinogenic potential of furan, as well as data on metabolism and disposition, short-term 
toxicity, reproductive developmental toxicity, perinatal carcinogenicity and immunotoxicity 
was assessed. In rats, but not mice, high incidences of cholangiocarcinomas were observed in 
all dose groups. Accordingly, no point of departure could be identified for this end point. 
Furthermore, the relevance of cholangiocarcinomas for humans was considered as unclear. 
Hepatocellular neoplasms were induced in both mice and rats, and a BMDL10 of 1.3 mg/kg 
bw (corresponding to 0.96 mg/kg bw/day) for induction of hepatocellular adenomas and 
carcinomas in female mice was selected. The Committee suggested that the major route of 
exposure to furan is through consumption of heat-treated foods and beverages. A dietary 
exposure representing the average exposure of furan for the general population of 0.001 
mg/kg bw/day and a dietary exposure of 0.002 mg/kg bw/day for consumers with high 
exposures was estimated. The highest estimate also covers the dietary exposure of children. 
Comparison of these exposure values with the selected BMDL10, gives MOEs of 960 for 
average and 480 for high dietary exposures. It was considered by the Committee that these 
MOEs indicate a human health concern for a carcinogenic compound that might act via a 
DNA-reactive genotoxic metabolite.  
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1.2 Formation and persistence (or stability) of furan in foods  
 
 
Figure 1: Furan, C4H4O 
 
Furan (C4H4O, CAS-Nr. 110-00-9) is a volatile and lipophilic compound. In addition to its 
formation through thermal treatment of food, furan is also known as a by-product of high-
energy radiation of food. Furthermore it serves as an intermediate in the synthesis and 
preparation of numerous polymers. The occurrence of furan in a variety of foods suggests that 
there are probably multiple routes of formation rather than a single mechanism. The proposed 
routes for furan formation are mainly based on Maillard reactions, thermal degradation of 
carbohydrates or certain amino acids, thermal oxidation of ascorbic acid, polyunsaturated 
fatty acids and carotenoids, and free radical reactions during irradiation. The Danish 
Technical University has, in a project on behalf of EFSA, investigated the formation of furan 
in heat processed food products, including home-cooked foods. The results from this project 
indicated that foods with a high level of carbohydrates are most likely to produce furan 
formation. It was further shown that foods that were home-cooked using furan-containing 
ingredients did not lead to increased concentrations of furan in the prepared home-cooked 
foods (DTU, 2009). Higher amounts of furan are normally formed under roasting conditions 
(dry heating, 200 ºC, 10 min) compared with pressure cooking conditions (sterilization, 121 
ºC, 25 min), and pH plays a complex role in the mechanism of furan formation (JECFA, 
2011). 
 
Most results on furan concentrations in food items are derived from samples that were 
analysed as purchased, which means that only limited data are available on the formation of 
furan in home-cooked food as well as on furan stability during cooking, storage and reheating 
of meals (EFSA, 2010). Furan is stable in hot food and appears to be well dissolved within the 
food matrix. Despite its volatility, evaporation is believed to be hindered by slow diffusion 
inside the matrix (e.g. opening the jars of baby foods exposes only a relative small surface 
area). However, larger declines of furan content can be observed when canned and jarred 
foods are heated in a saucepan under stirring. In general, furan concentrations did not 
decrease as much when foods were heated in a microwave oven, as compared to the same 
food heated in a saucepan. Studies on reduction of furan concentration during warming 
procedures for ready-to-eat foods have shown conflicting results, with some authors reporting 
decreases of 29-85% in the furan concentration, and others finding persistent furan levels 
during normal heating practices. Decreases in furan concentrations in heated foods that are 
left for cooling, seem to be insignificant (JECFA, 2011; EFSA, 2010).   
 
Furan evaporates to varying degrees from food during heating and may thus lead to exposure 
through inhalation of kitchen air. In 2009, EFSA published a scientific/technical report 
“Consumer exposure to furan from heat-processed foods and kitchen air”, submitted by The 
Food and Environment Research Agency (FERA, 2009). In this project, the concentrations of 
furan were analysed in different types of foods before and after cooking, and also in the 
kitchen air during cooking. The results confirmed that furan exposure from diet depends on 
the food type and the cooking method. For cooking activities of short duration (<10 min), 
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furan concentrations in the air were low and variable, for cooking practices lasting more than 
10 minutes data was more uniform. Concentrations up to about 10 ng/L of inhaled furan were 
calculated by multiplying the average furan content of the air in the cooking period (exposure 
period) with an assumed inhalation rate of 5 l/min. However, considerably more data on 
exhalation of furan is needed in order to calculate the net exposure from breathing. 
Accordingly, exposure by inhalation will not be further discussed in this opinion. 
 
2 Furan contents in food  
Furan is formed in a variety of heat-treated commercial foods and contributes to the sensory 
properties of the product. The substance has been found in a number of foods such as coffee, 
canned and jarred foods including baby food containing meat, and various vegetables. High 
concentrations of furan have been found in coffee and the presence of furan in jarred baby 
food and infant formulae has also received much attention since such products may form the 
sole diet for many infants. 
 
2.1 Monitoring of furan contents in food reported by EFSA  
In order to collect more information, EFSA issued a call for scientific data on furan in 2006 
(EFSA, 2006a). In 2009, EFSA was asked by the European Commission to assemble 
occurrence data on furan in heat-treated commercial food products, collected by the Member 
states in 2007 and 2008 (EFSA, 2009). Reporting on occurrence data for furan now continues 
on a regular basis and a second EFSA report including data sampled and analysed between 
2004 and 2009 was published in August 2010 (EFSA, 2010). A new EFSA report with an 
update on furan levels in food from 2004-2010, including an exposure assessment was 
published in August 2011 (EFSA, 2011). 
A total of 5050 analytical results for furan content in food, submitted by 20 countries between 
2004 and 2010 have been reported and included in the latest update on furan levels from 
EFSA. The data have been sorted into 21 different food categories (5 coffee and 16 non-
coffee categories) in accordance with previously reported results in the literature. The highest 
furan concentrations were found in coffee with mean values varying between 45 µg/kg for 
brewed coffee and 3660 µg/kg for roasted coffee beans. In the non-coffee categories, mean 
values ranged between 3.2 µg/kg for infant formula and 49 µg/kg for certain baby food 
categories (vegetables only). The highest concentrations (95th percentile) reported were 6407 
µg/kg for roasted coffee beans, and 123 µg/kg in jarred baby food (vegetables only) for the 
non-coffee categories (EFSA, 2011). 
 
2.2 Norwegian data on furan contents in food 
The Norwegian Food Safety Authority has in 2008 and 2009 collected data on furan 
concentrations in different food products sold in the Norwegian market (Norwegian Food 
Safety Authority, 2008). In all, 38 samples distributed into the following food categories; 
jarred baby food (24 samples), canned and jarred vegetables (4 samples), jarred sauces (8 
samples) and baked beans (2 samples) were analysed. The data was collected in response to 
Commission Recommendation 2007/196/EC that requests Member States to monitor the 
presence of furan in foodstuffs that have undergone heat treatment and are included in the 
EFSA reports on furan levels in food published in 2010 and 2011 (EFSA, 2010; 2011). 
In 2011, the Norwegian Food Safety Authority also decided to analyse commercial porridges 
for infants and children sold in the Norwegian market, to see if furan could be detected in 
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such products. A total of 14 commercial porridge samples was analysed; 12 powder-based 
porridges which should be mixed with water or milk and 2 ready-to-eat glass jars. 
 
2.2.1 Sampling procedure and analytical method 
All 38 Norwegian samples were analysed for the content of furan without any preparation of 
the purchased foodstuff. Thirty of the collected products were also analysed after further 
preparation as if consumed in the laboratory, e.g. canned and jarred products heated for 
consumption. 
The sample preparation before analysis was carried out with care to ensure that the furan 
content of the samples was not altered. The furan concentrations in pooled samples of 3 
identical products from the same producer were monitored. The products that were analysed 
after heat-treatment were heated in accordance with the instructions on the packaging. 
The baby food samples (20 products) were transferred to a plate and microwave heated for 30 
seconds at 750 watt. The pasta and dinner sauces (6 products) were transferred to a cup and 
gently boiled without a lid for 5 minutes. Canned vegetables (2 products) were heated with a 
similar procedure as the sauces. One of the 2 products of baked beans was heated after the 
liquid was removed and the beans were rinsed in water, while beans and liquid was 
homogenised and analysed together for the other product. 
The 12 samples of powder-based commercial porridges were analysed for the furan content in 
the powder, without further preparation. The 2 ready-to-eat commercial porridges on glass 
jars were only analysed as purchased and not after heat-treatment. 
The analytical method used for monitoring the furan concentrations was static headspace gas 
chromatography/mass spectrometry (GC-MS). All the food samples were analysed at the 
commercial laboratory Eurofins Analytic GmbH Wiertz-Eggert-Jörissen in Hamburg, 
Germany. 
 
2.2.2 Reported LOD, LOQ and measurement uncertainty 
The analytical method used was accredited in accordance with EN/ISO 17025 and validated 
for all relevant sample matrixes tested. The limit of detection (LOD) and limit of 
quantification (LOQ) reported for all matrixes tested were 2 and 5 µg/kg respectively. The 
measurement uncertainty was 80% for furan concentration below 20 µg/kg, while for 
concentrations higher than 20 µg/kg, the measurement uncertainty was 50%. 
 
2.2.3 Results from the Norwegian monitoring of furan concentrations in food 
The results from the analysis of the furan content in different food products sold in the 
Norwegian market in 2008, 2009 and 2011 are presented in Tables 1 to 5. The mean furan 
contents from the national monitoring data are reported as middle bound values, i.e. values 
below the LOQ (< 5 µg/kg) are set to the half of LOQ (2.5 µg/kg). This should be taken into 
consideration when the furan contents in different food samples are compared with 
occurrence data from the EFSA database, as the latter are reported as mean upper bound 
values (all values below LOQ are set to LOQ). 
It should also be noted that considering the given uncertainties in the analyses (see section 
2.2.2) the furan concentrations are presented with too many digits. However, VKM has 
chosen to use the furan concentrations as they were reported by the laboratory to ease tracing 
of the results used in this opinion back to the original data source. 
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2.2.3.1 Jarred baby food 
An overview of the furan content in all jarred baby food samples analysed (both as purchased 
and after heat-treatment) in the Norwegian monitoring survey is shown in Table 1. In order to 
reflect the influence of ingredients on the furan content in jarred baby food, the results have 
been subdivided into different ingredient combinations in a similar way as in the monitoring 
reports of furan levels in food published by EFSA in 2010 and 2011 (EFSA, 2010; 2011). 
However, the different subcategories presented in Table 1 have also been adapted to which 
products that are included in the national food consumption surveys, i.e. the subcategory “fish 
and vegetables”. 
Table 1: Furan content in jarred baby food  
Product (in Norwegian) Furan content (µg/kg) 
Analysed as purchased Analysed after heat-treatment 
Meat and vegetables 
Nestlé Grønnsaker med kalkun 
(6 months) 
24 22 
Nestlé Grønnsaker med lam  
(6 months) 
39 28 
Småfolk Mors lapskaus (6 months) 29 29 
Småfolk Høstgryte med lam (6 months) 21 28 
Hipp Gulrøtter og mais med kalvekjøtt  
(6 months) 
28 27 
Nestlé Favorittgryte kalkun (8 months) 60 48 
Småfolk Kjøttkaker (8 months) 49 51 
Småfolk Pasta bolognese (8 months) 25 42 
Hipp Grønnsak og kyllingrisotto  
(8 months) 
56 63 
Nestlé Potet og kalkungryte (12 
months) 
46 45 
Nestlé Ris og kyllinggryte (12 months) 46 47 
Nestlé Spaghetti bolognese (12 months) 38 38 
Nestlé Lasagne (12 months) 52 114 
Småfolk Frikasé m/viltkjøtt (12 
months) 
32 35 
Nestlé Lapskaus (15 months) 36 27 
 Min. Mean Max. Min. Mean Max. 
Meat and vegetables (N=15) 21 38.7 60 22 42.9 114 
Vitenskapskomiteen for mattrygghet (VKM) 10/404-2 final 
 
17 
 
Product (in Norwegian) Furan content (µg/kg) 
Analysed as purchased Analysed after heat-treatment 
Vegetables  
Helios Gulrot med eple (4 months) 16 21 
Helios Blandede grønnsaker (6 months) 47 56 
 Min. Mean Max. Min. Mean Max. 
Vegetables (N=2)  16 31.5 47 21 38.5 56 
Fruits  
Helios Pære/eple/havre (4 months) <5 - 
Nestlé Frutti Eple Mango (4 months) <5 - 
Nestlé Sviskemos (4 months) 20 - 
Nestlé Pære banan m/yoghurt (6 
months) 
7 - 
 Min. Mean Max. Min. Mean Max. 
Fruits (N=4) <5 8 20 - - - 
Cereal based 
Hipp Grønnsakslasagne (8 months) 50 50 
Hipp Pasta rigatoni (12 months) 65 51 
 Min. Mean Max. Min. Mean Max. 
Cereal based (pasta) (N=2) 50 57.5 65 50 50.5 51 
Fish and vegetables 
Småfolk fiskeboller i hvit saus (8 
months) 
31 30 
 Min. Mean Max. Min. Mean Max. 
Fish and vegetables (N=1) 31 31 31 30 30 30 
Jarred baby food (all products analysed independent of subcategories) 
 Min. Mean Max. Min. Mean Max. 
Jarred baby food (all products) 
(N=24) 
<5 34 65 21 43 114 
 
The results presented in Table 1 show that the furan content in jarred baby food containing 
meat and vegetables, only vegetables or cereals (pastas) were higher than in products 
containing fruits. This is in accordance with the results presented by EFSA in 2011 showing 
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that the mean upper bound furan content in the different baby food subcategories ranged from 
5.3 µg/kg for baby food containing fruits only (N=250) to 49 µg/kg for baby food containing 
only vegetables (N=281). The mean furan content in Norwegian jarred baby food products 
containing meat and vegetables (38.7 µg/kg) was similar to the results reported by EFSA for 
this subcategory (40 µg/kg, N=550). For jarred cereal based (pasta) baby food sold on the 
Norwegian market, it was found a slightly higher furan content than what was reported by 
EFSA (57.5 versus 25 µg/kg), but this could be due to only 2 products being analysed in this 
subcategory. The baby food samples containing fish and vegetables had a mean furan content 
of 31 µg/kg.  
The mean furan content in jarred baby food containing meat and vegetables which was 
analysed after heat-treatment was slightly higher than the same samples analysed as 
purchased. For cereal based (pasta) baby food, the opposite situation was found. It should be 
noted that only a limited number of samples was analysed in this survey, so the results should 
be interpreted with caution. None of the samples of jarred baby food containing fruits only 
were analysed after heat-treatment as such products are usually consumed cold. 
Looking at the furan content in all the 24 samples of jarred baby food, not divided into 
different subcategories, concentrations in the range <5-65 µg/kg, with a mean value (middle 
bound) of 34 µg/kg, was found for products analysed as purchased. For the 20 samples which 
were also analysed after heat-treatment, the furan content varied from 21-114 µg/kg. The 
mean value of all the heat-treated samples was 43 µg/kg. 
 
2.2.3.2 Commercial porridge 
The furan content in 14 commercial porridges for infants and small children sold on the 
Norwegian market in 2011 is shown in Table 2. The 12 powder-based porridges analysed 
have been divided into two subcategories; 8 products with fruits and 4 products without fruits. 
Two products of ready-to-eat porridges on glass jars were also analysed.   
 
Table 2: Furan content in commercial porridges 
Products (in Norwegian) Furan content (µg/kg) 
Powder-based porridges with fruits  
Nestlé usukret musligrøt med pære og banan 38 
Nestlé usukret havregrøt med pære og banan 28 
Nestlé usukret fullkornsgrøt med frukt 32 
Nestlé usukret havregrøt med eple  24  
Småfolk mild fruktgrøt med eple og banan <5 
Småfolk havregrøt med banan, bringebær og yoghurt <5 
Småfolk mild fullkornsgrøt med pære, eple og bringebær <5 
Hipp mild grøt med frukt <5 
Mean value 16.5 
Minimum – Maximum value <5 - 38 
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Products (in Norwegian) Furan content (µg/kg) 
Powder-based porridges without fruits  
Nestlé usukret hvetegrøt med havre <5 
Småfolk kveldsgrøt med ris og pasta <5 
Hipp mild fullkornsgrøt <5 
Hipp fullkornsgrøt multikorn  <5 
Mean value 2.5 
Minimum – Maximum value <5 - <5 
Ready-to-eat porridges on glass jars  
Småfolk mild risgrøt med mango, banan og pære <5 
Småfolk havregrøt med eple og pære <5 
Mean value 2.5 
Minimum – Maximum value <5 - <5 
 
The results presented in Table 5 show that 4 of all the commercial porridges analysed had 
furan contents above the LOQ. The mean middle bound furan content in the powder-based 
porridges with fruits was found to be 16.5 µg/kg. None of the powder-based porridges without 
fruits and the ready-to-eat porridges in glass jars had furan contents above LOQ. The mean 
furan content (middle bound) in these two subcategories of commercial porridges was 2.5 
µg/kg. 
Powder-based porridges with fruits were expected to have a higher furan content than 
powder-based porridges without fruits as furan have been found in several samples of dried 
fruits and vegetables (DTU, 2009).  
 
2.2.3.3 Canned and jarred vegetables 
The furan content in the four analysed products with canned and jarred vegetables is shown in 
Table 3. 
 
Table 3: Furan content in canned and jarred vegetables 
Manufacturer Product (in Norwegian) Furan content (µg/kg) 
Analysed as 
purchased 
Analysed after 
heat-treatment 
Eldorado Grovhakkede tomater, hermetiske <5 <5 
Eldorado Hele/skrelte tomater, hermetiske 6 <5 
Euroshopper Sylteagurk <5 - 
Euroshopper Rødbeter <5 - 
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Mean value 3.4 2.5 
Minimum – Maximum value <5-6 <5 
 
The mean furan content (middle bound) in canned and jarred vegetables, was found to be 3.4 
µg/kg, with the highest value being 6 µg/kg in canned tomatoes. The results are in accordance 
with the results presented by EFSA in 2011 where the mean furan content in vegetables were 
6.9-9.6 µg/kg (N=192). The 2 products with pickled vegetables were not analysed after heat-
treatment, as they are usually consumed cold.  
 
2.2.3.4 Jarred tomato sauces 
Table 4 shows the furan content in the eight different jarred tomato sauces analysed.  
 
Table 4: Furan content in jarred tomato sauces 
Manufacturer Product (in Norwegian) Furan content (µg/kg) 
Analysed as 
purchased  
Analysed after 
heat-treatment 
Dolmio Classico (tomatsaus til pasta) 7 <5 
Dolmio Pastasaus ekstra hvitløk 10 5 
Uncle Bens Sweet and sour <5 <5 
Uncle Bens Korma sauce 8 6 
Barilla Basilico Tomato-sauce with basilico 
for pasta 
12 7 
Sopps Tomato-sauce for pasta 16 9 
Santa Maria Taco saus, Medium 11 - 
Old El Paso Taco saus, Medium 7 - 
Mean value 9.2 5.3 
Minimum – Maximum value <5-16 <5-9 
 
The furan content in the eight jarred tomato sauces analysed as purchased ranged from <5 to 
16 µg/kg, with a mean furan content (middle bound) of 9.2 µg/kg. Slightly lower furan 
concentrations were found in the samples analysed after heat-treatment of the same products, 
with a mean middle bound furan content of 5.3 µg/kg. The results are in the same order of 
magnitude as the results presented for sauces by EFSA in 2011 where the mean furan content 
was 8.3-11 µg/kg (N=271). The two products with taco sauce were not analysed after heat-
treatment.  
 
2.2.3.5 Baked beans 
The furan content in the two analysed products with baked beans is shown in Table 5. 
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Table 5: Furan content in baked beans 
Manufacturer Product (in Norwegian) Furan content (µg/kg) 
Analysed as 
purchased 
Analysed after 
heat-treatment 
Eldorado Salat og grytebønner, hermetiske 6 <5 
Coop Tomatbønner 20 13 
Mean value 13 7.8 
Minimum – Maximum value 6-20 <5-13 
 
The mean furan content in the two products with baked beans analysed as purchased was 13 
µg/kg. Slightly lower concentrations were found for the samples that were analysed after heat-
treatment, with a mean furan content (middle bound) of 9 µg/kg. The results for baked beans 
are somewhat lower compared with the results presented by EFSA in 2011 where a mean 
furan content of 22-24 µg/kg was found (N=57). However, it should be noted that the 
Norwegian results are based on analyses of only two products. 
 
3 Exposure characterisation  
3.1 Dietary exposure to furan  
3.1.1 Norwegian data on furan contents in food used in the exposure assessment 
The furan contents measured in various food products sold in the Norwegian market in 2008 
and 2009 has been analysed both as purchased and after heat-treatment (Table 1-4). The furan 
content in powder based and ready-to-eat commercial porridges was only analysed as 
purchased (Table 2). For the exposure assessment in this opinion, VKM has chosen to use 
only the furan concentrations measured in products analysed as purchased, based on the 
Norwegian monitoring data. This decision is based on the high measurement uncertainty 
described in section 2.2.2 and the fact that the furan contents in identical food products 
analysed as purchased and after heat-treatment are of the same order of magnitude, except for 
a few products.  
The calculated furan exposures in the exposure characterisation are based on the mean middle 
bound value of furan (analysed as purchased) found in the different food categories included 
in the Norwegian monitoring data (see section 2.2.3). 
The two food categories canned and jarred vegetables and baked beans have been merged in 
the exposure calculations to simplify the linkage between the occurrence and food 
consumption data. The mean middle bound furan content in the 6 products analysed was 
calculated to 6.6 µg/kg (not shown), using the half of LOQ (2.5 µg/kg) for the three samples 
below LOQ. Consumption data on canned mackerel fillet in tomato sauce have been included 
in the exposure calculations for the food category jarred sauces, even though the Norwegian 
monitoring data only include occurrence data on jarred dinner sauces (see section 2.2.3.3). 
The questionnaires used in the dietary surveys are not able to divide between commercial 
porridge with or without fruits. VKM has chosen a conservative approach in this risk 
assessment, where it is assumed that all commercial porridge consumed is porridge with 
fruits. Porridge with fruits has been found to have more than three times the amount of furan 
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compared with porridge without fruit. There is no data on ready-to-eat commercial porridges 
in the national food consumption surveys; therefore these products have not been included in 
the exposure calculations. 
 
3.1.2 International data on furan contents in food used in the exposure assessment 
National data on all relevant furan sources from food and beveragess is not available. For the 
exposure calculations of furan from other relevant sources than described in section 2.2, 
VKM has used the EFSA database on occurrence data on furan in heat-treated commercial 
food products (EFSA, 2011). If considered relevant, occurrence data on furan reported in the 
scientific literature or in research projects has also been used (DTU, 2009). It should be noted 
that the mean upper bound furan values reported in the EFSA database have been used in the 
exposure calculations, whereas middle bound furan values have been used for the national 
monitoring data and for the data from the research project carried out at the Danish Technical 
University National Food Institute. 
VKM is aware of a comprehensive set of analytical data on furan contents in various food 
samples reported in the scientific literature and from other governmental agencies (e.g. 
Kuballa 2007; Zoller et al., 2007; Becalski et al., 2010; FSA, 2012; Lachenmeier et al., 
2012). However, for the exposure characterisation in this VKM opinion, it was decided to 
emphasize the national monitoring data on furan and the occurrence data available in the 
EFSA furan database. 
A description of the food categories and respective furan concentrations that have been 
included in the exposure calculations in this opinion from VKM is given in the following 
sections.  
 
3.1.2.1  Infant formula 
No occurrence data for furan content in infant formula sold in the Norwegian market is 
available. The calculated furan exposures have therefore been based on the mean furan 
content (upper bound) in dry infant formulae of 3.2 µg/kg (N=11), as reported in the most 
recent EFSA monitoring report (EFSA, 2011). A conversion factor of 0.119 was applied to 
the food consumption data, as they were reported for liquid infant formula (prepared), to 
convert them back to dry infant formulae and to map the consumption with the occurrence 
data for furan from the EFSA report (EFSA, 2009; 2010). 
 
3.1.2.2  Canned fruits 
No data on the furan content is available for products sold in the Norwegian market. The 
mean furan content (upper bound) of 6.4 µg/kg (N=142), reported for the product category 
fruits in the most recent monitoring report from EFSA (EFSA, 2011), has been used in the 
exposure calculations. 
 
3.1.2.3  Milk products 
Since no furan concentration data for milk products sold in the Norwegian market is 
available, the concentration data reported by EFSA was used in the exposure calculations. 
The mean furan content (upper bound) of 5.6 µg/kg (N=64) reported for milk based processed 
food in the most recent monitoring report from EFSA (EFSA, 2011) has been linked to 
Norwegian consumption data for milk products (yoghurts, cheeses). It should, however, be 
noted that there is no detailed information on which foods have been included in the food 
category milk products in the EFSA report. Milk as such was not included as a relevant furan 
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source, as all milk samples present in the database on existing data for furan in food from the 
EU-project FURAN-RA (SSPE-CT-2006-44393) contained furan levels below the LOQ 
(VUA, 2007).  
 
3.1.2.4  Chocolate and sweets 
The mean furan content (upper bound) of 6 µg/kg (N=61) for the food category sweets in the 
EFSA report from 2011 has been used to calculate the furan exposure based on the national 
consumption data for chocolate and sweets in the exposure calculations. 
 
3.1.2.5  Coffee 
Since there is no data available on the furan content in Norwegian coffee, the occurrence data 
for coffee brew, subcategorised according to different coffee types presented in the EFSA 
report from 2011 are used in the exposure calculations. From the EFSA data, it could be 
observed that the mean furan content was considerably lower for coffee brew samples than for 
the respective solid coffee samples (see Table 5 and 8 in EFSA, 2011). The mean furan 
contents (upper bound) in coffee instant brew of 7 µg/L (N=15) and in coffee, roasted ground, 
brew of 42 µg/L (N=51) have been linked with the consumption data for coffee in the national 
consumption surveys.  
 
3.1.2.6  Breakfast cereals 
Results from a project carried out by the Danish Technical University National Food Institute 
on behalf of EFSA showed high contents of furan in breakfast cereals, products highly 
consumed by children. A total of 11 breakfast cereal products, including 2 honey-coated 
products were analysed in the Danish project. The furan concentrations ranged from <2.4 to a 
high value of 387 µg/kg in one of the honey-coated products (DTU, 2009). The national food 
consumption data include information on both sweet breakfast cereals (Honny korn, Frosties, 
Chocofrokost and Ricekrisp) and ordinary breakfast cereals. To link the national food 
consumption data to the Danish occurrence data, VKM has used the mean middle bound furan 
contents in the 2 honey-coated breakfast cereals of 224 µg/kg (N=2) and in the ordinary 
breakfast cereals of 20.7 µg/kg (N=9) in the exposure calculations.  
These furan values reported in the Danish project were chosen rather than the upper bound 
value of 18 µg/kg (N=190) reported for cereal products in the EFSA furan database (EFSA, 
2011), since the breakfast cereal products in the Norwegian market are assumed to be more 
similar to the products in the Danish market, than in the other EU countries.   
 
3.1.2.7  Snacks and crisps 
Snacks and crisps are other food products analysed in the Danish furan project. A total of 9 
products were analysed and the furan concentrations varied from <2.4 - 90.6 µg/kg, of which 
the highest concentration was found in popcorn. The mean middle bound furan content in the 
Danish investigation was calculated to be 24.7 µg/kg. This is somewhat higher, compared to 
the furan data for snacks and crisps presented by EFSA in 2011, where a mean furan content 
(upper bound) of 10 µg/kg was reported (N=133). It was decided to use the mean furan 
content from the Danish furan project (DTU, 2009) in the exposure calculations since snacks 
and crisps sold in the Danish and Norwegian markets are considered to be more similar than 
all products included for this product category in the EFSA furan database.  
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3.1.2.8  Overview of the mean furan contents in the food categories included in the 
exposure calculations 
An overview of the mean furan contents used in the exposure calculations for the various food 
categories included in this opinion is presented in Table 6.  
Table 6: Mean furan content in the various food categories included in the exposure calculations. 
Food category N Furan content 
(µg/kg) 
Source 
Jarred baby food (meat and vegetables) 15 38.7a National monitoring data (analysed as 
purchased) 
Jarred baby food (vegetables) 2 31.5a National monitoring data (analysed as 
purchased) 
Jarred baby food (fruits) 4 8a National monitoring data (analysed as 
purchased) 
Jarred baby food (cereal based (pasta)) 2 57.5a National monitoring data (analysed as 
purchased) 
Jarred baby food (fish and vegetables) 1 31a National monitoring data (analysed as 
purchased) 
Canned and jarred vegetables 
(including baked beans) 
6 6.6a National monitoring data (analysed as 
purchased) 
Jarred tomato sauces 8 9.2a National monitoring data (analysed as 
purchased) 
Commercial porridges (powder based 
containing fruits) 
8 16.5a National monitoring data (analysed as 
purchased in powder) 
Commercial porridges (powder based 
without fruits) 
4 2.5a National monitoring data (analysed as 
purchased in powder) 
Infant formula 11 3.2b EFSA database on furan levels (2011) 
Canned fruits 142 6.4b EFSA database on furan levels (2011) 
Milk products (yoghurts, cheeses) 64 5.6b EFSA database on furan levels (2011) 
Chocolate and sweets 61 6b EFSA database on furan levels (2011) 
Coffee, roasted ground, brew 51 42b EFSA database on furan levels (2011) 
Coffee, instant, brew 15 7b EFSA database on furan levels (2011) 
Sweet breakfast cereals  2 224c DTU report (2009)  
Breakfast cereals 9 20.7c DTU report (2009) 
Snacks and crisps 9 24.7c DTU report (2009) 
a
 Mean middle bound values from the Norwegian monitoring data. 
b
 Mean upper bound values from the EFSA furan database (EFSA, 2011). 
c
 Mean middle bound values from the Danish furan report (DTU, 2009). 
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3.1.3  Methodological description of the national consumption surveys 
In the present opinion, the calculated furan exposures from food and beverages are based on 
data from the nationally representative food consumption surveys; Spedkost, Småbarnskost, 
Ungkost and Norkost. The consumption for each relevant food and food category in the 
dietary surveys were multiplied with the corresponding mean furan concentrations as 
described in section 3.1.1 and 3.1.2 and totalled for each individual.  
A short description of the consumption surveys and the different methodologies used is given 
below:  
• 6-month-old infants; Spedkost 2006-2007 is based on a semi-quantitative frequency 
questionnaire. The study was conducted in 2006, and a total of 1986 6-month-old 
infants participated (Øverby et al., 2008). 
• 1-year-old infants; Spedkost 2006-2007 is based on a semi-quantitative food 
frequency questionnaire. In addition to predefined household units, food amounts were 
also estimated from photographs. The study was conducted in 2007, and a total of 
1635 1-year-old infants participated (Øverby et al., 2009).  
• 2-year-old children; Småbarnskost 2007 is based on a semi-quantitative food 
frequency questionnaire. In addition to predefined household units, food amounts were 
also estimated from photographs. The study was conducted in 2007, and a total of 
1674 2-year-olds participated (Kristiansen et al., 2009). 
• 4-year-old children; Ungkost 2000 is based on a 4-day food intake registration with a 
precoded food diary. Food amounts were presented in predefined household units or 
as portions estimated from photographs (Pollestad et al., 2002). The study was 
conducted in 2001, and 391 4-year-olds participated.  
• 9- and 13-year-old children/adolescents; Ungkost 2000 is based on a 4-day food 
intake registration with a precoded food diary. Food amounts were presented in 
predefined household units or as portions estimated from photographs (Øverby and 
Andersen, 2002). The study was conducted in 2000 and 810 9-year-old children and 
1005 13-year-old adolescents participated. 
• Adults; Norkost 3 is based on two 24-hour recalls by telephone at least one month 
apart. Food amounts were presented in household measures or estimated from 
photographs (Totland et al., 2012). The study was conducted in 2010/2011 and 1787 
adults aged 18-70 years participated. 
 
Daily consumption of foods containing furan was computed by using food databases in the 
software system (KBS) developed at the Institute of Basic Medical Sciences, Department of 
Nutrition, at the University of Oslo. The food databases are mainly based on various versions 
of the official Norwegian Food Composition Table (Rimestad et al., 2000, The Norwegian 
Food Composition Table 1995 and 2006). The three dietary surveys that are the basis for this 
risk assessment were conducted at three different time points, Ungkost-2000 in 2000-2001, 
Sped- and Småbarnskost in 2007 and the data for Norkost 3 were collected in 2010-2011. The 
national furan analyses were conducted in the time period 2008-2011.  
 
3.1.3.1  Breastfed and non-breastfed infants  
The exposure assessment for furan in the Norwegian population has been performed on two 
different groups in the dietary surveys for infants 6 and 12 months of age. The furan exposure 
has been calculated for all participants, both breastfed and non-breastfed, and for the group of 
infants that were not breastfed. The calculation was performed to see if the two groups varied 
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in consumption of furan-containing food products and if that could lead to higher exposure 
estimates in one of the groups. 
 
3.1.3.2  Consumers only 
The tables describing the consumption of food categories in each age group are based on 
persons who actually reported a consumption of the relevant food (consumers only) in the 
dietary survey.  
Furthermore, the risk assessment has one table for each age group where the furan exposure 
for the consumers of the most important furan source in that age group is presented. The furan 
exposure is calculated in consumers only of this most important age specific furan source, 
with an additional contribution from all relevant food categories.  
 
3.1.3.3 Body weight 
The mean body weights reported for the different age groups in the dietary surveys have been 
used to calculate the exposure in mg furan/kg bw. An overview of these body weights is given 
in Table 7.   
 
Table 7: Mean body weight of different age groups in the Norwegian population. 
Age Mean body weight (kg) 
6-month-old infants 8 
12-month-old infants 9.9 
24-month-old children 12.8 
4-year-old children 18 
9-year-old children 32 
13-year-old adolescents 49.5 
Adults aged 18-70 years 77.5 
 
3.1.4  Dietary exposure to furan in 6-month-old infants (Spedkost 2006) 
3.1.4.1  Jarred baby food 
An overview of the consumption of different subcategories jarred baby food and exposure to 
furan in 6-month-old infants is given in Table 8. The mean and 95 percentile consumptions of 
jarred baby food are calculated based on the frequency of consumption reported in the dietary 
survey and the amount of baby food assumed to be consumed per meal (1/4 jar ≈ 50 g) 
(Øverby et al., 2008). 
The furan exposures have been calculated based on the mean furan contents in the different 
subcategories of jarred baby food analysed as purchased (see Table 1 and 6) and on the mean 
and 95 percentile consumptions shown in Table 8. A calculation of the furan exposure from 
the total of jarred baby food consumed has also been included, based on the individual 
consumption data reported for 6-month-old infants. All values in Table 8 are given for 
consumers only among all participants (n=1986) in the dietary survey. 
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Table 8: Consumption of different subcategories jarred baby food and exposure to furan in 6-month-old infants 
(n=1986). Values for consumers only within each subcategory are given. 
  Frequency of 
consumption, 
times/day 
Amount 
consumed 
per meal, g 
Consumption, 
g/day 
Furan exposure,  
µg/kg bw/daya 
Baby food 
subcategory  
Number of 
consumers  
(% of 1986) 
Mean 
(SD) 
95 
percentile  
1/4  jar of baby 
food 
Mean 
(SD) 
95 
percentile  
Mean  95 
percentile  
Meat and 
vegetables 
578 (29) 0.7 (0.4) 1.0 50 37 (19) 50 0.18 0.24 
Vegetables  479 (24) 0.6 (0.4) 1.0 50 30 (18) 50 0.12 0.20 
Fish and 
vegetables 
107 (5) 0.5 (0.3) 1.0 50 26 (16) 50 0.10 0.19 
Fruitsb 1028 (52) 0.9 (0.7) 2.0 50 45 (33) 100 0.05 0.10 
Total jarred 
baby food  
1220 (61) 1.4 (0.9) 3.0 50 70 (47) 150 0.18 0.45 
a Calculated based on the mean body weight of 8.0 kg reported for 6-month-old infants (see Table 7). 
b Include berries but not juice. 
 
The results show that jarred baby food containing meat and vegetables gave the highest 
contribution with mean and 95 percentile furan exposures of 0.18 and 0.24 µg/kg bw/day, 
respectively. The mean furan exposure from the total of jarred baby food consumed by 6-
month-old infants was 0.18 µg/kg bw/day, while the exposure at the 95 percentile was found 
to be 0.45 µg/kg bw/day.  
Similar calculations have been carried out for consumers only of non-breastfed participants in 
the dietary survey (n=397). The mean and 95 percentile furan exposures from consumption of 
the total of jarred baby food in this group of 6-month-old infants was found to be 0.23 and 
0.49 µg/kg bw/day, respectively (see Table A1 in Appendix I).  
 
3.1.4.2  Infant formula 
The furan exposure from consumption of infant formula in 6-month-old infants is shown in 
Table 9. The furan exposure has been calculated based on the mean furan content in dry infant 
formula reported in the EFSA database (see Table 6) and on the mean and 95 percentile 
consumption of infant formula reported for all participants and for the non-breastfed infants in 
the dietary survey (consumers only for both groups).  
 
The results presented in Table 9 show a mean furan exposure from consumption of infant 
formula of 0.02 µg/kg bw/day for consumers only among all participants. The exposure at the 
95 percentile was 0.05 µg/kg bw/day. For the group of infants that were not breastfed, 
respective mean and 95 percentile furan exposures of 0.03 and 0.06 µg/kg bw/day were 
calculated.  
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Table 9: Furan exposure from dry infant formula in 6-month-old infants (n=1986) and among non-breastfed 
participants (n=397). Values are given for consumers only.  
  Consumption, g/day Furan exposure,  
µg/kg bw/daya,b 
Infant formula Number of 
consumers (%) 
Mean 
(SD) 
95 
percentile  
Mean  95 
percentile  
Consumers only among all 
participants (n=1986) 
728 (37) 61 (40)c 114c 0.02 0.05 
Consumers only among non-
breastfed participants (n=397) 
388 (98) 84 (31)c 143c 0.03 0.06 
a Calculated based on the mean body weight of 8.0 kg reported for 6-month-old infants (see Table 7). 
b Based on a mean furan content in dry infant formula of 3.2 µg/kg (EFSA, 2011). 
c Conversion factor from wet to dry infant formula of 0.119 was used (EFSA, 2009). 
 
Table 9 shows values for dry infant formula. Converted to liquid volume the consumption of 
61 g of dry infant formula equals 513 g of ready-to-drink infant formula. 
 
3.1.4.3  Commercial powder-based porridge  
The furan exposure from consumption of powder-based commercial porridge in 6-month-old 
infants is shown in Table 10. The furan exposure has been calculated based on the mean furan 
contents in porridge powder with fruits and without fruits (see Table 2) and on the mean and 
95 percentile consumption of porridge reported for all participants and for the non-breastfed 
infants in the dietary survey (consumers only for both groups). 
 
Table 10: Furan exposure from commercial powder-based porridge in 6-month-old infants (n=1986) and non-
breastfed participants (n=397). Values are given for consumers only. Furan exposure is shown in two scenarios, where 
all porridge powder is assumed either with fruits (16.5 µg furan/kg) or without fruits (2.5 µg furan/kg). 
  Consumption, g/day Furan exposure,  
µg/kg bw/daya 
Type of commercial porridge Number of 
consumers (%) 
Mean (SD) 95 
percentile  
Mean  95 
percentile  
Consumers only among all participants (n=1986) 
Porridge powder  
with fruitsb 
1652 (83) 32 (31) 89 0.07 0.18 
Porridge powder without 
fruitsb 
1652 (83) 32 (31) 89 0.01 0.03 
Consumers only among non-breastfed participants (n=397) 
Porridge powder  
with fruitsb 
369 (93) 44 (36) 104 0.09 0.21 
Porridge powder without 
fruitsb 
369 (93) 44 (36) 104 0.01 0.03 
a Calculated based on the mean body weight of 8.0 kg reported for 6-month-old infants (see Table 7). 
b Amount porridge powder derived from standardised recipes in the KBS software.  
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The results in Table 10 show that the respective mean and 95 percentile furan exposures from 
consumption of commercial powder-based porridge with fruits were 0.07 and 0.18 µg/kg 
bw/day for consumers only among all participants. Mean and 95 percentile furan exposures of 
0.09 and 0.21 µg/kg bw/day were calculated for the group of infants that was not breastfed. 
Consumption of powder-based commercial porridges without fruits resulted in mean and 95 
percentile furan exposures of 0.01 and 0.03 µg/kg bw/day for consumers only of all 
participants. In the group of infants that were not breastfed, mean and 95 percentile furan 
exposures from consumption of porridges without fruits were 0.01 and 0.03 µg/kg bw/day, 
respectively. 
Table 10 shows values for dry porridge powder. To get a picture of how much powder is 
needed to get the mean ready-to-eat volume of porridge among all participants in the dietary 
survey; 32 g of porridge powder equals 163 g of ready-to-eat porridge.  
 
3.1.4.4  Furan exposure in 6-month-old infants 
Three different estimates for the furan exposure in Norwegian 6-month-old infants are shown 
in Table 11 (all participants) and 12 (non-breastfed participants). First an estimate based on 
individual consumption data for the participants in the dietary survey with a reported 
consumption of jarred baby food only (also presented in Table 8 and Table A1). This food 
category was found to be the most important furan source in this age group. Secondly, an 
estimate for the consumers of jarred baby food with an additional contribution from infant 
formula and commercial powder-based porridge with fruits was calculated (see Table 9 and 
10). Finally, an estimate that shows the average furan exposure from jarred baby food, infant 
formula and commercial powder-based porridge with fruits for all participants (Table 11) and 
for all non-breastfed participants (Table 12) in the dietary survey, was calculated.  
 
Table 11: Furan exposure in 6-month-old infants for consumers of jarred baby food (n=1220), for consumers of 
jarred baby food with an additional contribution from infant formula and commercial powder-based porridge 
(n=1220) and average furan exposure in all participants (n=1986).  
 Number of 
consumers 
(%) 
Mean,  
µg/kg bw/daya,b 
(SD) 
95 percentile, 
µg/kg bw/daya,b 
Consumers of jarred baby foodc 1220 (61) 0.18 (0.14) 0.45 
Consumers of jarred baby food with an 
additional contribution from infant 
formula and commercial powder-based 
porridge  
1220 (61) 0.26 (0.18) 0.58 
Average furan exposure from jarred 
baby food, infant formula and 
commercial powder-based porridge in all 
participants 
1986 (100) 0.17 (0.18) 0.51 
a Calculated based on the mean body weight of 8.0 kg reported for 6-month-old infants (see Table 7). 
b Based on a mean furan content in jarred baby food, infant formula and porridge powder with fruits as reported in Table 6. 
c Exposure estimate presented in Table 8. 
 
The results in Table 11 show that 6-month-old consumers of jarred baby food have mean and 
95 percentile furan exposures of 0.18 and 0.45 µg/kg bw/day, respectively. Taking into 
account the additional contribution from infant formula and commercial powder-based 
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porridge with fruits, the mean and 95 percentile furan exposures increase to respective 0.26 
and 0.58 µg/kg bw/day. In the third estimate showing the average furan exposure from jarred 
baby food, infant formula and commercial powder-based porridge with fruits for all 
participants in the dietary survey, respective mean and 95 percentile values of 0.17 and 0.51 
µg/kg bw/day were found. 
 
Table 12: Furan exposure in 6-month-old non-breastfed infants for consumers of jarred baby food (n=331), for 
consumers of jarred baby food with an additional contribution from infant formula and commercial powder-based 
porridge (n=331) and average furan exposure in all non-breastfed participants (n=397).  
 Number of 
consumers 
(%) 
Mean,  
µg/kg bw/daya,b 
(SD) 
95 percentile, 
µg/kg bw/daya,b 
Consumers of jarred baby foodc 331 (83) 0.23 (0.14) 0.49 
Consumers of jarred baby food with an 
additional contribution from infant formula 
and commercial powder-based porridge 
331 (83) 0.35 (0.17) 0.65 
Average furan exposure from jarred baby 
food, infant formula and commercial 
powder-based porridge in all non-breastfed 
participants 
397 (100) 0.31 (0.19) 0.62 
a Calculated based on the mean body weight of 8.0 kg reported for 6-month-old infants (see Table 7). 
b Based on a mean furan content in jarred baby food, infant formula and porridge powder with fruits as reported in Table 6.  
c Exposure estimate presented in Table A1. 
 
Table 12 shows that the mean and 95 percentile furan exposures in the group of 6-month-old 
non-breastfed consumers of jarred baby food were calculated to 0.23 and 0.49 µg/kg bw/day, 
respectively. In the estimate which includes an additional contribution from infant formula 
and commercial powder-based porridge with fruits, the mean and 95 percentile furan 
exposures increase to 0.35 and 0.65 µg/kg bw/day. The average furan exposures from jarred 
baby food, infant formula and commercial powder-based porridge with fruits in all non-
breastfed participants resulted in mean and 95 percentile values of 0.31 and 0.62 µg/kg 
bw/day, respectively. 
 
The relative contribution from various food categories to the furan exposure in 6-month-old 
infants is illustrated in Figure 2 (all participants, n=1986) and 3 (all non-breastfed 
participants, n=397). 
 
Vitenskapskomiteen for mattrygghet (VKM) 10/404-2 final 
 
31 
 
 
Figure 2: The relative contribution from various food categories (jarred baby food, porridge powder and infant 
formula) to furan exposure in 6-month-old infants (all participants, n=1986).  
 
 
Figure 3: The relative contribution from various food categories (jarred baby food, porridge powder and infant 
formula) to furan exposure in 6-month-old infants (all non-breastfed participants, n=397).  
 
Consumption of jarred baby food resulted in the largest relative contribution to the furan 
exposure in 6-month-old infants, both among all participants in the dietary survey (61%) and 
in the group of non-breastfed participants (64%). The relative contribution from porridge 
powder was larger in the group of all participants (33%) compared to the non-breastfed 
participants (26%), while the relative contribution from infant formula was largest in non-
breastfed infants (10%). 
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3.1.5  Dietary exposure to furan in 12-month-old infants (Spedkost 2007) 
3.1.5.1  Jarred baby food 
An overview of the consumption of different subcategories jarred baby food and exposure to 
furan in 12-month-old infants is shown in Table 13. The furan exposures have been calculated 
based on the mean furan contents in jarred baby food analysed as purchased (see Table 1 and 
6) and on the mean and 95 percentile consumption of the different subcategories of jarred 
baby food reported in the dietary survey. A calculation of the furan exposure from the total of 
jarred baby food consumed has also been included, based on the individual consumption data 
reported for 12-month-old infants. All values in Table 13 are given for consumers only among 
all participants (n=1986) in the dietary survey. 
 
Table 13: Consumption of different subcategories jarred baby food and exposure to furan in 12-month-old infants 
(n=1635). Values for consumers only within each subcategory are given. 
  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Baby food subcategory Number of consumers 
(% of 1635) 
Mean (SD) 95 percentile Mean 95 percentile 
Meat and vegetables 1185 (72) 112 (82) 249 0.44 0.97 
Fish and vegetables 585 (36) 54 (31) 139 0.17 0.43 
Cereal based 265 (16) 53 (33) 139 0.31 0.80 
Vegetables 144 (9) 55 (39) 183 0.17 0.58 
Fruitsb 1157 (71) 83 (78) 226 0.07 0.18 
Total jarred baby food  1436 (88) 196 (155) 447 0.56 1.30 
a Calculated based on the mean body weight of 9.9 kg reported for 12-month-old infants (see Table 7). 
b Includes berries but not juice. 
 
The calculations presented in Table 13 show that jarred baby food containing meat and 
vegetables gave the highest contribution to the furan exposure with mean and 95 percentile 
values of 0.44 and 0.97 µg/kg bw/day, respectively. The mean furan exposure from the total 
of jarred baby food consumed by this age group was 0.56 µg/kg bw/day, while the exposure at 
the 95 percentile was 1.30 µg/kg bw/day.  
Similar calculations have been performed for consumers only of non-breastfed participants in 
the dietary survey (n=881). The furan exposures from consumption of the total of jarred baby 
food in this group of infants were in the same order of magnitude as what was calculated for 
all participants, with mean and 95 percentile furan exposures of 0.58 and 1.33 µg/kg bw/day, 
respectively (see Table A2 in Appendix I).  
 
3.1.5.2  Infant formula 
The furan exposure from consumption of infant formula, in 12-month-old infants, is shown in 
Table 14. The furan exposure has been calculated based on the mean upper bound furan 
content in dry infant formula reported in the EFSA database (see Table 6) and on the mean 
and 95 percentile consumption of infant formula reported for all participants and for the non-
breastfed infants in the dietary survey (consumers only for both groups).  
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Table 14: Furan exposure from dry infant formula in 12-month-old infants (n=1635) and among non-breastfed 
participants (n=881). Values are given for consumers only.  
  Consumption, g/day Furan exposure, 
µg/kg bw/daya,b 
Infant formula Number of 
consumers (%) 
Mean 
(SD) 
95 
percentile  
Mean  95 
percentile  
Consumers only among all 
participants (n=1635) 
654 (40) 43 (27)c 86c 0.01 0.03 
Consumers only among non-
breastfed participants (n=881)  
516 (59) 47 (27)c 86c 0.02 0.03 
a Calculated based on the mean body weight of 9.9 kg reported for 12-month-old infants (see Table 7). 
b Based on a mean furan content in infant formula of 3.2 µg/kg (EFSA, 2011). 
c Conversion factor from wet to dry infant formula of 0.119 was used (EFSA, 2009). 
 
The calculations resulted in a mean furan exposure from consumption of infant formula of 
0.01 µg/kg bw/day for consumers only among all participants. The exposure at the 95 
percentile was 0.03 µg/kg bw/day. The group of infants that were not breastfed had mean and 
95 percentile furan exposures of 0.02 and 0.03 µg/kg bw/day, respectively.  
Table 14 shows values for dry infant formula. Converted to liquid volume the consumption of 
43 g of dry infant formula equals 360 g of ready-to-drink infant formula. 
 
3.1.5.3 Milk products 
The furan exposure from consumption of milk products (yoghurt, cheese) in 12-month-old 
infants is presented in Table 15. Milk as such has not been included as a relevant furan source 
(VUA, 2007). The furan exposure has been calculated based on the mean upper bound furan 
content in milk products reported in the EFSA database (see Table 6) and on the mean and 95 
percentile consumption of milk products (yoghurt, cheese) reported for all participants and for 
the non-breastfed infants in the dietary survey (consumers only for both groups).  
 
Table 15: Furan exposure from milk products (yoghurt, cheese) in 12-month-old infants (n=1635) and among non-
breastfed participants (n=881). Values are given for consumers only.  
  Consumption, g/day Furan exposure, 
µg/kg bw/daya,b 
Milk products (yoghurt, cheese) Number of 
consumers (%) 
Mean 
(SD) 
95 
percentile  
Mean  95 
percentile  
Consumers only among all 
participants (n=1635) 
1494 (91) 57 (56) 154 0.03 0.09 
Consumers only among non-
breastfed participants (n=881)  
821 (93) 61 (55) 161 0.03 0.09 
 
Consumption of milk products (yoghurt, cheese) was reported for up to 93% of 12-month-old 
infants. The mean furan exposure was 0.03 µg/kg bw/day both for consumers only among all 
participants and in the group of participants that were not breastfed. The 95 percentile furan 
exposures also showed similar results for the two groups of participants, with an exposure of 
0.09 µg/kg bw/day. 
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3.1.5.4 Commercial powder-based porridge 
The furan exposure from consumption of commercial powder-based porridge in 12-month-old 
infants is shown in Table 16. The furan exposure has been calculated based on the mean furan 
contents in porridge powder with fruits and without fruits (see Table 2) and on the mean and 
95 percentile consumption of commercial porridge reported for all participants and for the 
non-breastfed infants in the dietary survey (consumers only for both groups). 
 
Table 16: Furan exposure from commercial powder-based porridge in 12-month-old infants (n=1635) and non-
breastfed participants (n=881). Values are given for consumers only. Furan exposure is shown in two scenarios, where 
all porridge is assumed either with fruits (16.5 µg furan/kg) or without fruits (2.5 µg furan/kg). 
  Consumption, g/day Furan exposure,  
µg/kg bw/daya 
Type of commercial 
porridge 
Number of consumers 
(%) 
Mean 
(SD) 
95 
percentile  
Mean  95 
percentile  
Consumers only among all participants (n=1635) 
Porridge powder  
with fruitsb 
1348 (82) 69 (51) 166 0.12 0.28 
Porridge powder without 
fruitsb 
1348 (82) 69 (51) 166 0.02 0.04 
Consumers only among non-breastfed participants (n=881) 
Porridge powder  
with fruitsb 
713 (81) 66 (46) 140 0.11 0.23 
Porridge powder without 
fruitsb 
713 (81) 66 (46) 140 0.02 0.04 
a Calculated based on the mean body weight of 9.9 kg reported for 12-month-old infants (see Table 7). 
b Amount porridge powder derived from standardised recipes in the KBS software.  
 
The calculations show mean and 95 percentile furan exposures from consumption of 
commercial powder-based porridge with fruits of 0.12 and 0.28 µg/kg bw/day, respectively, 
for consumers only among all participants. In the group of consumers that were not breastfed, 
mean and 95 percentile furan exposures of 0.11 and 0.23 µg/kg bw/day were found. 
Consumption of powder-based commercial porridges without fruits resulted in mean and 95 
percentile furan exposures of 0.02 and 0.04 µg/kg bw/day for consumers only among all 
participants. The respective values in the group of infants that were not breastfed were 0.02 
and 0.04 µg/kg bw/day. 
Table 16 shows values for dry porridge powder. To get a picture of how much powder is 
needed to get the mean ready-to-eat volume of porridge among all participants in the dietary 
survey; 69 g of porridge powder equals 321 g of ready-to-eat porridge. 
 
3.1.5.5 Furan exposure in 12-month-old infants 
Three different estimates for the furan exposure in Norwegian 12-month-old infants are 
shown in Table 17 (all participants) and 19 (non-breastfed participants). First, an estimate 
based on individual consumption data for the participants in the dietary survey with a reported 
consumption of jarred baby food (also presented in Table 13 and Table A2). This food 
category was found to be the most important furan source in this age group. Secondly, an 
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estimate for the consumers of jarred baby food with an additional contribution from infant 
formula, milk products and commercial powder-based porridge with fruits was calculated (see 
Tables 14, 15 and 16). The third estimate shows the average furan exposure from jarred baby 
food, infant formula, milk products and commercial powder-based porridge with fruits for all 
participants (Table 17) and for all non-breastfed participants (Table 18) in the dietary survey.  
Table 17: Furan exposure in 12-month-old infants for consumers of jarred baby food (n=1436), for consumers of 
jarred baby food with an additional contribution from infant formula, milk products and commercial powder-based 
porridge (n=1436) and average furan exposure in all participants (n=1635). 
 Number of 
consumers 
(%) 
Mean,  
µg/kg 
bw/daya,b 
95 percentile, 
µg/kg 
bw/daya,b 
Consumers of jarred baby foodc 1436 (88) 0.56 1.30 
Consumers of jarred baby food with an additional 
contribution from infant formula, milk products and 
commercial powder-based porridge 
1436 (88) 0.69 1.51 
Average furan exposure from jarred baby food, 
infant formula, milk products and commercial 
powder-based porridge in all participants 
1635 (100) 0.62 1.43 
a Calculated based on the mean body weight of 9.9 kg reported for 12-month-old infants (see Table 7). 
b Based on a mean furan content in jarred baby food, infant formula, milk products and porridge powder with fruits as 
   reported in Table 6. 
c Exposure estimate presented in Table 13. 
 
The results in Table 17 show that the mean and 95 percentile furan exposures in 12-month-old 
consumers of jarred baby food were 0.56 and 1.30 µg/kg bw/day, respectively. Looking at the 
additional contributions from infant formula, milk products and commercial powder-based 
porridge with fruits, the mean and 95 percentile exposure values increase to 0.69 and 1.51 
µg/kg bw/day. In the third estimate illustrating the average furan exposure from all food 
categories considered to be relevant for all participants in this age group, mean and 95 
percentile values of 0.62 and 1.43 µg/kg bw/day were calculated. 
Table 18: Furan exposure in 12-month-old non-breastfed infants for consumers of jarred baby food (n=777), for 
consumers of jarred baby food with an additional contribution from infant formula, milk products and commercial 
powder-based porridge (n=777) and average furan exposure in all non-breastfed participants (n=881). 
 Number of 
consumers (%) 
Mean,  
µg/kg bw/daya,b 
95 percentile, 
µg/kg bw/daya,b 
Consumers of jarred baby foodc 777 (88) 0.58 1.33 
Consumers of jarred baby food with an 
additional contribution from infant formula, 
milk products and commercial powder-based 
porridge 
777 (88) 0.72 1.54 
Average furan exposure from jarred baby 
food, infant formula, milk products and 
commercial powder-based porridge in all non-
breastfed participants 
881 (100) 0.65 1.47 
a Calculated based on the mean body weight of 9.9 kg reported for 12-month-old infants (see Table 7). 
b Based on a mean furan content in jarred baby food, infant formula, milk products and porridge powder with fruits as 
   reported in Table 6. 
 
c Exposure estimate presented in Table A2. 
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Table 18 shows that consumers of jarred baby food in the group of 12-month-old non-
breastfed infants have respective mean and 95-percentile furan exposures of 0.58 and 1.33 
µg/kg bw/day. In the estimate that includes an additional contribution from infant formula, 
milk products and commercial powder-based porridge with fruits, the mean and 95 percentile 
furan exposures increase to 0.72 and 1.54 µg/kg bw/day. The calculation of the average furan 
exposures from jarred baby food, infant formula, milk products and commercial powder-
based porridge with fruits in all non-breastfed participants resulted in mean and 95 percentile 
values of 0.65 and 1.47 µg/kg bw/day, respectively. 
 
The relative contribution from various food categories to the furan exposure in 12-month-old 
infants is illustrated in Figure 4 (all participants, n=1635). 
 
 
Figure 4: The relative contribution from various food categories (jarred baby food, porridge powder, infant formula 
and milk products) to furan exposure in 12-month-old infants (all participants, n=1635). 
  
Consumption of jarred baby food represented the largest relative contribution to the furan 
exposure in 12-month-old infants (78%). The relative contribution from porridge powder 
amounted to 16%, while consumption of milk products gave a relative contribution of 5%. 
Consumption of infant formula is less important in 12-month-old infants with a relative 
contribution of only 1%.  
The relative contribution from various food categories in 12-month-old non-breastfed infants 
gave almost identical results and is therefore not shown. 
 
3.1.6  Dietary exposure to furan in 24-month-old children (Småbarnskost 2007) 
3.1.6.1  Jarred baby food 
The consumption of different subcategories jarred baby food with the corresponding furan 
exposure from this food category in 24-month-old children is presented in Table 19. The 
furan exposures have been calculated based on the mean furan contents in jarred baby food 
analysed as purchased given in Tables 1 and 6 and on the mean and 95 percentile 
consumption of the different subcategories of jarred baby food reported in the dietary survey. 
A calculation of the furan exposure from the total of jarred baby food consumed has also been 
included, based on the individual consumption data reported for 24-month-old children. All 
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values in Table 19 are given for consumers only among all participants (n=1674) in the 
dietary survey. 
 
Table 19: Consumption of different subcategories jarred baby food and exposure to furan in 24-month-old children 
(n=1674). Values for consumers only within each subcategory are given. 
  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Baby food subcategory Number of consumers 
(% of 1674) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Meat and vegetables 198 (12) 87 (53) 195 0.26 0.59 
Fish and vegetables 68 (4) 54 (29) 139 0.13 0.34 
Cereal based 35 (2) 49 (21) 73 0.22 0.33 
Vegetables 19 (1) 54 (44) 195 0.13 0.48 
Fruitsb 275 (16) 34 (49) 148 0.02 0.09 
Total jarred baby food  420 (25)     79 (93) 258 0.18 0.64 
a Calculated based on the mean body weight of 12.8 kg reported for 24-month-old children (see Table 7). 
b Include berries but not juice. 
 
From Table 19, it can be seen that jarred baby food containing meat and vegetables resulted in 
the highest furan exposures with respective mean and 95 percentile values of 0.26 and 0.59 
µg/kg bw/day. The mean furan exposure from the total of jarred baby food consumed by 24-
month-old children was calculated to 0.18 µg/kg bw/day, while the exposure at the 95 
percentile was 0.64 µg/kg bw/day.  
 
3.1.6.2  Other relevant food categories 
The consumption of other food categories considered relevant for 24-month-old children, with 
the corresponding furan exposures, is shown in Table 20. The furan exposure have been 
calculated based on the furan contents given for relevant food categories in Table 6 and on the 
mean and 95 percentile consumption of these food categories reported in the dietary survey.  
The following food categories have been included for this age group: canned and jarred 
vegetables, canned fruits, milk products (yoghurt, cheese), jarred tomato sauces, sweet 
breakfast cereals, breakfast cereals, chocolate and sweets, snacks, and commercial powder-
based porridge with and without fruits. All results were calculated based on individual 
consumption data from the participants in the dietary survey (consumers only). 
 
Table 20: Consumption of relevant food categories and exposure to furan in 24-month-old children (n=1674). Values 
are given for consumers only. 
  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Food category Number of consumers 
(% of 1674) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Canned and jarred vegetables 1298 (77) 0 (0) 1 <0.01 <0.01 
Canned fruits 50 (3) 17 (12) 58 <0.01 0.03 
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  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Food category Number of consumers 
(% of 1674) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Milk products (yoghurt, cheese) 1492 (89) 79 (64) 205 0.03 0.09 
Jarred tomato sauces 1446 (86) 2 (3) 7 <0.01 <0.01 
Sweet breakfast cereals 147 (9) 2 (1) 5 0.03 0.09 
Breakfast cerealsb 819 (49) 11 (11) 33 0.02 0.05 
Chocolate, sweets 1293 (77) 4 (3) 10 <0.01 <0.01 
Snacks 1079 (64) 1 (1) 4 <0.01 <0.01 
Commercial powder-based 
porridge with fruits 
285 (17) 31 (31) 89 0.04  0.11 
Commercial powder-based 
porridge without fruits 
285 (17) 31 (31) 89 <0.01 0.02 
a Calculated based on the mean body weight of 12.8 kg reported for 24-month-old children (see Table 7). 
b Ordinary breakfast cereals excluding sweet breakfast cereals.  
 
Table 20 shows that consumption of commercial powder-based porridge with fruits resulted 
in the highest furan exposure from other food categories than jarred baby food in 24-month-
old children. The mean and 95 percentile furan exposures from consumption of this food 
category were calculated to 0.04 and 0.11 µg/kg bw/day, respectively. Consumption of milk 
products and sweet breakfast cereals resulted in respective mean and 95 percentile furan 
exposures of 0.03 and 0.09 µg/kg bw/day. The furan exposures from consumption of other 
relevant food categories in this age group were found to be of limited importance. 
 
3.1.6.3 Furan exposure in 24-month-old children 
Three different estimates for the furan exposure in Norwegian 24-month-old children are 
shown in Table 21. First, an estimate based on individual consumption data for the 
participants in the dietary survey with a reported consumption of jarred baby food (also 
presented in Table 19). This food category was found to be the most important furan source in 
this age group. Secondly, an estimate for the consumers of jarred baby food with an additional 
contribution from canned and jarred vegetables, canned fruits, milk products, jarred tomato 
sauces, all breakfast cereals, chocolate and sweets, snacks and commercial powder-based 
porridge was calculated (see Table 20). Finally, an estimate showing the average furan 
exposure from all food categories considered relevant for this age group for all participants in 
the dietary survey was calculated.  
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Table 21: Furan exposure in 24-month-old children for consumers of jarred baby food (n=420), for consumers of 
jarred baby food with an additional contribution from canned and jarred vegetables, canned fruits, milk products, 
jarred tomato sauces, all breakfast cereals, chocolate and sweets, snacks, and commercial powder-based porridge 
(n=420) and average furan exposure in all participants (n=1674). 
 Number of 
consumers 
(%) 
Mean,  
µg/kg 
bw/daya,b 
95 percentile, 
µg/kg bw/daya,b 
Consumers of jarred baby foodc 420 (25) 0.18 0.64 
Consumers of jarred baby food with an additional 
contribution from canned and jarred vegetables, 
canned fruits, milk products, jarred tomato sauces, all 
breakfast cereals, chocolate and sweets, snacks, and 
commercial powder-based porridge 
420 (25) 0.25 0.77 
Average furan exposure from jarred baby food, canned 
and jarred vegetables, canned fruits, milk products, 
jarred tomato sauces, all breakfast cereals, chocolate 
and sweets, snacks, and commercial powder-based 
porridge in all participants  
1674 (100) 0.10 0.41 
a Calculated based on the mean body weight of 12.8 kg reported for 24-month-old children (see Table 7). 
b Based on the furan contents in jarred baby food, canned and jarred vegetables, canned fruits, milk products, jarred 
tomato sauces, all breakfast cereals, chocolate and sweets, snacks, and commercial powder-based porridge with 
fruits as reported in Table 6. 
c Exposure estimate presented in Table 19. 
 
Table 21 shows respective mean and 95 percentile furan exposures in 24-month-old 
consumers of jarred baby food of 0.18 and 0.64 µg/kg bw/day. Taking into account the 
additional contribution from other food categories considered relevant for this age group, the 
mean and 95 percentile furan exposures for consumers of jarred baby food increased to 0.25 
and 0.77 µg/kg bw/day. The calculation of the average furan exposure from all relevant food 
categories in all participants resulted in a mean value of 0.10 µg/kg bw/day and a 95 
percentile value of 0.41 µg/kg bw/day. 
 
3.1.7 Dietary exposure to furan in 4-year-old children (Ungkost 2001) 
3.1.7.1  Relevant food categories 
The consumption of different food categories considered relevant for 4-year-old children, 
with the corresponding furan exposures, is presented in Table 22. The furan exposures have 
been calculated based on the furan contents given for relevant food categories in Table 6 and 
on the mean and 95 percentile consumption of these food categories reported in the dietary 
survey. The following food categories have been included for this age group: canned and 
jarred vegetables, canned fruits, milk products (yoghurt, cheese), jarred tomato sauces, sweet 
breakfast cereals, breakfast cereals, chocolate and sweets, and snacks. All results were 
calculated based on individual consumption data from the participants in the dietary survey 
(consumers only). 
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Table 22: Consumption of relevant food categories and exposure to furan in 4-year-old children (n=391). Values are 
given for consumers only.  
  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Food category Number of consumers 
(%) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Canned and jarred vegetables 102 (26) 11 (10) 28 <0.01 0.01 
Canned fruits 12 (3) 33 (25) 88 0.01 0.03 
Milk products (yoghurt, 
cheese) 
352 (90) 36 (45) 143 0.01 0.04 
Jarred tomato sauces 150 (38) 23 (23) 61 0.01 0.03 
Sweet breakfast cereals 65 (17) 14 (11) 34 0.18 0.43 
Breakfast cerealsb 182 (47) 22 (30) 95 0.03 0.11 
Chocolate, sweets 349 (89) 14 (13) 43 <0.01 0.01 
Snacks 168 (43) 6 (7) 25 <0.01 0.03 
a Calculated based on the mean body weight of 18 kg reported for 4-year-old children (see Table 7). 
b Ordinary breakfast cereals excluding sweet breakfast cereals.  
 
The calculations presented in Table 22 show that consumption of breakfast cereals (especially 
sweet breakfast cereals) gave the highest contribution to furan exposure from relevant food 
categories in 4-year-old children. Respective mean and 95 percentile furan exposures of 0.03 
and 0.11 µg/kg bw/day were found for breakfast cereals, while consumption of sweet 
breakfast cereals resulted in mean and 95 percentile exposures of 0.18 and 0.43 µg/kg bw/day. 
Since both the number of consumers with a reported consumption in the dietary survey (see 
Table 22) and the number of products analysed (DTU, 2009) were higher for breakfast cereals 
than sweet breakfast cereals, the food category breakfast cereals was considered the most 
important furan source in this age group. The furan exposures from consumption of the other 
food categories included in the exposure calculations shown in Table 22 were found to be 
low.  
 
3.1.7.2 Furan exposure in 4-year-old children 
Three different estimates for furan exposure in Norwegian 4-year-old children are shown in 
Table 23. First, an estimate based on individual consumption data for the participants in the 
dietary survey with a reported consumption of breakfast cereals (also presented in Table 22). 
This food category was found to be the most important furan source in this age group. 
Secondly, an estimate for the consumers of breakfast cereals with an additional contribution 
from canned and jarred vegetables, canned fruits, milk products, jarred tomato sauces, sweet 
breakfast cereals, chocolate and sweets, and snacks was calculated (see Table 22). The third 
estimate shows the average furan exposure from all relevant food categories considered 
relevant for this age group among all participants in the dietary survey.  
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Table 23: Furan exposure in 4-year-old children for consumers of breakfast cereals (n=182), for consumers of 
breakfast cereals with an additional contribution from canned and jarred vegetables, canned fruits, milk products, 
jarred tomato sauces, sweet breakfast cereals, chocolate and sweets, and snacks (n=182) and average furan exposure 
in all participants (n=391). 
 Number of 
consumers 
(%) 
Mean,  
µg/kg 
bw/daya,b 
95 percentile, 
µg/kg 
bw/daya,b 
Consumers of breakfast cerealsc 182 (47) 0.03  
 
0.11  
Consumers of breakfast cereals with an additional 
contribution from canned and jarred vegetables, 
canned fruits, milk products, jarred tomato sauces, 
sweet breakfast cereals, chocolate and sweets, and 
snacks 
182 (47) 0.08 0.26 
Average furan exposure from breakfast cereals,  
canned and jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, sweet breakfast 
cereals, chocolate and sweets, and snacks in all 
participants 
391 (100) 0.07  
 
0.25  
 
a Calculated based on the mean body weight of 18 kg reported for 4-year-old children (see Table 7). 
b Based on the furan contents in relevant food categories reported in Table 6. 
c Exposure estimate presented in Table 22. 
 
From Table 23 it can be seen that the additional contribution from other relevant food 
categories would increase the mean and 95 percentile furan exposures for the consumers of 
breakfast cereals from 0.03 and 0.11 µg/kg bw/day (exposure from breakfast cereals) to 0.08 
and 0.26 µg/kg bw/day, respectively. The average furan exposure from all relevant food 
categories considered relevant for all participants in the dietary survey resulted in mean and 
95 percentile furan exposures of 0.07 and 0.25 µg/kg bw/day, respectively. 
 
3.1.8 Dietary exposure to furan in 9-year-old children (Ungkost 2000) 
3.1.8.1  Relevant food categories 
The consumption of different food categories considered relevant for 9-year-old children, 
with the corresponding furan exposures, is presented in Table 24. The furan exposures have 
been calculated based on the furan contents given for relevant food categories in Table 6 and 
on the mean and 95 percentile consumption of these food categories reported in the dietary 
survey. The following food categories have been included for this age group: canned and 
jarred vegetables, canned fruits, milk products (yoghurt, cheese), jarred tomato sauces, sweet 
breakfast cereals, breakfast cereals, chocolate and sweets, and snacks. All results were 
calculated based on individual consumption data from the participants in the dietary survey 
(consumers only). 
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Table 24: Consumption of relevant food categories and exposure to furan in 9-year-old children (n=810). Values are 
given for consumers only. 
  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Food category Number of consumers 
(%) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Canned and jarred vegetables 237 (29) 13 (11) 37 <0.01 <0.01 
Canned fruits 62 (8) 26 (30) 88 <0.01 0.02 
Milk products (yoghurt, 
cheese) 
731 (90) 73 (75) 208 0.01 0.04 
Jarred tomato sauces 274 (34) 35 (40) 123 0.01 0.04 
Sweet breakfast cereals 125 (15) 21 (23) 75 0.15 0.52 
Breakfast cerealsb 323 (40) 34 (44) 136 0.02 0.09 
Chocolate, sweets 727 (90) 31 (29) 84 <0.01 0.02 
Snacks 459 (57) 14 (21) 50 0.01 0.04 
a Calculated based on the mean body weight of 32 kg reported for 9-year-old children (see Table 7). 
b Ordinary breakfast cereals excluding sweet breakfast cereals.  
 
The results presented in Table 24 show that consumption of breakfast cereals (especially 
sweet breakfast cereals) gave the highest contribution to furan exposure from the food 
categories considered relevant for 9-year-old children. The mean furan exposure from 
breakfast cereals was calculated to 0.02 µg/kg bw/day, while the exposure at the 95 percentile 
was 0.09 µg/kg bw/day. Consumption of sweet breakfast cereals could result in mean and 95 
percentile furan exposures of 0.15 and 0.52 µg/kg bw/day, respectively. Since both the 
number of consumers with a reported consumption in the dietary survey (see Table 24) and 
the number of products analysed (DTU, 2009) were higher for breakfast cereals than sweet 
breakfast cereals, the food category breakfast cereals was considered the most important furan 
source in this age group. Consumption of milk products (yoghurt, cheese) and snacks could 
both lead to a furan exposure of 0.04 µg/kg bw/day at the 95 percentile, but overall the furan 
exposure from other food categories than breakfast cereals was found to be low in 9-year-old 
children.  
 
3.1.8.2  Furan exposure in 9-year-old children 
Three different estimates for furan exposure in Norwegian 9-year-old children are shown in 
Table 25. First, an estimate based on individual consumption data for the participants in the 
dietary survey with a reported consumption of breakfast cereals (also presented in Table 24). 
This food category was found to be the most important furan source in this age group. 
Secondly, an estimate for the consumers of breakfast cereals with an additional contribution 
from canned and jarred vegetables, canned fruits, milk products, jarred tomato sauces, sweet 
breakfast cereals, chocolate and sweets, and snacks was calculated (see Table 24). Finally, an 
estimate showing the average furan exposure from all food categories considered relevant for 
this age group among all participants in the dietary survey was calculated. 
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Table 25: Furan exposure in 9-year-old children for consumers of breakfast cereals (n=323), for consumers of 
breakfast cereals with an additional contribution from canned and jarred vegetables, canned fruits, milk products, 
jarred tomato sauces, sweet breakfast cereals, chocolate and sweets, and snacks (n=323) and average furan exposure 
in all participants (n=810).  
 Number of 
consumers 
(%) 
Mean,  
µg/kg 
bw/daya,b 
95 percentile, 
µg/kg 
bw/daya,b 
Consumers of breakfast cerealsc 323 (40) 0.02  0.09  
Consumers of breakfast cereals with an additional 
contribution from canned and jarred vegetables, 
canned fruits, milk products, jarred tomato sauces, 
sweet breakfast cereals, chocolate and sweets, and 
snacks 
323 (40) 0.06 0.17 
Average furan exposure from breakfast cereals, 
canned and jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, sweet breakfast 
cereals, chocolate and sweets, and snacks in all 
participants 
810 (100) 0.06 0.20 
a Calculated based on the mean body weight of 32 kg reported for 9-year-old children (see Table 7). 
b Based on the mean furan content in relevant food categories (Table 6). 
c Exposure estimate presented in Table 24. 
 
The exposure calculations presented in Table 25 show that the mean furan exposure for 9-
year-old consumers of breakfast cereals would increase from 0.02 (exposure from breakfast 
cereals) to 0.06 µg/kg bw/day when the additional contributions from other relevant food 
categories were taken into account. The furan exposure at the 95 percentile for the consumers 
of breakfast cereals was found to be 0.17 µg/kg bw/day when all relevant food sources are 
included. The average furan exposure from all relevant food categories considered relevant 
for all participants in the dietary survey resulted in a mean and 95 percentile furan exposures 
of 0.06 and 0.20 µg/kg bw/day, respectively. 
 
3.1.9 Dietary exposure to furan in 13-year-old adolescents (Ungkost 2000) 
3.1.9.1  Relevant food categories 
The consumption of different food categories considered relevant for 13-year-old adolescents, 
with the corresponding furan exposures, is presented in Table 26. The furan exposures have 
been calculated based on the furan contents given for relevant food categories in Table 6 and 
on the mean and 95 percentile consumption of these food categories reported in the dietary 
survey. The following food categories have been included for this age group: canned and 
jarred vegetables, canned fruits, milk products (yoghurt, cheese), jarred tomato sauces, sweet 
breakfast cereals, breakfast cereals, chocolate and sweets, snacks and coffee (coffee roasted 
ground). All results were calculated based on individual consumption data from the 
participants in the dietary survey (consumers only). 
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Table 26: Consumption of relevant food categories and exposure to furan in 13-year-old adolescents (n=1005). Values 
are given for consumers only.  
  Consumption,  
g/day 
Furan exposure,  
µg/kg bw/daya 
Food category Number of consumers 
(%) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Canned and jarred vegetables 351 (35) 19 (19) 52 <0.01 <0.01 
Canned fruits 73 (7) 27 (34) 100 <0.01 0.01 
Milk products (yoghurt, 
cheese) 
875 (87) 74 (86) 224 <0.01 0.03 
Jarred tomato sauces 248 (25) 38 (49) 105 <0.01 0.02 
Sweet breakfast cereals 116 (12) 24 (24) 70 0.11 0.32 
Breakfast cerealsb 285 (28) 35 (43) 112 0.01 0.05 
Chocolate, sweets 911 (91) 44 (45) 130 <0.01 0.02 
Snacks 594 (59) 26 (40) 88 0.01 0.04 
Coffee roasted ground 13 (1) 55 (21) 100 0.05 0.08 
a Calculated based on the mean body weight of 49.5 kg reported for 13-year-old adolescents (see Table 7). 
b Ordinary breakfast cereals excluding sweet breakfast cereals.  
 
As for 4- and 9-year-old children, consumption of sweet breakfast cereals resulted in the 
highest contribution to furan from the food categories considered relevant for 13-year-old 
adolescents (Table 26). The mean furan exposure from sweet breakfast cereals was calculated 
to 0.11 µg/kg bw/day, while the exposure at the 95 percentile was 0.32 µg/kg bw/day. 
Consumers of ordinary breakfast cereals were found to have mean and 95 percentile furan 
exposures of 0.01 and 0.05 µg/kg bw/day. Since both the number of consumers with a 
reported consumption in the dietary survey (see Table 26) and the number of products 
analysed (DTU, 2009) were higher for breakfast cereals than sweet breakfast cereals, the food 
category breakfast cereals was considered the most important furan source in this age group. 
It should be noted that mean and 95 percentile furan exposures of 0.05 and 0.08 µg/kg bw/day 
were calculated for consumption of coffee roasted ground. However, due to the low number 
of consumers (N=13), coffee was not considered as an important furan source in 13-year-old 
adolescents. Consumption of milk products and snacks could lead to respective furan 
exposures of 0.03 and 0.04 µg/kg bw/day at the 95 percentile, but overall the furan exposure 
to other food categories was found to be low in this age group.  
 
3.1.9.2  Furan exposure in 13-year-old adolescents 
Three different estimates for furan exposure in Norwegian 13-year-old adolescents are shown 
in Table 27. First, an estimate based on individual consumption data for the participants in the 
dietary survey with a reported consumption of breakfast cereals (also presented in Table 26). 
This food category was found to be the most important furan source in this age group. 
Secondly, an estimate for the consumers of breakfast cereals with an additional contribution 
from canned and jarred vegetables, canned fruits, milk products, jarred tomato sauces, sweet 
breakfast cereals, chocolate and sweets, snacks, and coffee (see Table 26). The third estimate 
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shows the average exposure from all relevant food categories considered relevant for this age 
group among all participants in the dietary survey.  
 
Table 27: Furan exposure in 13-year-old adolescents for consumers of breakfast cereals (n=285), for consumers of 
breakfast cereals with an additional contribution from canned and jarred vegetables, canned fruits, milk products, 
jarred tomato sauces, sweet breakfast cereals, chocolate and sweets, and snacks (n=285) and average furan exposure 
in all participants (n=1005).  
 Number of 
consumers 
(%) 
Mean,  
µg/kg 
bw/daya,b 
95 percentile, 
µg/kg 
bw/daya,b 
Consumers of breakfast cerealsc 285 (28) 0.01  0.05 
Consumers of breakfast cereals with an additional 
contribution from canned and jarred vegetables, 
canned fruits, milk products, jarred tomato sauces, 
sweet breakfast cereals, chocolate and sweets, snacks, 
and coffee 
285 (28) 0.05 0.16 
Average furan exposure from breakfast cereals, 
canned and jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, sweet breakfast 
cereals, chocolate and sweets, snacks, and coffee in all 
participants 
1005 (100) 0.04 0.14 
a Calculated based on the mean body weight of 49.5 kg reported for 13-year-old adolescents (see Table 7). 
b Based on the mean furan content in relevant food categories (Table 6). 
c Exposure estimate presented in Table 26. 
 
From Table 27 it can be seen that the additional contribution from other relevant food 
categories would increase the mean and 95 percentile furan exposures for the consumers of 
breakfast cereals from 0.01 and 0.05 µg/kg bw/day (exposure from breakfast cereals) to 0.05 
and 0.16 µg/kg bw/day, respectively. The average exposure from all relevant food categories 
considered relevant for all participants in the dietary survey resulted in mean and 95 
percentile furan exposures of 0.04 and 0.14 µg/kg bw/day, respectively. 
 
3.1.10  Dietary exposure to furan in adults aged 18-70 years (Norkost 3) 
3.1.10.1  Relevant food categories 
The consumption of different food categories considered relevant for adults aged 18-70 years, 
with the corresponding furan exposures, is presented in Table 26. The furan exposures have 
been calculated based on the furan contents given for relevant food categories in Table 6 and 
on the mean and 95 percentile consumption of these food categories reported in the dietary 
survey. The following food categories have been included for adults: canned and jarred 
vegetables, canned fruits, milk products (yoghurt, cheese), jarred tomato sauces, sweet 
breakfast cereals, breakfast cereals, chocolate and sweets, snacks and coffee (coffee roasted 
ground and instant coffee). All results were calculated based on individual consumption data 
from the participants in the dietary survey (consumers only). 
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Table 28: Consumption of relevant food categories and exposure to furan in adults aged 18-70 years (n=1787). Values 
are given for consumers only. 
  Consumption, 
g/day 
Furan exposure, 
µg/kg bw/daya 
Food category Number of consumers 
(%) 
Mean 
(SD) 
95 
percentile 
Mean 95 percentile 
Canned and jarred vegetables 274 (15) 23 (34) 91 <0.01 <0.01 
Canned fruits 121 (7) 29 (35) 87 <0.01 <0.01 
Milk products (yoghurt, cheese) 1605 (90) 74 (70) 204 <0.01 0.01 
Jarred tomato sauces 478 (27) 30 (32) 100 <0.01 0.01 
Sweet breakfast cereals 7 (0) 30 (6) - 0.09 - 
Breakfast cerealsb 491 (27) 60 (54) 174 0.02 0.05 
Chocolate, sweets 1229 (69) 18 (23) 64 <0.01 <0.01 
Snacks 277 (16) 31 (33) 75 <0.01 0.02 
Coffee roasted ground 1398 (78) 604 (456) 1500 0.33 0.81 
Instant coffee 266 (15) 319 (303) 997 0.03 0.09 
a Calculated based on the mean body weight of 77.5 kg reported for adults aged 18-70 years (see Table 7). 
b Ordinary breakfast cereals excluding sweet breakfast cereals.  
 
The calculations presented in Table 28 show that consumption of coffee gave the highest 
contribution to furan exposure from relevant food categories in adults aged 18-70 years. 
Consumption of coffee roasted ground resulted in mean and 95 percentile furan exposures of 
0.33 and 0.81 µg/kg bw/day, respectively, while consumption of instant coffee gave 
respective mean and 95 percentile values of 0.03 and 0.09 µg/kg bw/day. Consumption of 
breakfast cereals could result in mean and 95 percentile furan exposures of 0.02 and 0.05 
µg/kg bw/day, but overall the furan exposures from other relevant food categories, except 
coffee, were found to be low in the exposure calculations for adults.  
 
3.1.10.2  Furan exposure in adults aged 18-70 years 
Three different estimates for furan exposure in Norwegian adults aged 18-70 years are shown 
in Table 29. First, an estimate based on individual consumption data for the participants in the 
dietary survey with a reported consumption of coffee roasted ground (also presented in Table 
28). This food category was found to be the most important furan source in this age group. 
Secondly, an estimate for the consumers of coffee roasted ground with an additional 
contribution from canned and jarred vegetables, canned fruits, milk products, jarred tomato 
sauces, all breakfast cereals, chocolate and sweets, snacks, and instant coffee (see Table 28). 
The third estimate shows the average exposure from all relevant food categories considered 
relevant for this age group among all participants in the dietary survey.  
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Table 29: Furan exposure in adults for consumers of coffee roasted ground (n=1398), for consumers of coffee roasted 
ground with an additional contribution from canned and jarred vegetables, canned fruits, milk products, 
jarred tomato sauces, all breakfast cereals, chocolate and sweets, snacks, and instant coffee (n=1398) and 
average furan exposure in all participants (n=1787). 
 Number of 
consumers 
(%) 
Mean,  
µg/kg 
bw/daya,b 
95 percentile, 
µg/kg 
bw/daya,b 
Consumers of coffee roasted groundc 1398 (78) 0.33 0.81 
Consumers of coffee roasted ground with an additional 
contribution from canned and jarred vegetables, 
canned fruits, milk products, jarred tomato sauces, all 
breakfast cereals, chocolate and sweets,  snacks, and 
instant coffee 
1398 (78) 0.34 0.82 
Average furan exposure from coffee roasted ground,  
canned and jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, all breakfast cereals, 
chocolate and sweets,  snacks, and instant coffee in all 
participants 
1787 (100) 0.27 0.77 
a Calculated based on the mean body weight of 77.5 kg reported for adults aged 18-70 years (see Table 7). 
b Based on the mean furan content in relevant food categories (Table 6). 
c Exposure estimate presented in Table 28. 
 
Table 29 shows respective mean and 95 percentile furan exposures in adults with a 
consumption of coffee roasted ground of 0.33 and 0.81 µg/kg bw/day. The mean and 95 
percentile furan exposures for consumers of coffee roasted ground increased to 0.34 and 0.82 
µg/kg bw/day, respectively, when the additional contribution from other relevant food 
categories in this age group was taken into account. The calculation of the average furan 
exposure from all relevant food categories in all participants resulted in a mean value of 0.27 
µg/kg bw/day and a 95 percentile value of 0.77 µg/kg bw/day, respectively. 
The relative contribution from various food categories to the furan exposure in adults aged 
18-70 years is illustrated in Figure 5 (all participants, n=1787).   
 
 
Figure 5: The relative contribution from four food categories (coffee, instant coffee, breakfast cereals, milk products) 
to furan exposure in adults in all participants (n=1787).  
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Consumption of coffee (coffee roasted ground) resulted in the largest relative contribution to 
the furan exposure in adults aged 18-70 years, amounting to as much as 91% of the overall 
exposure. Consumption of instant coffee, breakfast cereals and milk products all gave a 
relative contribution of 3%.  
 
3.1.11 Summary of exposure assessments for furan in the Norwegian population 
An overview of the calculated furan exposures from various food categories considered 
relevant for the different age groups is shown in Table 30 and 31. Table 30 shows the 
population average of furan exposure among all participants in each age group, and also the 
average among all non-breastfed 6- and 12-month-old children. Furthermore, the 95-
percentiles of furan exposure among all participants in each age group are shown. In Table 31, 
the furan exposures for the consumers of the most important furan source (values given for 
consumers only) with an additional contribution from all relevant food categories are 
presented for each age group. 
 
Table 30: Furan exposure from food and beverages for all participants in different age groups in Norway (population 
average) 
Age groups Number of consumers 
(%) 
Mean,  
µg/kg bw/daya 
95 percentile, 
µg/kg bw/daya 
6 months old children 
6 months old children (non-breastfed) 
1986 (100) 
397 (100) 
0.17 
0.31 
0.51 
0.62 
12 months old children 
12 months old children (non-breastfed) 
1635 (100) 
881 (100) 
0.62 
0.65 
1.43 
1.47 
24 months old children 1674 (100) 0.10 0.41 
4 years old children 391 (100) 0.07 0.25 
9 years old children 810 (100) 0.06 0.20 
13 years old children 1005 (100) 0.04 0.14 
Adults 1787 (100) 0.27 0.77 
a Calculated based on the mean body weights for different age groups reported in the dietary surveys (see Table 7).  
 
 
Table 31: Furan exposure from food and beverages for consumers of the most important furan sources in different 
age groups in Norway (values given for consumers only). 
Age groups Number of consumers 
(%) 
Mean,  
µg/kg bw/daya 
95 percentile, 
µg/kg bw/daya 
6 months old children 
6 months old children (non-breastfed) 
1220 (61) 
331 (83) 
0.26 
0.35 
0.58 
0.65 
12 months old children 
12 months old children (non-breastfed) 
1436 (88) 
777 (88) 
0.69 
0.72 
1.51 
1.54 
24 months old children 420 (25) 0.25 0.77 
4 years old children 182 (47) 0.08  0.26  
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Age groups Number of consumers 
(%) 
Mean,  
µg/kg bw/daya 
95 percentile, 
µg/kg bw/daya 
9 years old children 323 (40) 0.06 0.17 
13 years old children 285 (28) 0.05  0.16  
Adults 1398 (78) 0.34 0.82 
a Calculated based on the mean body weights for different age groups reported in the dietary surveys (see Table 7).  
 
The highest population average was found in 12-month-old infants with a mean furan 
exposure of 0.62 µg/kg bw/day (0.65 µg/kg bw/day in non-breastfed infants). Adults also had 
a high population average with a mean furan exposure of 0.27 µg/kg bw/day, while 13-year-
old adolescents was found to have the lowest mean furan exposure (0.04 µg/kg bw/day) based 
on the consumption of all relevant furan-containing food categories (Table 30). 
If the furan exposures were calculated for the consumers of the most important food source 
with an additional contribution from all relevant food categories (Table 31), slightly higher or 
similar furan exposures as for the population averages were found in all age groups. This 
indicates that the population averages are a realistic exposure estimate for different 
consumers, also for those who consume foods with a high furan content. 
 
3.1.12 Comparison with previous exposure assessments of furan 
EFSA has in their third scientific report on the results of the monitoring of furan levels in 
Europe between 2004 and 2010 also presented furan exposure estimates based on the 
monitoring results (EFSA, 2011). The exposure to furan was estimated for different target 
populations by combining pooled mean furan occurrence values from all Member States 
obtained through the monitoring program with individual dietary national consumption data 
from Member States derived from the EFSA Comprehensive European Food Consumption 
Database.  
The mean furan exposure across surveys was estimated to range between 0.03 and 0.59 µg/kg 
bw/day for adults, between 0.02 and 0.13 µg/kg bw/day for adolescents, between 0.04 and 
0.22 µg/kg bw/day for other children, between 0.05 and 0.31 µg/kg bw/day for toddlers and 
between 0.09 and 0.22 µg/kg bw/day for infants. High exposure at the 95 percentile was 
found to be from 0.06 to 1.38 µg/kg bw/day in adults, while the surveys covering toddlers and 
other children had respective 95 percentiles ranged between 0.20 and 1.40 and 0.09 and 0.46 
µg/kg bw/day. Only two surveys related to infants are included in the EFSA Comprehensive 
Database and a possible 95 percentile furan exposure of 0.97 µg/kg bw/day was reported 
(EFSA, 2011).  
Brewed coffee was the main contributor to the exposure in adults, with an average of 85% of 
total furan exposure. Fruit juice, milk-based products and cereal-based products was 
important contributors to the furan exposure in toddlers and other children, whereas in 
addition for toddlers jarred baby food were found to be a major contributor (EFSA, 2011). 
Estimates of dietary exposure to furan have also been included in the recent JECFA 
evaluation of furan (JECFA, 2011). In general, the mean dietary exposure to furan from 
national assessments ranged from 0.25 to 1.17 µg/kg bw/day for adults, from 0.08 to 0.23 
µg/kg bw/day for children 1-6 years of age and from 0.27 to 1.01 µg/kg bw/day for infants up 
to 12 months of age. For consumers at high percentiles of dietary exposure, estimates ranged 
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from 0.60 to 2.22 µg/kg bw/day for adults and from 0.99 to 1.34 µg/kg bw/day for infants. No 
high-percentile data were reported for children. (JECFA, 2011).  
A dietary exposure assessment based on Danish consumption data has been presented in the 
report from the project carried out by the Danish Technical University National Food Institute 
on behalf of EFSA (DTU, 2009). The result revealed that 95% of the furan exposure in adults 
came from consumption of coffee. For Danish children, breakfast cereals were found to be the 
food category contributing most to the furan exposure. For children with a high consumption 
of breakfast cereals (the 95 percentile) and a mean consumption of other foods the furan 
exposure from breakfast cereals accounted for about 2/3 of the total exposure. The estimate of 
the total median furan exposure for adults (15-75 years old) was calculated to 33.5 µg/day and 
for children (4-6 years old) to 1.1 µg/day (DTU, 2009). 
 
4 Hazard identification and characterisation 
 
4.1 Toxicokinetics  
Furan is a small lipophilic molecule (MW: 68.07 g/mol) that easily can pass through 
biological membranes. Pharmacokinetic ADME parameters (absorption, distribution, 
metabolism, and excretion) of furan have been determined in a number of in vitro and in vivo 
studies (Egle and Gochberg, 1979; Burka et al., 1991; Wilson et al, 1992; Kedderis et al., 
1993; Carfagna et al., 1993; Kedderis and Held, 1996; Chen et al., 1995; Peterson et al., 
2005; Gill et al. 2010; Peterson et al., 2011). However, data are not complete and mostly 
based on rodent studies. Disposition characteristics of furan in humans are not available. 
Compiled ADME information on furan can also be retrieved from EFSA (2004) and JECFA 
(2011) reports as well as from a publication of the US National Research Council’s 
Subcommittee on Spacecraft Maximum Allowable Concentrations (2000). 
 
4.1.1 Absorption 
Furan was rapidly absorbed from the intestine into the portal vein after oral administration to 
rats and mice (Burka et al. 1991; Wilson et al., 1992). Portal vein blood flow is the limiting 
step for furan deliverance to the liver in all species investigated (Kedderis et al., 1993). 
However, oral application of high doses as used in toxicology studies (50 mg/kg bw) can 
cause direct diffusion through the stomach walls into the systemic circulation. In a study on 
absorption by inhalation 90 % of the dose was taken up in dogs and mice, and 95 % in rats 
(Egle and Gochberg, 1979). The amount of retained furan was proportional to the furan 
concentration in inhaled air. Physiological-based pharmacokinetic models have been used to 
develop dosimetry models for furan by inhalation showing that the absorbed dose in humans 
would be about 3 to 10-fold smaller than in rats and mice, respectively (Kedderis and Held, 
1996). It could be speculated that the ratio would be similar after oral administration. 
 
4.1.2  Distribution 
A single oral dose of 8 mg/kg bw radiolabelled furan [2,5-14C] in corn oil to rats resulted in 
recoveries of 307 nmol/g furan equivalents in the liver, 60 nmol/g in the kidneys, 44 nmol/g 
in the gastrointestinal tract, 6 nmol/g in blood, and 4 nmol/g in the lungs at 24 h post 
administration (p.a.) (Burka et al., 1991). The labelled equivalents represented about 15% of 
the total furan dose. They were almost completely bound to protein. Seven days p.a., 
Vitenskapskomiteen for mattrygghet (VKM) 10/404-2 final 
 
51 
 
radioactivity in the different organs was below the detection limit. Repeated dosing led to 
accumulation of radioactivity in liver and kidneys (Burka et al., 1991). In a 90-day gavage 
toxicity study in rats, unlabelled furan at doses 0.0, 0.03, 0.12, 0.5, 2.0, and 8.0 mg/kg bw/day 
five days a week were applied (Gill et al., 2010).  After 90 days, furan residues in the liver for 
the sentinel, controls and animals dosed with 0.03 and 0.12 mg/kg bw/day were almost 
similar and ranging from 0.05 to 0.08 ng/g liver tissue. Animals dosed with 0.5, 2.0, and 8.0 
mg/kg bw/day had about 0.11 ng/g, 0.21 ng/g and 0.30 ng/g furan in the liver tissue, 
respectively.  
 
4.1.3  Metabolism 
Furan is metabolized quickly by cytochrome P450 enzymes, mainly CYP 2E1, to form cis-2-
butene-1,4-dial (BDA), which has been identified as the major primary metabolite (Burka et 
al., 1991; Adger et al., 1993; Parmar and Burka, 1993; Carfagna et al., 1993; Chen et al., 
1995; Peterson et al., 2005; Peterson, 2006) (Figure 5). CYP 2E1 is known to metabolise and 
bioactivate multiple small-molecular weight toxicants such as ethanol, benzene, toluene and 
nitrosamines (Lieber, 1997). Other CYP P450 enzymes may also play roles in the 
bioactivation and/or metabolism of furan (Peterson et al., 2005). Furan metabolites such as 
BDA are known as reactive and cytotoxic. Only the bioactivated furan metabolites bind to 
proteins and nucleosides (Burka et al., 1991; Byrns et al., 2002; Peterson et al., 2011). BDA 
is formed by oxidation of one of the furan’s double bonds, possibly with the formation of an 
epoxide intermediate that is spontaneously rearranged and opened. The reaction may involve 
the successive electron and oxygen transfers from a CYP P450-perferryl intermediate 
[FE(V)O]. BDA is stabilized in cis-configuration by a cyclic hydrate (Chen et al., 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: CYP-mediated bioactivation of furan to form reactive metabolite. Possible reaction intermediates from 
metabolism of furan by cytochrome P-450 (Parmar and Burka, 1993). 
 
BDA reacts with glutathione (GSH) to a cyclic mono-glutathione conjugate that has been 
detected in the urine of furan-treated rats beside 18 additional minor metabolites (Burka et al., 
1991; Peterson et al., 2006). GSH-BDA (2-(S-gluthathionyl)-succinaldehyde) has been shown 
to form pyrrole cross-links with biogenic amines such as lysine (N-acetyllysine conjugate, N-
acetylcysteine-N-acetyllysine conjugate and its sulfoxide), glutamine (glutamic acid 
methanethiol), spermidine and ornithine. Their detection in primary hepatocytes and rat urine 
may indicate an important role in the toxicity of furan (Peterson et al., 2006; Kellert et al., 
2008a; Lu et al., 2009; Hamberger et al. 2010; Peterson et al., 2011). However, conjugates 
apart from GSH-BDA have not yet been extensively studied. 
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Rat hepatic microsomes incubated with radio-labelled furan in the presence of NADPH 
electron generating system resulted in the covalent incorporation of furan-derived 
radioactivity in microsomal proteins. After oral application of 8 and 25 mg/kg bw furan to 
rats,   decrease in cytochrome P450 (CYP) content and several CYP-dependent activities such 
as aniline hydroxylase (AH), 7-ethoxycoumarin-O-deethylase (ECOD), and 7-
ethoxyresorufin-O-deethylase (EROD) was observed suggesting that the reactive furan 
intermediate can bind to nucleophilic groups of the P450 enzymes (Parmar and Burka, 1993). 
Physiologically-based pharmacokinetic modelling (PBPK) including data from metabolism 
studies using primary hepatocytes from human and rodents in solution or culture has indicated 
that furan metabolism is rate-limited by the hepatic blood flow (Kedderis et al., 1993; 
Kedderis and Held, 1996). Therefore, induction of the main metabolizing enzyme CYP 2E1 
would probably not increase the rate of furan metabolism (Kedderis and Held, 1996). 
However, inter-individual differences in the hepatic CYP 2E1-activity could have an 
influence on the extent of first-pass metabolism and bioactivation of furan. CYP 2E1 can be 
induced by ethanol and chronic ethanol consumption is known to increase the rate of 
metabolism (Chang and Kam, 1999). In contrast, acute ethanol consumption may 
competitively inhibit 2E1 and decrease metabolism. However, it is unlikely that CYP2E1 
variations could considerably alter furan metabolism. Any increase in CYP 2E1 activity 
would not affect furan metabolism because it is the hepatic blood flow that is rate-limiting, 
not the CYP 2E enzyme activity. Only a substantial activity decrease could potentially reduce 
the formation of the noxious BDA. 
CYP 2E1 demonstrates genetic polymorphism affecting the noncoding region of the gene, 
which may influence the transcription and expression of the gene (Chang and Kam, 1999). 
However, it has been shown for e.g. trichloroethylene that metabolism was altered with less 
than 2 % under extreme values of CYP2E1 expression and activity (Lipscomb et al., 2003). 
Human hepatic CYP2E1 expression varies during human fetal liver development and in the 
early postnatal stage, but already in 90 days old infants the activity level was comparable to 
that in children and adults (Johnsrud et al., 2003). 
 
4.1.4 Elimination 
After a single oral dose of 8 mg/kg bw radiolabelled furan to rats, 80% of the total 
radioactivity was eliminated via lung (40 %), urine (20 %), and faeces (22 %) within 24 hours 
(Burka et al., 1991). The expired air contained 14 % unchanged furan and 26 % carbon 
dioxide (as a product from furan metabolism). The furan radioactivity in the urine (20 %) was 
a sum of more than 10 metabolites. 
Repeated dosing over 8 days resulted in the increase of excreted total radioactivity via urine 
to 33% whereas the fraction eliminated via the faeces remained approximately constant. 
However, the amount of tissue-bound radioactivity increased in liver (4-fold) and kidneys (6-
fold) (Burka et al., 1991).  
Pharmacokinetic data such as clearance, volume of distribution or half-life derived from in 
vivo studies are not yet available for furan. However, preliminary elimination parameters have 
been predicted on the basis of in vitro studies in rodent and human primary hepatocytes 
(Kedderis and Held, 1996). It was observed that the initial liver rate of furan metabolism in 
mouse, rat and human was approximately 13-, 24-, and 37-fold, respectively, greater than the 
respective hepatic blood flows (5.4 l/(h*kg), 4.2 l/(h*kg), and 1.4 l/(h*kg)). The maximal 
reaction velocity (Vmax) (48, 18, and 19-44 nmol/(h*106 hepatocytes)) and reaction constant 
(KM) (1.0, 0.4 and 2.1-3.3 µM) were determined for the three species (Table 32). 
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Hepatic enzyme activity can be determined as ratio of Vmax/KM provided that the substrate 
concentration in the assay is well below the KM-value. The experimentally measured CLint,assay 
= Vmax/KM has to be upscaled to assay-independent, intrinsic liver clearances (CLint) by 
considering the number of hepatocytes per g liver (hepatocellularities: HPGL) and the relative 
liver weight per kg body weight (RLW). This results in CLint = CLint,assay * HPGL * RLW if 
protein binding to hepatocytes in the assay is negligible. In vitro in vivo extrapolation 
(IVIVE) can be performed by applying the well-stirred liver model calculating the systemic 
blood clearance (CLb) from the CLint by considering the hepatic blood flow (Q) according to  
(CLb = Q * Clint/(Q + Clint) and assuming that protein binding of the furan molecule in plasma 
is irrelevant. 
 
Table 32: Estimated kinetic parameters of furan, derived from in vitro metabolism (Kedderis and Held, 1996). 
Parameter Mouse Rat Human 
Vmax [nmol/(h*106 hepatocytes)] 48 18 19-44 
KM,assay [µM] 1.0 0.4 2.1 – 3.3 
Clint,assay  [l/(h*106 hepatocytes)] 0.048 0.045 0.009-0.013 
HPGL [hepatocytes/g liver] 170*106 163*106 99*106 
RLW [g liver/kg bw] 50 40 21 
Clint  [l/(h*kg)] 408 293 19 - 27 
Q [l/(h*kg)] 5.4 4.2 1.4 
Clb [l/(h*kg)] ~ 5.4 ~ 4.2 ~ 1.4 
Vmax - maximal reaction velocity, KM - reaction constant, CLint - intrinsic liver clearances, HPGL – hepatocellularities, RLW 
- relative liver weight per kg body weight, Q - hepatic blood flow, CLb - systemic blood clearance. 
 
The calculated blood clearances for the different species approximate the respective hepatic 
blood flows, thus reaching the limits of the mathematical model. The in vivo blood clearances 
are equal to or exceeding the hepatic blood flow in the different species. 
 
4.1.5 Summary of toxicokinetics 
In conclusion, furan can pass through biological membranes and is rapidly absorbed from the 
lung and intestine. Systemic distribution is limited by high hepatic CYP 2E1-catalyzed 
elimination in high-capacity first-pass metabolism. Age-dependent expression of CYP 2E1 or 
polymorphisms have little impact on the furan metabolism. Oral exposure of up to 8 mg/kg 
bw/day resulted in furan liver levels of less than 1 ppb in rats. The amount of furan in the liver 
increased with the dose. The major metabolite BDA binds irreversible to proteins and 
nucleophiles. BDA can form conjugates in vivo, which have been little studied so far. Furan 
and furan-derived metabolites are eliminated via exhaled air, urine and faeces. 
 
4.1 General toxicity  
The general toxicity of furan has been described in several studies, and previously reviewed 
by EFSA (2004) and by Bakhiya and Appel (2010). The present overview is based on these 
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published reviews, NTP reports and some recent data (Gill et al., 2010). Only repeated and 
multiple dose toxicity studies with oral route of exposure have been included.  
 
4.2.1 Short-term toxicity 
4.2.1.1  Mice 
B6C3F1 mice (n=5/dose/sex) were given furan in a 16 days dose-range study at 0, 10, 20, 40, 
80 and 160 mg/kg bw in corn oil by gavage five days a week for 12 days, and at least two 
consecutive days before terminal sacrifice. The mice were weighted at the start of the study 
and at days 8 and 16. Clinical and toxicological observations were made twice daily. No 
histopathology was performed. Three male mice receiving 40 mg/kg bw and all male mice 
receiving 80 and 160 mg/kg bw did not survive beyond day 6. Four females receiving 80 
mg/kg bw and all female mice receiving 160 mg/kg bw did not survive beyond day 6. Final 
mean body weight of males receiving 10 and 20 mg/kg were significantly greater than 
controls. Reduced activity was the most consistent clinical finding observed among furan-
exposed mice. No observations at necropsy were clearly associated with furan treatment. No 
NOAEL could be allocated from this study (NTP, 1993). 
Hepatocyte proliferation, apoptosis and levels of liver enzymes in serum were analysed in 
female B6C3F1 mice (n=6-11/dose) exposed to 0, 4, 8 and 15 mg/kg bw 5 days a week for 3 
weeks. A statistical significant increase (2-3 fold) in serum liver enzymes (alanine 
aminotransferase (ALT) and sorbitol dehydrogenase (SHD)) was observed at 8 and 15 mg/kg 
bw doses. A dose-dependent increase in proliferation, measured by labelling index, was 
observed at all doses, and the apoptotic index increased 6- and 15-fold in mice receiving 8 
and 15 mg/kg bw, respectively. VKM allocated a NOAEL of 2.85 mg/kg bw/day (adjusted to 
a daily exposure) based on liver toxicity giving > 2-fold increase in ALT and SHD (Fransson-
Steen et al., 1997). 
Female B6C3F1 mice (n=15/dose) were exposed to furan at 0, 0.5, 1, 2 and 8 mg/kg bw in 
corn oil, 5 days a week for 3 weeks. Clinical chemistry, and cell proliferation and 
histopathology in the liver were examined. No treatment-related mortalities were observed 
during the study, and no treatment-related gross lesions were noted at the 3-week necropsy. A 
statistically significant increase in relative liver weight was observed in mice exposed to 8 
mg/kg bw. A dose-dependent significant increase in hepatotoxicity and ALT levels in serum 
was observed in mice exposed to 1 mg/kg bw and higher dose levels compared to controls. A 
respective significant increase in ALT levels of 1.13-, 1.58-, 2.9- and 4.7-fold were observed 
at doses 1.0, 2.0, 4.0 and 8.0 mg furan/kg bw. Increased hepatocyte proliferation was 
observed in the 8 mg/kg bw dose group (Moser et al., 2009). VKM allocated a NOAEL of 
1.42 mg/kg bw/day (adjusted to a daily exposure) based on liver toxicity giving > 2-fold 
increase in ALT. 
Male B6C3F1 mice (n=6/dose from the text or n=7-11/dose from the Table, n=8/control) 
were given furan in corn oil by gavage at doses 0, 2, 4, 8 and 15 mg/kg bw 5 days a week for 
28 days. Mortality, clinical signs and body weight were recorded, and histopathology, cell 
proliferation and apoptosis of the liver were reported. No mortality related to treatment was 
observed. Body weight or body weight gain was not significantly affected by treatment. A 
slight statistical significant increase in relative liver weight was observed in mice treated with 
4 mg/kg bw furan and above. At the two highest furan doses, liver necrosis was observed that 
were suggested to be related to regenerative hyperplasia. A statistical significant, but not 
dose-related, increase in cell proliferation was observed at the two highest furan doses. An 
increased incidence of apoptotic cells was reported at the highest furan dose, but no 
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quantitative data were given. No NOAEL could be allocated due to liver necrosis at the two 
highest furan doses (Cordelli et al., 2010).  
 
4.2.1.2  Rats 
F344 rats (n=5 /dose/sex) were given furan in a 16 days dose-range study at 0, 5, 10, 20, 40 
and 80 mg/kg bw (males) and 0, 10, 20, 40, 80 and 160 (females) in corn oil by gavage five 
days a week for 12 days, and at least two consecutive days. The rats were weighted at the start 
of the study and at days 8 and 16. Clinical and toxicological observations were made twice 
daily. All rats receiving ≥ 80 mg/kg bw of furan did not survive beyond day 8 of the study. 
Body weights of males receiving 20 or 40 mg/kg bw and females receiving 40 mg/kg bw were 
lower than those of control rats at the end of the study. Reduced activity was the only clinical 
finding consistently observed in the study, but the magnitude of this effect on the different 
dose levels was not given. No other significant findings were reported. No NOAEL could be 
allocated (NTP, 1993). 
 
4.2.2 Sub-chronic toxicity 
4.2.2.1  Mice 
No treatment related mortalities were observed in B6C3F1 mice (n=10/dose/sex) given furan 
by gavage at doses 0, 2, 4, 8, 15, 30 and 60 (females only) mg/kg bw 5 days a week for 13 
weeks. Final mean body weights of male mice receiving 30 mg/kg bw were lower than 
control mice. The absolute and relative liver weights at the two top dose levels (15 and 30 
mg/kg bw in male mice, and 30 and 60 mg/kg bw in female mice) showed a dose-dependent 
significant increase compared to controls. A weak dose-dependent incidence of liver lesions 
was observed at 8 mg/kg bw in male mice and at 15 mg/kg bw in female mice, and increasing 
with dose, but reached statistical significance first at 30 mg/kg bw for both sexes. Nearly all 
animals (9-10 animals) developed liver lesions at 30 and 60 mg/kg bw. Clinical chemistry 
were not examined (NTP, 1993). VKM allocated a NOAEL of 10.7 mg/kg bw/day (adjusted 
to a daily exposure) for both sexes based on the increase in liver lesions.  
Furan was given by gavage to F344 rats (n=10/dose/sex) at 0, 4, 8, 15, 30 and 60 (females 
only) mg/kg bw, 5 days a week for 13 weeks. Body weight was recorded weekly, and 
necropsies were performed on all animals at the end of the study. Complete histopathological 
examinations were made of all rats in the control group and on rats receiving 30 and 60 mg/kg 
bw. Nine male rats and four female rats from the 60 mg/kg bw dose group, did not survive to 
the end of the study. The final body weights of rats in the 15 and 30 mg/kg bw dose groups 
and remaining female rats in the 60 mg/kg bw dose group, were lower that the controls. In 
female rats, the relative and absolute liver and kidney weight were increased in the 15, 30 and 
60 mg/kg bw dose groups, while the absolute and relative liver weights were increased and 
the thymus weight reduced in males receiving 30 mg/kg bw. Although, lesions associated 
with furan exposure were most pronounced in the liver, the kidney, thymus, testes and ovaries 
were also affected. The most prominent change was a dose-dependent statistically significant 
increase in the incidence of bile duct hyperplasia, which occurred in all furan-dosed groups in 
both sexes (NTP, 1993). A statistical significant increase in the incidence of cholangiofibrosis 
was observed at all furan doses in male rats, and at ≥ 8 mg furan/kg bw in female rats. 
Therefore, no NOAEL could be allocated from this study by VKM.  
F344 rats (n=12 /dose/sex) were given furan at 0, 0.03, 0.12, 0.5, 2.0 and 8.0 mg/kg bw in 
corn oil by gavage, five days a week for 90 days. Animals were observed for clinical signs 
twice daily/week and once daily/weekends. Food consumption was measured weekly. At the 
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end of the study, the animals were sacrificed and blood samples were collected for 
measurements of haematology and clinical biochemistry. Necropsies were performed and 
liver, kidneys, thymus, uterus ovaries, ventral prostate, seminal vesicles and testes were 
weighted. A dose-related statistically significant increase in platelet count was observed at ≥ 
0.5 mg/kg bw in females, and at 8 mg/kg bw in males. Dose-related changes in clinical 
chemistry were noted for several parameters related to liver function. A significant change in 
clinical chemistry was observed from ≥ 2 mg furan/kg bw in females and from ≥ 0.12 mg 
furan/kg bw in males on thyroxine (T4) and triiodothyronine (T3), while other clinical 
parameters were increased from ≥ 2.0 mg furan/kg bw. A significant reduction in liver 
enzymes (alanine transaminase, alkaline phosphatise, aspartate transaminase) was observed in 
male and female rats from ≥ 2 mg/kg bw. The absolute liver weight was increased at the 
highest dose tested in both sexes. Macroscopic changes were observed in all of the livers of 
both males and females in this dose group. Histological lesions of the liver were observed in 
male and female rats, starting at 0.12 mg furan/kg bw. The severity and number of lesions 
increased with increasing furan dose. Increased incidence of cholangiofibrosis (17% and 
100%) and biliary tract hyperplasia (50% and 100%) were observed in the two highest dose 
groups for males increasing with the dose, and in the highest dose group for female rats 
(100% and 92% incidence for hyperplasia and cholangiofibrosis, respectively) (Gill et al., 
2010). An overview of the incidences of biliary toxicity in rats reported in this study is 
illustrated in Table 33. VKM allocated a NOAEL of 0.36 mg/kg bw/day (adjusted to a daily 
exposure) for both sexes based on the increase in hyperplasia and cholangiofibrosis in liver. 
 
Table 33: Incidences of biliary toxicity in rats (Gill et al., 2010) 
Biliary tract toxicity 
Females 
Ref. Control 0.03 
mg/kg 
0.12 
mg/kg 
0.5 
mg/kg 
2 
mg/kg 
8 
mg/kg 
Hyperplasia 0/12 0/12 
 
0/12 
 
0/12 1/12 12/12 Gill et al., 2010 
Cholangiofibrosis 0/12 0/12 
 
0/12 
 
0/12 0/12 11/12 Gill et al., 2010 
Biliary tract toxicity 
Males 
Ref. Control 0.03 
mg/kg 
0.12 
mg/kg 
0.5 
mg/kg 
2 
mg/kg 
8 
mg/kg 
Hyperplasia 0/12 0/12 
 
0/12 
 
0/12 6/12 12/12 Gill et al., 2010 
Cholangiofibrosis 0/12 0/12 
 
0/12 
 
0/12 2/12 12/12 Gill et al., 2010 
 
4.2.3 Chronic toxicity 
4.2.3.1  Mice 
B6C3F1 mice (n=50/dose/sex) were given furan in corn oil by gavage at doses of 0, 8 and 15 
mg/kg bw five days a week for 2 years. The mean body weights of both male and female mice 
in the high-dose group were lower than in the control group. From week 80 to termination of 
the study, survival of the males in both dose groups and females in the high dose group were 
lower than in the control group. The incidences of numerous non-neoplastic hepatocellular 
lesions were also increased in furan treated mice. These lesions included hepatocyte 
cytomegaly, degeneration, necrosis, multifocal hyperplasia, cytoplasmic vacuolization and 
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biliary tract dilatation, fibrosis, hyperplasia, and inflammation, and were significant for nearly 
all effects at both doses for both male and females. No NOAEL could be allocated from this 
study (NTP, 1993). 
Groups of female B6C3F1 mice were given furan by gavage at 0 (n = 50), 0.5 (n = 100), 1.0 
(n = 75), 2.0 (n = 50), 4.0 (n = 50) and 8.0 (n = 50) mg/kg bw five days a week for 2 years. 
Complete gross examination and macroscopic examination of the liver was performed at 
necropsy. There was no significant difference in the percentage of mice surviving at the 
termination of the study. In mice exposed to 2.0 and 8.0 mg furan/kg bw, there was a 
significant decrease in body weight gain from study initiation to terminal necropsy, but this 
decrease was not dose-related. In mice exposed to 4.0 and 8.0 mg furan/kg bw, absolute and 
relative liver weight were significantly increased, and a significant increase in gross liver 
nodules were observed at the same doses. A NOAEL for general toxicity of 2.0 mg/kg bw/day 
was allocated based on the increase in liver weight and gross liver nodules (Moser et al., 
2009). 
 
4.2.3.2  Rats 
F344 rats (n=70/dose/sex) were given furan by gavage at 0, 2, 4 and 8 mg/kg bw in corn oil 
for 5 days a week in 2 years. After dosing for 9 and 15 months, 10 rats from each group were 
evaluated for the presence of treatment-associated lesions. Mean body weight and survival 
were reduced in rats receiving 8 mg furan/kg from week 73 and 85, respectively. The most 
marked dose-related effects were observed in the liver. Non-neoplastic liver lesions were 
abundant in all rats administered furan at all doses, with the highest toxicity in the biliary tract 
in the liver. All effects in the biliary tract like; cyst, focal fibrosis, hyperplasia and metaplasia, 
occurred with an incidence of 88% and 98% at the lowest dose in male and female rats 
respectively. Non-neoplastic toxicity in the hepatocytes like degeneration, hyperplasia, 
necrosis and pigmentation occurred with an incidence of 36% to 98% at the lowest dose. Non-
neoplastic lesions were also observed in the hematopoietic system, like pancreatic lymph 
node, spleen and the bone marrow. No NOAEL could be allocated for chronic toxicity from 
this study. Since nearly 100% incidence of biliary tract toxicity are observed at the lowest 
dose, the data are not suitable for BMD calculations (NTP, 1993). 
 
4.2.4 Summary of general toxicity 
Furan exposure showed a dose-related toxicity in both mice and rats. The most critical 
toxicological effects were observed in the liver in both species, but rats were more sensitive to 
furan toxicity than mice. Non-neoplastic liver lesions were abundant in all rats administered 
furan at all doses in the chronic toxicity study, with the highest toxicity in the biliary tract in 
the liver. 
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4.3 Genotoxicity  
An overview of the genotoxicity studies on furan and its metabolite cis-2-butene-1,4-dial 
(BDA), with corresponding tables is presented in the following sections.  
 
4.3.1 In vitro 
4.3.1.1  Furan 
The studies commented on below are summarised in Table 34. 
Furan did not induce gene mutations when tested in the Salmonella typhimurium strains 
TA100, TA1535, TA1537 and TA98 either with or without S9-mix when tested with 33-
10.000 µg/plate (Mortelmans et al., 1986 cited in NTP, 1993).  
A concentration-dependent increase (at concentrations from 1100 to 3800 µg/ml) in gene 
mutations was found in the mouse lymphoma assay in the absence of S9-mix (McGregor et 
al., 1988, cited in NTP, 1993).  
Kellert et al., (2008b) could not reproduce this positive result for gene mutations in the mouse 
lymphoma assay without S9-mix. In the same study furan did not induce strand breaks or 
micronuclei in mouse lymphoma cells at effective concentrations (i.e. after corrections for 
decreased furan concentrations as measured by evaporation and diffusion of test materials in 
water) of 0, 0.225, 0.45, 0.9, 1.6 and 3.1 mM. No metabolic activation was used for all 
genetic end points. In the same study, BDA was also investigated for genotoxic effect (see 
section 4.3.1.2).  
At concentrations from around 5 to 200 mM (or 340 to 13614 µg/ml) furan induced a 
concentration-dependent increase in chromosomal aberrations (mainly exchanges) in Chinese 
hamster ovary (CHO) cells in the presence, but not in the absence of Aroclor 1254 induced rat 
liver S9 mix (Stich et al., 1981).  
Furan (tested up to 500 µg/mL) was weakly positive in a sister chromatid exchanges (SCE) 
test in CHO cells both in the absence and presence of S9 activation (Galloway, 1985; 1987 
cited in NTP, 1993), while it induced a concentration-dependent increase (when tested up to 
1000 µg/mL) in chromosomal aberrations in CHO cells both with and without S9 mix 
(Galloway, 1985; 1987 cited in NTP, 1993). 
Negative results were obtained in a micronucleus assay in human lymphocytes both with and 
without S9-mix when tested up to 100 mM (or 6805 µg/ml) (Durling et al., 2007).  
Exposure of rat and mouse hepatocytes to 10 mM (or 681 µg/ml) furan did not induce 
unscheduled DNA synthesis as an indicator of DNA damage (Wilson et al., 1992). This study 
was performed in conjunction with an in vivo UDS assay and the in vitro data was not shown. 
No metabolic activation was used.  
Furan was negative in the sex linked recessive lethal assay in Drosophila melanogaster (NTP, 
1993; Foureman et al., 1994).  
In addition to these studies recent data was found in a summary of the EU project “Role of 
genetic and non-genetic mechanisms in furan risk” (Dekant et al., 2007). These studies are 
not yet published and therefore used only as supplementary data. They are summarised below, 
but not included in Table 34. 
Furan and its metabolite BDA (see below) were tested for gene mutations in V79 and L5178Y 
cells at the hprt and tk locus, respectively. Furan itself was not mutagenic in either test at 
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concentrations up to the highest recommended concentration of 10 mM using 3 or 24 h 
exposure (Dekant et al., 2007).  
Furan was tested at 1.6, 2.5, 4.0, 6.3 and 10 mM in the absence and in the presence of  
optimized metabolic activation (CYP2E1) (Dekant et al., 2007). Different cell lines were 
used: “normal” lymphocytes and two lymphoblastoid cell lines from Fanconi´s anemia 
patients, the latter being special sensitive to DNA crosslinking substances. In normal 
lymphocytes furan did not induce chromosomal aberrations after 3 h exposure and 24h 
sampling time either with or without metabolic activation (CYP2E1). Surprisingly, there was 
an increase in chromosomal aberration without S9 after prolonged exposure times 24 h and 44 
h at the highest concentrations tested. The positive result without metabolic activation was 
unexpected and explained by the study authors as autoxidation of furan to DNA reactive 
metabolites (Mosesso, 2009). In Fanconi´s anemia cells furan induced chromosomal 
aberrations in the presence of optimized S9, and to a lesser extend also without S9 (Dekant et 
al., 2007).  
 
4.3.1.2 Cis-2-butene-1,4-dial (BDA) 
The studies commented on below are summarised in Table 35. 
In accordance with the possible role of cis-2-butene-1,4-dial (BDA) in furan toxicity and 
genotoxicity, it has been shown that this metabolite reacts rapidly with model protein and 
nucleic acids to form adducts (Chen et al., 1997). BDA was directly mutagenic in the S. 
typhimurium strain TA104, a strain sensitive to aldehydes and able to detect DNA-crosslinks, 
but negative in TA98, TA97, TA100 and TA102 strains (Peterson et al., 2000).  
In mouse lymphoma cells, BDA (6.3-50 µM)  induced gene mutations at the tk locus and  
DNA strand breaks in a concentration-dependent manner using the alkaline Comet assay, but 
it did not induce micronuclei (Kellert et al., 2008b).  
BDA induced DNA single-strand breaks and cross-links in CHO cells (Marinari et al., 1984). 
More recent in vitro studies have shown that BDA produced DNA adducts (Byrns et al., 
2002; Bohnert et al., 2004).  
In studies related to the EU project “Role of genetic and non-genetic mechanisms in furan 
risk” (Dekant et al., 2007), BDA was tested for gene mutations in mammalian cells (V79 and 
L5178Y cells at the hprt and tk locus, respectively) in parallel with furan. BDA was highly 
cytotoxic and induced mutations in both assays but in a very narrow concentration range. In 
the TK assay there was an increase in the relative number of small colonies indicating a 
clastogenic activity. This mode of action was confirmed by a positive response in a 
micronucleus assay in the same concentration range. BDA was only clastogenic in “normal” 
lymphocytes after 24h exposure, but was highly clastogenic in Fanconi´s anemia cell lines in 
a narrow concentration range. 
 
4.3.1.3 Summary of in vitro studies 
Furan is metabolised to a DNA reactive metabolite, BDA, by hepatic cytochromes P450 
enzymes (CYPs), predominantly CYP2E1. Furan and BDA have been tested in several in 
vitro genotoxicity tests using both bacteria and mammalian cells. BDA was found positive in 
the vast majority of studies, except for one inadequately performed micronucleus assay, 
whereas conflicting results have been obtained for furan, with many negative results in 
standard assays. 
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The in vitro genotoxicity of compounds like furan (and acrylamide) that require CYP2E1 
metabolism for activation is difficult to detect in standard in vitro genotoxicity assays due to 
inadequate metabolic activation systems. 
The negative results obtained with furan with standard S9 activation; do therefore not reflect 
absence of genotoxicity of furan via BDA, but rather a limitation of “conventional” 
genotoxicity assays to detect such compounds. When S9 with a high content of CYP2E1 was 
used in test systems, which can detect crosslinking substances, positive results for furan were 
obtained. 
Positive results have been obtained with furan without metabolic activation, which could be 
caused by artefacts due to the extremely high concentrations used in older studies, or because 
of an autooxidation of furan to DNA reactive substances after long exposure time in vitro. 
These results are not considered to be of biological relevance by VKM. 
 
Table 34: Genotoxicity of furan - In vitro studies 
Test system Test object Concentration End point Results Comments from VKM Ref. 
Ames test S. typhimurium 
TA100, 
TA1535, 
TA1537, TA98 
33, 100, 333, 1000, 3333, 10000 
µg/plate 
Gene mutations Negative (+S9) 
Negative (-S9) 
These strains cannot detect cross-linking agents. No 
appropriate metabolic activation 
NTP, 1993 
Mortelmans et al., 
1986 
Mouse 
lymphoma tk+/-  
assay  
Mouse L5178Y  
lymphoma cells 
Trial 1:125, 250, 500, 1000, 2000 
µg/mL 
Trial 2: 1400, 2000, 2600. 3200, 
3800 µg/mL 
Trial 3: 1139, 1627, 2116, 2604, 
3090 µg/mL 
Gene mutations and to some 
extent chrom. ab. 
Positive (-S9) 
(+ S9 – not tested) 
Trial 1: No effect. Trial 2: a concentration-dependent 
increase at the two highest concentrations. Trial 3: a 
concentration-dependent increase at all concentrations 
tested. LOED = 1139 µg/mL (=16.8 mM) 
These results are not considered biologically relevant 
because no metabolic activation was used 
NTP, 1993 
McGregor et al., 
1988 
Mouse 
lymphoma tk+/-  
assay 
Mouse L5178Y 
lymphoma cells 
0, 0.225, 0.45, 0.9, 1.6 or 3.1 mM 
(=211 µg/mL) 
Gene mutations and to some 
extent chrom. ab. 
Negative 
(no S9 mix used) 
Evaporation of furan in water measured, and furan conc. 
adjusted. No metabolic activation was used, in order to 
compare with previous positive results without S9 mix (NTP 
1993 and McGregor et al. 1988).  In the same study BDA 
was also tested.  
Kellert 
et al., 2008b 
Chromosomal 
aberration 
assay 
Chinese 
hamster ovary 
cells 
5 to 200 mM (340- 13610 µg/mL) Structural chrom. ab. Positive (+S9) (mainly 
exchanges) in the range 
from 100 to 200 mM 
(= 6805 to 13610 
µg/mL) 
Negative (-S9)  
A concentration-dependent increase in aberrations, at 
extremely high concentration 
Results only shown in small figures, without exact 
concentrations. Invalid study, positive only at concentrations  
above the highest recommended concentration of 10 mM 
Stich et al., 1981 
Chromosomal 
aberration 
assay 
Chinese 
hamster ovary 
cells 
0, 160, 300, 500, 1000 µg/mL 
(+S9) 
0, 100, 160, 300, 500 µg/mL (-S9) 
Structural chrom. ab. Positive (+S9) 
Positive (–S9) 
Positive at the two highest concentrations +S9 (1 test) 
Positive in two tests – S9 at all concentrations with a 
concentration related response , but not considered 
biologically relevant 
NTP, 1993 
Micronucleus 
assay 
Human 
lymphocytes 
Trial 1: 0, 2, 5, 7.5, 10, 15, 20 or 
100 mM  (=6805 µg/mL)  
Trial 2: 5, 10, 17.2 or 25 mM 
(=1701 µg/mL)  
Structural and numerical 
chrom. ab. 
Negative (+S9) 
Negative (-S9) 
Strong cytotoxicity was observed at the highest dose in both 
trials, i.e. 25 and 100 mM 
 
Durling et al., 
2007 
Micronucleus 
assay 
Mouse L5178Y 
lymphoma cells 
0, 0.225, 0.45, 0.9, 1.6 or 3.1 mM 
(=211 µg/mL) 
Structural and numerical 
chrom. ab. 
Negative 
(no S9 mix used) 
Evaporation of furan in water measured, and furan 
concentration adjusted. No metabolic activation was used. In 
the same study BDA was also tested 
Kellert et al., 
2008b 
Sister 
chromatid 
Chinese 
hamster ovary 
0, 16, 50, 160 and 500 µg/mL 
(+S9) 
Chromatid exchanges Weak positive (+S9) 
Weak positive (-S9) 
Positive in all concentrations first trial (weak concentration 
response) but only at the highest concentration in second 
NTP, 1993 
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Test system Test object Concentration End point Results Comments from VKM Ref. 
exchange test cells 0, 5, 50 and 160 µg/mL (-S9) trial–S9. Not considered biologically relevant   
Comet assay Mouse L5178Y 
lymphoma cells 
0, 0.225, 0.45, 0.9, 1.6 or 3.1 mM 
(=211 µg/mL) 
Primary DNA damage 
leading to strand breaks 
Negative 
(no S9 mix used) 
Evaporation of furan in water measured, and furan 
concentration adjusted. 
No metabolic activations used. In the same study BDA was 
also tested  
Kellert et al., 
2008b 
Unscheduled 
DNA synthesis 
Mouse and rat 
hepatocytes 
No doses given Indirect measure of DNA 
damage  
Negative 
(no S9 mix used) 
Evaporation of furan in water measured, but furan 
concentration NOT adjusted. Data not shown. No metabolic 
activation used 
Wilson et al., 1992 
Ref. – reference, chrom. ab. - chromosomal aberration, conc. – concentration, LOED – lowest observed effect dose 
 
Table 35: Genotoxicity of cis-2-butene-1,4-dial (BDA) - In vitro studies 
Test system Test object Concentration End point Results Comments from VKM Ref. 
Ames test TA98, TA 97, 
TA100, TA102 
and TA104 
1.4, 1.7, 2.1, 2.9, and 4.4 
µmol/plate  (=95, 116, 143, 197, 
299 µg/plate) 
Gene mutation Positive in TA104 –S9 
Negative in TA98, TA 
97, TA100 and TA102 
Potent inducer of gene mutation with a concentration related 
increase up to 2.1 µmol/plate, and toxic at higher 
concentrations. 
This study indicates that BDA can form DNA-DNA cross-
links. Mutagenicity was only detected in a narrow 
concentration range 
Peterson et al., 
2000  
Mouse 
lymphoma tk+/-  
assay  
Mouse L5178Y  
lymphoma cells 
6.3, 12.5, 25, 50 µM 
(= 0.4, 0.9, 1.7 3.4 µg/ml) 
Gene mutation and to some 
extend chrom. ab. 
Positive at all 
concentrations  
(-S9) 
A clear and concentration related increase at all 
concentrations. A strong cytotoxic effect observed at 50 mM 
(RTG=2%) at 25mM RTG =36% 
Three independent assays performed with the same results. 
The assay was performed together with a Micronucleus 
assay and a Comet assay with BDA and furan 
Kellert et al., 
2008b 
Micronucleus 
assay 
Mouse L5178Y  
lymphoma cells 
6.3, 12.5, 25, 50 µM (= 0.4, 0.9, 1.7 
3.4 µg/ml) 
Structural and numerical 
chrom. ab. 
Negative The assay was performed together with a gene mutation test 
and a Comet assay with BDA and furan. Inadequate 
protocol, longer treatment time should have been included 
Kellert et al., 
2008b 
Comet assay 
1. Standard 
alkaline  
2. Modified 
with gamma 
radiation  after 
BDA treatment  
Mouse L5178Y  
lymphoma cells 
6.3, 12.5, 25, 50 µM 
(= 0.4, 0.9, 1.7 3.4 µg/ml) 
DNA strand breaks and DNA 
cross-links 
1. Positive for strand 
breaks 
2.No indication of 
formation of DNA 
cross-links  
The assay was performed together with a gene mutation test 
and a Micronucleus assay with BDA and furan 
Kellert et al., 
2008b 
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Test system Test object Concentration End point Results Comments from VKM Ref. 
Alkaline 
elution with 
and without 
exposure to 
MMS 
CHO-K1 cells 0.17, 0.5 and 1.5 mM DNA breaks and DNA cross-
links 
Positive for strand 
breaks; increase in 
elution without MMS 
Positive for cross-links; 
decrease in elution with 
MMS 
 Marinari et al., 
1984 
Mouse 
lymphoma tk+/-  
assay  
 
Mouse L5178Y  
lymphoma cells 
Not given 
3 and 24 h exposure 
Genmutations and to some 
extend chrom. ab. 
Positive in a narrow 
concentration range 
close to cytotoxic 
concentrations. 
Increase in small 
colonies  
BDA was tested in parallel with furan.  
Summary report only 
Dekant et al., 2007 
Gene mutation 
at the hprt 
locus 
V79 cells Not given 
3 and 24 h exposure 
Gene mutations  Positive in a narrow 
concentration range 
close to cytotoxic 
concentrations 
BDA was tested in parallel with furan. 
Summary report only 
Dekant et al., 2007 
Micronucleus 
assay 
Mouse L5178Y  
lymphoma cells 
Not given 
3 and 24 h exposure 
Structural and numerical 
chrom. ab. 
Positive BDA was tested in parallel with furan. 
Summary report only 
Dekant et al., 2007 
Chromosomal 
aberration test 
“Normal human 
lymphocytes” 
1.6, 2.5, 4.0, 6.3 and 10 mM  
3 and 24 h exposure 
Structural chrom. ab. Positive but only after 
long treatment (24h) 
BDA was tested in parallel with furan. 
Summary report only 
Dekant et al., 2007 
Chromosomal 
aberration test 
Lymphoblastoi
d cell line from 
Fanconi´s 
anaemia 
patients 
3 and 24 h exposure Structural chrom. ab. Highly clastogenic BDA was tested in parallel with furan. 
Summary report only. This cell line is known to be special 
sensitive to DNAcross-linking agents 
Dekant et al., 2007 
Ref. – reference, chrom. ab. - chromosomal aberration 
 
4.3.2 In vivo 
4.3.2.1  Furan 
Rats 
Liver  
The studies commented on below are summarised in Table 36. 
After single oral exposure at doses up to 200 mg/kg body weight in male Fischer 344 rats, 
furan did not induce unscheduled DNA synthesis in the liver (Wilson et al., 1992). However, 
the UDS assay only detects bulky DNA adducts and is considered to be insensitive to 
genotoxicity resulting from misrepair and non-repair, and therefore has been considered 
unsuitable to demonstrate the absence of genotoxicity of furan in vivo (Heppner and Schlatter, 
2007; Leopardi et al., 2010).  
In a very recent study (Neuwirth et al,. 2012) from the EU project “Role of genetic and non-
genetic mechanisms in furan risk”, it was reported that in male rats treated with [3,4-14C]-
furan at a known carcinogenic dose (2 mg/kg bw) and a dose closer to estimated human 
exposure (0.1 mg/kg bw) a significant, dose-dependent increase in the 14C-content in the rat 
liver DNA was observed.  In this study it was stated that the majority of the 14C label was not 
associated with unmodified nucleotides, suggesting that the increase in 14C-content in DNA 
extracted from livers of rats treated with 14C-furan is primarily due to covalent binding to 
DNA rather than metabolic incorporation. Although, the structure of the furan-derived DNA 
adducts remains to be identified, this study indicates that furan metabolites can also react with 
DNA in vivo (Neuwirth et al., 2012). In the same study, DNA damage, measured by the 
Comet assay, was observed in the liver at the high dose.  
In another recent study, McDaniel et al. (2012) tested furan in Big Blue rats. The rats were 
dosed 5 times a week for 8 weeks with 2 doses of furan used in the NTP cancer bioassay (2 
and 8 mg/kg bw/day) and two higher doses (16 and 30 mg/kg bw/day). Several genetic end 
points were measured at different time points either in the liver or in blood/bone marrow (see 
below). In the liver, gene mutations were measured at the cII gene and DNA damage by the 
Comet assay. Furan induced DNA damage measured by the Comet assay occurred at the two 
highest doses in a dose-related manner, but gene mutations were not observed at the cII locus 
at any of the tested doses. Liver toxicity was observed at the highest tested dose (30 mg/kg 
bw). As discussed by the study authors the discrepancy between the results in these assays on 
the liver could be due to non-optimal sampling times (time between last treatment and time of 
sampling), which is later discussed in section 4.3.2.2.  
 
Table 36: Genotoxicity of furan - In vivo studies in rat – Liver 
Test system Test object 
and route of 
exposure 
Dose End point Results Comments from 
VKM  
Ref. 
Unscheduled DNA 
synthesis 
Male F-344 rats 
(n = 3)  
Gavage 
5, 30 and 100 
mg/kg bw 
Indirect measure 
of DNA damage. 
Negative Limited relevance as 
assay only detects 
bulky DNA adducts 
Wilson et al., 
1992 
DNA adducts in 
liver 
Male F-344 rats 
Gavage 
0, 0.1 and 2 mg/kg 
bw of [3,4-14C]-
furan 
DNA adducts  Positive Dose related increase 
in 14C rat liver DNA 
 
Neuwirth et 
al., 2012  
Comet assay on 
liver 
Male F-344 rats 
Gavage 
0, 0.1, 0.5 and 2 
mg/kg bw for  28 
days (5 days per 
week) 
Primary DNA 
damage leading to 
strand breaks 
Positive - Neuwirth et 
al., 2012  
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Test system Test object 
and route of 
exposure 
Dose End point Results Comments from 
VKM  
Ref. 
cII gene mutation 
test on liver 
Big Blue rats 
Gavage 
2, 8, 16, 30 mg/kg 
bw for 8 weeks (5 
days a week) 
Gene mutations Negative To short expression  
time for the fixation 
of mutations 
McDaniel et 
al., 2012 
Comet assay on 
liver 
Big Blue rats 
Gavage 
2, 8, 16, 30 mg/kg 
bw for 8 weeks (5 
days a week) 
Primary DNA 
damage  leading to 
strand breaks 
Positive at 
the 2 
highest 
(toxic 
doses) 
To long sampling 
time for the Comet 
assay. Standard 
Comet assay cannot 
detect crosslinks 
McDaniel et 
al., 2012 
Ref. – reference 
 
Spleen 
In the study by Neuwirth et al. (2012), oral administration of furan to Fischer rats of 0, 0.1, 
0.5 and 2 mg/kg bw/day by gavage for 4 weeks (5 days per week) induced significant 
increases of chromosomal aberrations in G0 splenocytes after growth stimulation in vitro (see 
Table 37).  
 
Table 37: Genotoxicity of furan - In vivo studies in rat – Spleen 
Test system Test object 
and route of 
exposure 
Dose End point Results Comments from VKM  Ref. 
Chromosomal 
aberrations in G0 
splenocytes 
After growth 
stimulation in vitro
 
Male F-344 rats 
Gavage 
0, 0.1, 0.5 and 2 
mg/kg bw for  5 
and 28 days (5 
days per week) 
Structural 
chrom. ab. 
Positive Accumulation in G0 cells 
expression after growth 
stimulation in vitro 
Neuwirth et 
al., 2012  
Ref. – reference, chrom. ab. - chromosomal aberration 
 
Bone marrow and peripheral blood 
The studies commented on below are summarised in Table 38. 
In the same study by Neuwirth et al. (2012), negative results were obtained for induction of 
micronuclei, chromosomal aberrations and sister chromatid exchanges and DNA strand 
breaks measured by the Comet assay in the bone marrow of male F344/N rats orally dosed 
with 0.1, 0.5 and 2 mg/kg bw/day for 5 and 28 days, followed by a 2 week recovery period. 
The study authors explained the negative results in the bone marrow by limited distribution of 
the furan-metabolite BDA to the bone marrow and a selective elimination of cells with 
damaged DNA due to cell proliferation.  
In the Big Blue rat study by McDaniel et al. (2012), furan genotoxicity was also tested in the 
bone marrow and on peripheral blood. Twenty four hours after the 5th dose (one week of 
dosing) blood samples were taken and used to assay for micronucleus (MN) frequency in 
normachromatic erythrocytes (NCEs) and reticulocytes (RETs) and Pig-a gene mutations in 
total red blood cells (RBCs). Twenty four hours after the last dose of the 8-week treatment 
schedule, the rats were sacrificed and their tissues were used to perform NCE and RET MN 
assays, the Pig-a RBC assay,  Pig-a and hprt lymphocyte gene mutation assay. Negative 
responses were obtained for all the gene mutation assays and the MN assays at both sampling 
times. As discussed by the study authors the negative result in the MN, Pig-a and hprt assays 
could be explained by the fact that the putative genotoxic metabolite, BDA, is likely formed 
in the liver and due to its high reactivity will react with the liver constituents and not reach the 
bone marrow.  
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Table 38: Genotoxicity of furan - In vivo studies in rat – Bone marrow or peripheral blood  
Test system Test object 
and route 
of 
exposure 
Dose End point Results Comments 
from VKM  
Ref. 
Pig-a gene 
mutation test and 
hprt gene 
mutation assay on 
blood cells 
Big Blue rats 
Gavage 
2, 8, 16, 30 mg/kg 
bw for 8 weeks (5 
days a week)  
Gene mutations Negative Substance may not 
have reach the 
target organ 
 
McDaniel et al., 
2012 
Micronuclei on 
blood cells and 
bone marrow  
Big Blue rats 
Gavage 
2, 8, 16, 30 mg/kg 
bw for 8 weeks (5 
days a week)  
Structural and 
numerical chrom. 
ab. 
Negative Substance may not 
have reach the 
target organ 
Mc Daniel et 
al., 2012 
Micronuclei, 
Chrom. ab. and 
SCE in bone 
marrow 
Male F-344 
rats 
Gavage 
0, 0.1, 0.5 and 2 
mg/kg bw for 5 
and 28 days (5 
days per week) 
Structural and 
numerical chrom. 
ab. and chromatid 
exchanges 
Negative Substance may  
not have reach  
target organ 
Neuwirth et al., 
2012  
Comet assay in 
bone marrow and 
blood cells 
Male F-344 
rats 
Gavage 
2 mg/kg bw for 5 
and  28 days (5 
days per week) 
Primary DNA 
damage  leading to 
strand breaks 
Negative Substance may  
not have reach 
target organ 
Neuwirth et al., 
2012  
Ref. – reference, chrom. ab. - chromosomal aberration 
 
Mice 
Liver 
The studies commented on below are summarised in Table 39. 
After oral exposure at single doses up to 100 mg/kg body weight in male B6C3F1 mice, furan 
did not induce unscheduled DNA-synthesis in the liver (Wilson et al., 1992). However, the 
UDS assay only detects bulky DNA-adducts and is considered to be insensitive to 
genotoxicity resulting from misrepair and non-repair, and therefore has been considered 
unsuitable for demonstrating the absence of genotoxicity of furan in vivo (Heppner and 
Schlatter, 2007, Leopardi et al., 2010).  
In order to study the mode of action of the liver carcinogenicity of furan, Cordelli and co-
workers (2010) investigated different end points, including genotoxicity, involved in the 
development of cancer in the liver of B6C3F1 mice in a 28-day repeated oral toxicity study 
using the same dose levels as in the NTP carcinogenicity study (2, 4, 8 and 15 mg/kg bw/day).  
No induction of DNA double-strand breaks, measured as λ-H2AX foci, increase in overall 
DNA methylation, or induction of DNA single-strand breaks or cross-links measured by the 
Comet assay after repeated exposure to relative low doses of furan were observed. However, 
there was an over-expression of several DNA repair genes, which according to the authors 
could be an indirect evidence of genotoxicity, also indicating that the Comet assay cannot 
detect furan induced DNA damage at low exposure levels. 
In addition, there was a significant increase in polyploid (8N) and endo-reduplicated liver 
cells, which according to the study authors could be associated with accumulation of DNA 
damage.  
In the same study by Cordelli et al. (2010), administration of a single dose of furan (15, 100, 
250 mg/kg bw) gave an increase of DNA damage in the liver measured by the Comet assay at 
the highest toxic dose (250 mg/kg bw) and a distinct decrease in λ-ray DNA damage 
indicating the induction of DNA cross-links, possibly due to the metabolite BDA. 
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Table 39: Genotoxicity of furan - In vivo studies in mice – Liver 
Test system Test object 
and route of 
exposure 
Dose End point Results Comments 
from VKM 
Ref. 
Unscheduled 
DNA synthesis 
Male 
B6C3F1/CrIBR 
mice (n = 1-4) 
Gavage 
5, 50, 100 and  
200 mg/kg bw 
Indirect measure 
of DNA damage. 
Negative Limited relevance 
as assay only 
detects bulky 
DNA adducts 
Wilson et 
al., 1992 
Comet assay Male B6C3F1 
mice (n = 7-9) 
Gavage 
0, 2, 4, 8 or 15 
mg/kg bw/day for 
28 days 
Primary DNA 
damage  leading to 
strand breaks 
Negative 
(liver) 
 Cordelli et 
al., 2010 
Comet assay Male B6C3F1 
mice (n = 5-6) 
Gavage 
Single dose of 0, 
15, 100 or 200 
mg/kg bw 
Primary DNA 
damage leading to 
strand breaks 
Positive 
(liver) 
Positive in liver at 
the highest dose, 
with liver toxicity 
Cordelli et 
al., 2010 
Comet assay 
(modified with 
γ-ray) 
Male B6C3F1 
(n = 5-6) 
Gavage 
Single doses of 0, 
15, 100 or 250 
mg/kg bw 
Cross binding of 
DNA  
Positive 
(liver) 
Positive in liver at 
the highest dose, 
with liver toxicity 
Cordelli et 
al., 2010 
Ref. – reference 
 
Spleen 
The studies commented on below are summarised in Table 40. 
Due to the ability of splenocytes to accumulate DNA damage, the spleen was selected as the 
target organ for genotoxicity assessment in another in vivo genotoxicity study with furan by 
the same research group as above (Leopardi et al., 2010). Male B6C1F1 mice were given 
furan by gavage at doses 0, 2, 4, 8 or 15 mg/kg bw/day five days a week for 28 days. In 
another experiment by Leopardi et al. (2010), mice were exposed to single doses of 0, 15, 100 
or 200 mg/kg bw of furan.  
In mitogen-stimulated splenocytes a dose-dependent increase in micronucleated binucleate 
splenocytes was observed after 28 days of furan exposure. Also, an increase in induction of 
DNA double-strand breaks, measured as λ-H2AX foci, was observed at the two highest dose-
levels. The authors concluded that these results indicate that furan exposure in vivo gives rise 
to pre-mutagenic lesions, which can be converted to chromosomal aberrations after growth 
stimulation. After acute exposure to much higher doses a treatment related trend in 
micronucleated binucleate splenocytes was observed, which, however, did not reach statistical 
significance.   
In non-stimulated isolated splenocytes furan did not induce strand breaks in the Comet assay 
after both acute and 28 days furan exposure, which could be due to formation of DNA-DNA 
cross-links, which is not expected to be detected in a standard Comet assay. However, in a 
modified Comet assay no indication of DNA cross-linking was observed in splenocytes after 
γ-ray treatment (Leopardi et al., 2010). 
 
Table 40: Genotoxicity of furan - In vivo studies in mice – Spleen 
Test system Test object 
and route of 
exposure 
Dose End point Results Comments 
from 
VKM 
Ref. 
Comet assay Male B6C3F1 
(n = 5-6) 
Gavage 
0, 2, 4, 8 or15 
mg/kg bw/day for 
28 days 
Primary DNA 
damage  leading to 
strand breaks 
Negative 
(splenocytes) 
 Leopardi et 
al., 2010 
Micronucleus 
assay 
(splenocytes) 
Male B6C3F1 
(n = 5-6) 
Gavage 
0, 2, 4, 8 or15 
mg/kg bw/day for 
28 days 
Structural and 
numerical chrom. 
ab. 
Positive 
(growth 
stimulated 
Dose-
dependent 
increase 
Leopardi et 
al., 2010 
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Test system Test object 
and route of 
exposure 
Dose End point Results Comments 
from 
VKM 
Ref. 
and λ-H2AX foci splenocytes) 
Comet assay  Male B6C3F1 
(n = 5-6) 
Gavage 
Single doses of 0, 
15, 100 or 250 
mg/kg bw 
Primary DNA 
damage leading to 
strand breaks 
Negative 
(splenocytes) 
 Leopardi et 
al., 2010 
Comet assay 
(modified with γ-
ray) 
Male B6C3F1 
(n = 5-6) 
Gavage 
Single doses of 0, 
15, 100 or 250 
mg/kg bw 
Cross binding of 
DNA 
Negative 
(splenocytes) 
 Leopardi et 
al., 2010 
Ref. – reference, chrom. ab. - chromosomal aberration 
 
Bone marrow 
The studies commented on below are summarised in Table 41. 
Intraperitoneal injection of furan was given to male B6C3F1 mice. Bone marrow cells were 
analysed for chromosomal aberrations (CA) and sister chromatid exchange (SCE). Furan 
induced structural CA but not SCE after doses up to 350 mg/kg bw (trial 1, harvest after 17 
hours) and after doses up to 250 mg/kg bw (trial 2 and 3, harvest after 36 hours) (NTP, 1993). 
Durling et al. (2007) performed 3 in vivo micronucleus assays with different furan exposure 
routes: intraperitoneal or subcutaneous injection of furan in male Balb/C mice (0–300 and 0–
275 mg/kg body weight, respectively) and intraperitoneal injection of male CBA mice (0 and 
225 mg/kg body weight). In these experiments, no increased levels of micronucleated 
erythrocytes were detected when a sensitive flow cytometric method was used.  
 
Table 41: Genotoxicity of furan - In vivo studies in mice – Bone marrow  
Test system Test object 
and route of 
exposure 
Dose End point Results Comments 
from VKM 
Ref. 
Chromosomal 
aberration test 
Male B6C3F1 
(n = 10) 
Ip injection 
0, 87.5, 175 or 350 mg/kg 
bw (trial 1 harvested after 
17 hours) 
0, 62.5, 125,or 250 mg/kg 
bw (trial 2 and 3, 
harvested after 36 hours) 
(n = 10) 
Structural 
chrom. ab. 
Positive Positive at 
highest dose 
(250 mg/kg bw) 
in trial 2 and 3, 
when cells are 
harvested after 
36 hours  
NTP, 1993 
Micronucleous 
assay  
Male Balb/C 
and male CBA 
mice 
Ip and sc 
injections 
Balb/C: 0 – 300 mg/kg bw 
Ip, 0 – 275 mg/kg bw sc 
CBA (n = 2-3) 0 – 225 
mg/kg bw ip  
Structural and 
numerical 
chrom. ab. 
Negative  Durling et 
al., 2007 
Sister chromatid 
exhange 
Male B6C3F1  
Ip injection 
0, 87.5, 175 or 350 mg/kg 
bw (trial 1 harvested after 
23 hours).  0, 25, 50 or 100 
mg/kg bw (trial 2 
harvested after 42 hours) 
Chromatid 
exchanges 
Negative  NTP, 1993 
Ref. – reference, chrom.ab. - chromosomal aberration, Ip – intraperitoneal, sc – subcutaneous  
 
Turkey 
 
Turkey eggs (BELT) assay 
The studies commented on below are summarised in Table 42. 
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In recent study by Jeffrey et al. (2012) the DNA damaging effect of furan was studied in 
livers of turkey fetuses using the Comet assay. The turkey eggs assay has previously been 
used as an alternative to carcinogenicity/genotoxicity assays with the liver as target organ 
(Enzmann et al., 1992, 1995; Enzmann and Brunnemann, 1997; Brunnemann et al., 2002; 
Perrone et al., 2004; Williams et al., 2011a,b) and the assay is referred to as the Bird Egg 
Liver Toxicity (BELT) assay. It has been shown (Perrone et al., 2004) that turkey fetal livers 
on day 20 of development expressed a variety of xenobiotic biotransformation enzymes, 
which can activate pro-carcinogens like 2-acetylaminofluorene, aflatoxin B1, 2-amino-3,8-
dimethylimidazo[4,5-f]quinoxaline, benzo[a]pyrene, and 4,4´-methylenebis-(2-chloroaniline), 
and that all compounds formed DNA adducts as measured by 32P-postlabeling and DNA 
strand breaks as measured by the Comet assay (Williams et al., 2011b).  
In this study by Jeffrey et al. (2012) a single dose of furan was injected into turkey eggs at 
day 23 after start of incubation of eggs at 37ºC. At this time the liver is well developed. After 
24 hours of exposure to different doses (2-20 µmoles), the livers were removed from the 
fetuses. The “normal” alkaline Comet assay was performed on liver cells for the detection of 
DNA strand breaks and a modification of the Comet assay, with proteinase K, was performed 
for the detection of DNA strand breaks in the presence of DNA-protein crosslinks (DPXL). 
1,3-Propandiol (PDO), which is metabolized to the dialdehyde, malondialdehyde (MDA), was 
used as a positive control for induction of DPXL. In the Comet assay without proteinase K a 
dose related decrease in % DNA in tail, as a measure of DNA strand breaks was observed. 
This effect (the negative slope) was consistently observed in 7 independent experiments, 
indicating that furan induced DPXL in turkey fetal liver cells. On the contrary, a positive 
slope was observed with proteinase K, indicative of removal of DPXL and expression of 
single and/or double DNA strand breaks. This study clearly indicated that furan induced 
DPXL and DNA single and/or double strand breaks. Effects were observed at low exposures, 
corresponding to 2 µmol/0.6 g liver (= 0.23 mg/g liver), assuming that the entire 
administrated dose was metabolised by the liver.  
For comparison, in the study by Cordelli et al. (2010) the lowest effective dose in the Comet 
assay on mouse liver corresponded to 5.12 mg/g liver. 
 
Table 42: Genotoxicity of furan in liver of turkey foetuses (Jeffrey et al., 2012) 
Test system Test object 
and route of 
exposure 
Dose End point Results 
Standard Comet assay 
on liver of foetuses 
BELT assay on 
Turkey eggs 
2-20 µ mol 
for 24 hours 
Primary DNA damage  leading 
to strand breaks 
Negative, but with indication of DNA-
DNA cross-links (dose dependant 
decrease in DNA damage) 
Modified Comet assay 
for the detection of 
crosslinking agents on 
liver of fetuses 
BELT assay on 
Turkey eggs 
2-20 µ mol  
for 24 hours 
Primary DNA damage  leading 
to strand breaks and DNA-
protein crosslinks 
Positive 
(DNA-protein cross-links) 
 
 
 
4.3.2.2 Summary of in vivo studies 
In vivo experiments on genotoxicity of furan showed conflicting results. Furan has been tested 
in different species: rats, mice and turkey fetuses and different organs: liver, spleen and bone 
marrow/peripheral blood.  
Only few studies have been published on the genotoxicity of furan in rats so far.  Negative 
results were obtained for the induction of UDS in the liver at a relative high dose. However 
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DNA adducts were measured after exposure to low doses and also DNA damage measured by 
the Comet assay (Neuwirth et al., 2012). In another recent study in rats (McDaniel et al. 
(2012)), furan induced DNA strand breaks but not gene mutations in the liver.  
VKM finds it surprising that increase in mutations was not observed in the rat liver in the cII 
assay at doses that were higher than used in the NTP cancer bioassay, with clear liver toxicity 
at the highest dose (30 mg/kg bw), while positive responses were observed in the Comet 
assay. The discrepancy between the results in these assays could be due to the repair of the 
primary DNA damage measured in the Comet assay or cell death (apoptosis/necrosis) of cells 
with DNA damage. It should be mentioned that DNA damage is only observed at high toxic 
doses. On the other hand, the negative results could also be due to non-optimal sampling 
times (time between last treatment and time of sampling). In order to save animals, the same 
sampling time (24 hours) was used for all genetic end points in the present study. The 
sampling time is the period needed for a mutation to be fixed and is a critical variable in 
mutation tests. A sampling time of 3 days is recommended for fast proliferating tissues 
(OECD 488), and an even longer sampling time may be needed for slow proliferating tissues 
as the liver. Therefore, the sampling time for the cII assay might be too short, although some 
accumulation of mutants could be expected during the 8 weeks treatment time. For the Comet 
assay the sampling time is longer than recommended (2-6 hours), and in a study by Ding et al. 
(2012) the optimal sampling time for the Comet assay performed on rats orally exposed to 16 
mg/kg bw of furan was claimed to be 1 hour. It is therefore possible that at a shorter sampling 
time a higher response at lower doses would have been observed.  Unfortunately, this very 
comprehensive study cannot give a clear answer to the question on the mechanism of action 
(MOA) of furan toxicity, although the study authors concluded that the results point to a non-
genotoxic mode of action.  
The data on mitogen-stimulated splenocytes in mice is supported by a similar study in rats, 
where low doses induced chromosomal aberrations in mitogen stimulated splenocytes 
(Neuwirth et al., 2012). 
Also in rats, genotoxicity data performed on bone marrow or peripheral blood cells were 
consistently negative for gene mutations, CA, MN, SCE and DNA strand breaks.  
In mice the most important studies were performed by Cordelli et al. (2010), and Leopardi et 
al. (2010). They used the same mouse strain, exposure route and doses as in the NTP 
carcinogenicity study as well as higher acute doses. At the low doses there were only 
indications of genotoxicity in the liver (overexpression of several DNA repair genes). Furan 
induced DNA strand breaks and showed indication of DNA-cross-links, measured by the 
Comet assay, in the liver, but at high acute doses only. No induction of DNA repair was 
measured in the UDS assay. 
At low repeated doses furan induced micronuclei and cross-links in mitogen stimulated 
splenocytes. DNA damage was not observed in non-stimulated splenocytes. 
Several studies performed on the bone marrow with different exposure routes were 
consistently negative for CA, MN and SCE. 
In the liver of turkey fetuses relatively low doses of furan induced a dose-dependent decrease 
in DNA strand breaks in the standard Comet assay. In a modified version, where DNA-
protein crosslinks were cleaved by proteinase K, a dose-dependent increase was observed in 
DNA strand breaks. This study gives a clear indication that furan, or its reactive metabolite, 
BDA, can cause DNA-DNA and DNA-protein crosslinks.  
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4.3.3 Summary of genotoxic effect of furan and BDA  
In in vitro studies conflicting results have been obtained for furan, with many negative results 
in standard assays. However, genotoxic effects of furan were found in vitro, but only when 
tested under appropriate test conditions, whereas its metabolite BDA was consistently 
genotoxic, with a much higher potency than the parent compound. In general, mainly 
chromosomal aberrations were induced, but gene mutations in mammalian cells and in special 
sensitive strains of Salmonella typhimurium were also observed. Some of the negative results 
found in vitro with furan might be due to: 1) volatility of furan with subsequent reduction in 
test media/plates concentrations, 2) the insensitivity of the assay for the specific end point 3) 
inadequate metabolic activation of furan to BDA. 
In vitro studies with BDA, the active metabolite of furan, were positive in a narrow 
concentration range in nearly all studies reported. To VKM’s knowledge, no in vivo studies 
on genotoxicity of BDA have been performed. 
Recent in vivo studies of furan, where different end points of genotoxicity and the expression 
of DNA damage related genes were measured, show genotoxic effects in the spleen and 
possibly also in the liver even at low exposure levels. At high exposure levels, DNA damage 
was measured in the liver of mice and rats, when standard tests were performed. DNA-DNA 
and DNA-protein crosslinks were observed in the liver of turkey fetuses at low exposure 
level, when the assay was modified to detect these specific kinds of DNA damages. 
Although furan produced negative results in some in vivo studies, many of these negative in 
vivo tests may not be the most relevant for genotoxicity testing of furan (gene mutations in 
blood cells, micronucleus assay in bone marrow in rodents and UDS assay in liver). 
The negative results obtained for furan in vivo could be due to: 1) the genotoxic effects were 
measured in other tissues than the target organ (liver), and the reactive metabolite, BDA, did 
not reach these tissues, 2) a crosslinking agent like BDA is not detected in standard 
genotoxicity tests (e.g. the standard Comet assay) or only at high exposure level, 3) DNA 
damages were not detected due to non-appropriate sampling times used in some in vivo 
studies.  
As supporting evidence to a genotoxic mechanism of action, for the carcinogenicity of furan, 
radio labelled furan has recently been reported to bind to DNA in a dose-dependent manner 
after oral exposure to male rats at low doses (close to the estimated human exposure dose).   
Available in vivo data with furan indicate that a reactive metabolite, most likely BDA, is 
formed and that this metabolite can react with DNA and induce mutations. To VKM’s 
knowledge, no in vivo studies on genotoxicity of BDA have been performed, but BDA was 
found genotoxic in several in vitro tests. VKM therefore considers that genotoxic mechanisms 
in furan induced carcinogenesis cannot be excluded. 
 
4.4 Carcinogenicity  
4.4.1 Mice 
B6C3F1 mice (n=50/dose/gender) were given furan in corn oil by gavage at doses of 0, 8 and 
15 mg/kg bw five days a week for 2 years (see also section for chronic toxicity). The 
incidence of hepatocellular adenomas and carcinomas both separately and in combination 
were significantly increased in both male and female mice in both dose groups (Table 43). 
NTP concluded that there is a clear evidence of carcinogenicity for both male and female 
mice based on the liver tumours (NTP, 1993). 
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Groups of female B6C3F1 mice were given furan by gavage at 0 (n = 50), 0.5 (n = 100), 1.0 
(n = 75), 2.0 (n = 50), 4.0 (n = 50) and 8.0 (n = 50) mg/kg bw five days a week for 2 years. 
Complete gross examination and macroscopic examination of the liver was performed at 
necropsy. A statistical significant increase in the incidence of hepatocellular foci in mice 
exposed to 4.0 and 8.0 mg furan/kg bw was observed. Significant increases in the incidence of 
hepatocellular adenomas were also observed in the same dose groups. Hepatocellular 
carcinomas significantly increased in mice exposed to 8.0 mg furan/kg bw, and combined 
adenomas and carcinomas were significantly increased in mice exposed to 4.0 and 8.0 mg 
furan/kg bw (Moser et al., 2009).  
 
Table 43: Incidences of tumours in mice taken from NTP (1993) and Moser et al., (2009)  
Tumour 
Females 
Ref. Control 0.5 
mg/kg 
1 
mg/kg 
2 
mg/kg 
4 
mg/kg 
8 
mg/kg 
15 
mg/kg 
Hepatocellular adenomas 5/50 (10%) - 
 
- 
 
- - 
31/50* 
(62%) 
48/50* 
(96%) 
NTP,  
1993 
Hepatocellular 
carcinomas 
2/50 
(4%) - 
 
- 
 
- - 
7/50* 
(14%) 
27/50* 
(54%) 
NTP,  
1993 
Hepatocellular adenomas 
and carcinomas 
7/50 
(14%) - - - - 
34/50* 
(68%) 
50/50* 
(100%) 
NTP,  
1993 
Hepatocellular adenomas 3/36 (8%) 
4/72 
(6%) 
4/53 
(8%) 
4/41 
(10%) 
11/36* 
(31%) 
25/39* 
(64%) - 
Moser et 
al., 
2009 
Hepatocellular 
carcinomas 
0/36 
(0%) 
4/72 
(6%) 
4/53 
(4%) 
1/41 
(2%) 
2/36* 
(6%) 
11/39* 
(28%) - 
Moser et 
al., 
2009 
Hepatocellular adenomas 
and carcinomas 
3/36 
(8%) 
8/72 
(11%) 
6/53 
(11%) 
5/41 
(12%) 
12/36 
(33%) 
29/39 
(74%) - 
Moser et 
al., 
2009 
Tumour 
Males 
Ref. Control 0.5 
mg/kg 
1 
mg/kg 
2 
mg/kg 
4 
mg/kg 
8 
mg/kg 
15 
mg/kg 
Hepatocellular adenomas 20/50 (40%) - 
 
- 
 
- - 
33/50* 
(66%) 
42/50* 
(84%) 
NTP, 
1993 
Hepatocellular 
carcinomas 
7/50 
(14%) - 
 
- 
- - 
32/50* 
(64%) 
34/50* 
(68%) 
NTP, 
 1993 
Hepatocellular adenomas 
and carcinomas 
26/50 
(52%) - - - - 
44/50* 
(88%) 
50/50* 
(100%) 
NTP, 
1993 
*Significant increase as compared to control mice. 
- denotes “not tested”. 
 
4.4.2 Rats 
F344 rats (n=70/dose/gender) were given furan by gavage at 0, 2, 4 and 8 mg/kg bw in corn 
oil for 5 days a week in 2 years. After dosing for 9 and 15 months, 10 rats from each group 
were evaluated for the presence of treatment-associated lesions. A significant and dose-related 
increase in the incidence of cholangiocarcinomas was observed in male and female rats in the 
9-month interim study (Table 44). In the 15-month interim study, 78% and 90% incidences of 
cholangiocarcinomas were observed at the lowest dose in males and females, respectively. In 
all dose groups in the 2-year study, cholangiocarcinomas of the liver were observed with an 
overall rate of 98% in female rats at all doses after 2 years (Table 44). The incidences of 
hepatocellular adenomas and carcinomas (both separate and combined) increased significantly 
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and dose-dependent in male rats after 2-years at 4 and 8 mg/kg bw. Hepatocellular adenomas 
increased significantly in female rats at the same dose levels. The incidence of mononuclear 
cell leukemia increased in male and female rats receiving 4 and 8 mg furan/kg bw, and the 
incidence of the 8 mg/kg bw group exceeded the historical control ranges for corn oil gavage 
studies. NTP concluded that there is a clear evidence of carcinogenicity in both male and 
female rats based on liver tumours, cholangiocarcinoma and mononuclear cell leukemia 
(NTP, 1993).  
 
Table 44: Incidence of tumours in rats taken from NTP (1993). 
Tumour 
Females 
Ref. Control 2 
mg/kg 
4 
mg/kg 
8 
mg/kg 
Cholangiocarcinomas 
(9-month interim) 
0/10 
(0%) 
4/10* 
(40%) 
9/10* 
(90%) 
10/10* 
(100%) 
NTP, 
1993 
Cholangiocarcinomas 
(15-month interim) 
0/9 
(0%) 
9/10* 
(90%) 
9/9* 
(100%) 
7/7* 
(100%) 
NTP, 
1993 
Cholangiocarcinomas 0/50 (0%) 
49/50* 
(98%) 
50/50* 
(100%) 
48/50* 
(96%) 
NTP, 
1993 
Hepatocellular adenomas  0/50 (0%) 
2/50 
(4%) 
4/50* 
(8%) 
7/50* 
(14%) 
NTP, 
1993 
Hepatocellular 
carcinomas 
0/50 
(0%) 
0/50 
(0%) 
0/50 
(0%) 
1/50 
(2%) 
NTP, 
1993 
Hepatocellular adenomas 
and carcinomas 
0/50 
(0%) 
2/50 
(4%) 
4/50* 
(8%) 
8/50* 
(16%) 
NTP, 
1993 
Mononuclear cell 
leukemia 
8/50 
(16%) 
9/50 
(18%) 
17/50* 
(34%) 
21/50* 
(42%) 
NTP, 
1993 
Tumour 
Males 
Ref. Control 2 
mg/kg 
4 
mg/kg 
8 
mg/kg 
Cholangiocarcinomas 
(9-month interim) 
0/10 
(0%) 
5/10* 
(50%) 
7/10* 
(70%) 
10/10* 
(100%) 
NTP, 
1993 
Cholangiocarcinomas 
(15-month interim) 
0/9 
(0%) 
7/9* 
(78%) 
9/9* 
(100%) 
6/6* 
(100%) 
NTP, 
1993 
Cholangiocarcinomas 0/50 (0%) 
43/50* 
(86%) 
48/50* 
(96%) 
49/50* 
(98%) 
NTP, 
1993 
Hepatocellular adenomas  1/50 (2%) 
4/50 
(8%) 
18/50* 
(36%) 
27/50* 
(54%) 
NTP, 
1993 
Hepatocellular 
carcinomas 
0/50 
(0%) 
1/50 
(2%) 
6/50* 
(12%) 
18/50* 
(36%) 
NTP, 
1993 
Hepatocellular adenomas 
and carcinomas 
1/50 
(2%) 
5/50 
(10%) 
22/50* 
(44%) 
35/50* 
(70%) 
NTP, 
1993 
Mononuclear cell 
leukemia 
8/50 
(16%) 
11/50 
(22%) 
17/50* 
(34%) 
25/50* 
(50%) 
NTP, 
1993 
*Significant increase as compared to control rats. – denotes “not tested”. 
 
4.4.3 Summary of carcinogenicity 
The carcinogenicity studies show significant correlation between furan dose and increasing 
incidence of hepatocellular adenomas and carcinomas in male and female mice and rats. In 
addition, a dose-dependent increase in mononuclear cell leukemia was observed in male and 
female rats. The increase in cholangiocarcinomas in male and female rats was considered by 
VKM as the most adverse tumour development observed in rodents, with a 98% incidence 
already at the lowest furan dose in female rats. The background level of cholangiocarcinoma 
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development in this rat strain is normally low after chemical exposure. A considerable amount 
of furan metabolites are excreted in the bile and may consequently cause the incidence of 
cholangiocarcinomas in rats exposed to furan. Since the lowest furan dose tested induced 
nearly 100% incidence of cholangiocarcinomas in female rats, new carcinogenicity studies 
with testing of lower furan doses are needed for a more robust risk assessment of furan in 
food. 
 
4.5 Mechanisms of action 
Several mechanisms have been suggested to be involved in the toxicity and carcinogenicity of 
furan. The genotoxicity of furan has been described in a separate section (see section 4.3). 
The involvement of other mechanisms such as irreversible chronic inflammation associated 
with secondary oxidative DNA damage, oxidative stress, increased proliferation and reduced 
apoptosis will be described shortly in this section. The evidence for cholangiofibrosis as a 
pre-stage in the development of cholangiocarcinomas and the differences in histopathology of 
the cholangiocarcinomas between rats and humans will also be addressed. 
The liver is the main target organ for furan toxicity. In the most sensitive species, the rat, both 
hepatocellular carcinomas and cholangiocarcinomas were observed in the liver. However, it 
has been argued that the major mechanism in the development of cholangiocarcinomas is 
oxidative stress, and that indirect secondary DNA damage rather than a direct genotoxic 
mechanism is involved (Hickling et al., 2010). Sprague Dawley rats (n=5/time point) were 
administered 30 mg/kg bw furan for 5 days a week. Animals were put to death after 8 hr; 1, 3, 
7, 10, 12, and 20 days; and 1, 2 and 3 months of furan treatment. A recovery group was 
included at the three-month time, after one-month off dose, for assessment of recovery. 
Increased necrosis and reduced apoptosis were observed in hepatocytes in all lobes of the 
liver after both eight hours and one day, but the caudate right (target lobe) and lateral left lobe 
were most severely affected. From day 12, increased incidence of biliary proliferation, 
intestinal metaplasia and cholangiofibrosis occurred. The hepatocyte response occurred in all 
liver lobes, while the biliary response was confined to areas of severe initial damage. It was 
shown an increase in oxidative DNA damage by an increase in 8-oxo-dG after furan treatment 
using immunofluorescence, both in hepatocytes in the vicinity of cholangiofibrosis and in 
biliary cells in the same areas. These DNA damages were persistent during the recovery 
phase. Microarray analyses showing an increased gene expression of genes related to 
oxidative stress and proliferation, both during continuous furan exposure and after the 
recovery phase (Hickling et al., 2010). An increase in the expression of genes involved in 
proliferation, oxidative stress and DNA repair was observed in mice exposed to furan 
(Cordelli et al., 2010), supporting the findings from Hickling et al. (2010). In a recent paper, 
changes in the expression of genes related to apoptosis, cell cycle and DNA damage were 
observed in Sprague Dawley rats after oral treatment with 30 mg/kg bw furan five days a 
week for 3 months. In addition, a change in the micro-RNA (miRNA) profile and 
hypermethylation of genes were observed in furan-treated rats. The authors suggested that 
non-genotoxic mechanisms are important for furan carcinogenicity (Chen et al., 2012).  
It has been suggested that cholangiofibrosis is a structural anomaly that precedes the 
development of cholangiocarcinomas. In a “stop-study”, fifty male F344 rats were given 30 
mg/kg bw furan by gavage 5 days a week for 90 days. Ten treated rats were necropsied at day 
90 and the remaining 40 rats were then held without further treatment. Ten of these previously 
treated rats were put to death at 9- and 15-months, respectively, while the rest of the animals 
did not survive or were sacrificed at or prior to the 21th month of the study. A total of 21 
primary cholangiocarcinomas (five from the 9 month “stop–study” and 16 from the 2-year 
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carcinogenicity study by NTP, 1993) were transplanted into 5-10 recipients to study the 
malignant properties of these tumours. “Stop-study” rats sacrificed at 9- and 15-months had 
gross and microscopic liver changes that were similar in severity and extent to those seen at 
90 days. However, the liver changes were more severe than those seen in the rats 
continuously dosed with 8 mg/kg bw furan for 9- and 15-months. A 100% incidence of 
cholangiocarcinomas was observed already after 9-month duration of the “stop study”. 
Cholangiocarcinomas that metastasized to pancreas, lymph nodes and spleen were observed 
in two 15-month rats. Four of the transplanted cholangiocarcinomas showed growth in the 
recipients and metastases occurred for 2 of the 4 transplantable cholangiocarcinomas. The 
authors conclude that the proliferative cholangial lesions are considered to be malignant or 
potentially malignant (study described partly in Maronpot et al., 1991 and NTP, 1993).  
It has been suggested that there can be a tendency to overdiagnose the cholangiofibrosis and 
adenofibrosis as cholangiocarcinoma in rats. However, this has only been reported in a 
textbook without further references to detailed descriptions (Greaves, 2007). However, 
similar histopathology (intestinal differentiation) of the cholangiofibrosis and 
cholangiocarcinomas has also been reported by Elmore and Sirica (1993), indicating that 
there might be some difficulties in separating the cholangiocarcinomas from the 
cholangiofibrotic lesions. Elmore and Sirica (1993) studied the histopathology of the furan-
induced cholangiocarcinomas (also called primary hepatic adenocarcinomas by the author) in 
rats and found that 96% of the cholangiocarcinomas were characterized by intestinal cell 
differentiation (i.e. goblet cells, Paneth cells and neuroendocrine cells). The author had 
previously shown similar changes in cell structure in cholangiofibrotic lesions induced in rat 
liver after 2-4 weeks of furan treatment. This strongly suggest that cholangiofibrosis is 
connected to the later development of cholangiocarcinomas. In cases where a benign tumour 
is known to be able to progress to a malign tumour, e.g. hepatocellular adenomas to 
carcinomas, they are often considered together in the risk characterisation. Thus, the 
possibility of over-diagnosis of cholangiocarcinomas due to the presence of cholangiofibrosis 
will most likely not affect the risk characterisation. This is the case in the present situation 
where cholangiocarcinomas were found in nearly 100% at the low dose already after 15 
months. Small intestinal metaplasia has been suggested as a risk factor in the development of 
cholangiocarcinomas in the biliary tract of humans (Elmore and Sirica, 1993). 
It is expected that children can be more susceptible to genotoxic carcinogens than adults, and 
this has been previously characterised by U.S. Environmental Protection Agency (EPA, 2005) 
and Hattis et al. (2005). Some aspects potentially leading to childhood susceptibility include 
more frequent cell division, reduced level of DNA repair enzymes in some tissues and a less 
developed immune system (EPA, 2005). Quantification analyses based on some genotoxic 
carcinogens support the conclusion that there can be greater susceptibility for the 
development of tumours as a result of exposure to chemicals acting through a mutagenic 
mode of action, if the exposure occurs in early life stage as compared with later life stages. 
However, the overall database as basis for the analyses is of limited size (EPA, 2005; Hattis et 
al. 2005). In vivo studies starting furan exposure when the animals are 6-7 weeks old, do not 
take the increased susceptibility of children into account. 
 
4.5.1 Summary of mechanism of action 
Based on the results from the abovementioned studies, VKM finds it likely that cellular 
mechanisms such as oxidative stress, changes in cell cycle, proliferation and apoptosis are 
involved in furan-induced carcinogenesis. However, this does not exclude a concurrent 
genotoxic mechanism of furan (see section 4.3). Although there might be a possibility for 
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over-diagnosis of the cholangiocarcinomas due to the presence of cholangiofibrosis, this will 
most likely not affect the risk characterisation since cholangiofibrosis is known to be able to 
progress to carcinomas. VKM recognises that the cholangiocarcinomas from rats have the 
ability to give metastases when transplanted in recipient rats. This has been characterised by 
intestinal cell differentiation, which has been suggested as a risk factor for the development of 
cholangiocarcinomas in the biliary tract of humans. Therefore, VKM will take the furan-
induced development of cholangiocarcinomas into account in this risk assessment of furan. 
 
4.6 Conclusions on hazard 
The liver is the main target organ for furan toxicity both in mice and rats, but the rat is the 
most sensitive species. A dose-dependent increase in hepatocellular adenomas and 
carcinomas was observed in mice and rats, and an increase in the incidence of 
cholangiocarcinomas was observed in rat liver. Cholangiocarcinomas in male and female rats 
is the most sensitive toxicological end point observed in rodents. On the basis of the available 
data, VKM considers that rat cholangiocarcinomas may be relevant for assessing human risk 
from furan.  
Available in vivo data with furan indicate that a reactive metabolite, most likely BDA, is 
formed and that this metabolite can react with DNA and induce mutations. To VKM’s 
knowledge, no in vivo studies on genotoxicity of BDA have been performed, but BDA was 
found genotoxic in several in vitro tests. VKM therefore considers that genotoxic mechanisms 
in furan-induced carcinogenesis cannot be excluded. Since a threshold cannot be identified, 
the substance was assessed as a genotoxic carcinogen.  
 
5 Critical effect and choice of point of departure (POD)  
In the studies on furan carcinogenesis, rats were found to be more sensitive than mice. 
Therefore, rats were used to establish a point of departure (POD) for furan toxicity. The 
calculation of a benchmark dose (BMD) and using the benchmark dose lower bound (BMDL) 
as a point of departure is the most appropriate method for risk characterisation of substances 
in food that are genotoxic and carcinogenic. In cases where data are unsuitable for deriving a 
benchmark dose, the use of T25, representing the dose corresponding to a 25% incidence of 
tumours, is recommended (EFSA, 2005). Even though the data available were not optimal, 
VKM considered them suitable for a BMDL approach. However, for comparison, the 
calculation of T25, which resulted in a value of 0.14, is described in Annex III. The Panels 
have chosen to base the risk assessment of furan on a POD derived using the BMD method as 
described below. 
 
5.1 Summary of previous BMD calculations for furan in food 
An expert group established by the International Life Science Institute – European branch 
(ILSI Europe) calculated the BMD and used the BMDL as a point of departure in the risk 
assessment of twelve genotoxic and carcinogenic chemicals including furan (Benford et al., 
2010). The risk assessment on furan is described in more detail in the paper by Carthew and 
co-workers (Carthew et al., 2010). BMD and BMDL(1, 5 and 10) were calculated for the main 
toxicological effects in mice and rats: cholangiocarcinomas, liver adenomas and carcinomas 
and mononuclear cell leukaemia. The BMDL10 were used for further risk assessment, and the 
lowest calculated BMDL10 (0.0012 mg/kg bw/day in the text, but 0.000723 in the table) were 
found for the male rat cholangiocarcinomas. The difference between the BMD and BMDL10 
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for cholangiocarcinomas was more than 70-fold, indicating high confidence interval and large 
uncertainties in the BMD calculations. This is most likely caused by a lack of dose-response 
in the development of cholangiocarcinomas, which shows 96% incidence at the lowest furan 
dose of 2 mg/kg bw/day in female rats. The authors in Carthew et al. (2010) argued that the 
cholangiocarcinomas induced by furan in rat are most likely derived by a mechanism 
involving oxidative stress and indirect DNA damage rather than a direct genotoxic 
mechanism (Hickling et al., 2010). In this paper, an increase in oxidative DNA damage by an 
increase in 8-oxo-dG after furan treatment using immunofluorescence, and microarray 
analyses showing an increased expression of genes related to oxidative stress, were shown. 
Carthew and co-workers suggested that a genotoxic mechanism was more likely for the 
development of hepatocellular adenomas and carcinomas than for cholangiocarcinomas. 
Therefore, the experts disregarded the BMDL10 for the cholangiocarcinomas, choosing the 
lowest BMDL10 based on hepatocellular adenomas and carcinomas in male rats of 1.28 mg/kg 
bw/day based on the model average to derive MOE.  
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) recently published a 
risk assessment of furan (JECFA, 2011), where they used the BMD approach and BMDL as 
the point of departure. JECFA also disregarded the cholangiocarcinomas in rats for 
calculation of BMDL, because these neoplasms were only observed in rats and were 
associated with extreme hepatotoxicity. In addition, these neoplasms were, according to 
JECFA, also associated with early and marked biliary tract proliferative response. 
Furthermore, JECFA argued that the relevance for humans of the cholangiocarcinomas was 
not clear, and the high incidence of these neoplasms at all furan doses precluded identification 
of a POD. The Committee chose to use the BMDL10 of 1.34 mg/kg bw calculated from the 
development of hepatocellular adenomas and carcinomas in female mice from the Moser et 
al. (2009) study as the POD. The BMDL10 corresponds to 0.96 mg/kg bw/day when adjusted 
from a 5 days/week dosing schedule to an average daily dose.  
 
5.2 Selection of POD from previous risk assessments of furan 
The most critical toxicological effect observed at the lowest furan dose (2 mg/kg bw/day) is 
the development of cholangiocarcinomas in male and female rats. Both the expert groups of 
ILSI Europe and JECFA (Carthew et al., 2010; JECFA, 2011) have disregarded the 
cholangiocarcinomas as the basis for the BMDL calculations. It is the view of VKM that 
several mechanisms, such as oxidative stress and proliferation are likely to be involved in the 
development of cholangiocarcinomas, but this does not exclude the possible involvement of a 
genotoxic mechanism. The relevance of cholangiocarcinomas for humans can also not be 
excluded, since this type of tumours does occur in humans, often with severe outcome as 
described by Hickling et al., (2010). However, the histopathology of the cholangiocarcinomas 
in rats is described as less malignant than its counterpart in humans. It is also suggested that 
cholangiofibrosis is connected to the later development of cholangiocarcinomas, due to 
similarities in histopathology. Small intestinal metaplasia as observed in both 
cholangiofibrosis and cholangiocarcinomas in rats has been suggested as a risk factor in the 
development of cholangiocarcinomas in the biliary tract of humans (Elmore and Sirica, 1993). 
VKM agrees with JECFA that the data from the NTP study (NTP, 1993) on the development 
of cholangiocarcinomas after 2 year are not suitable for calculating a BMDL as a POD for the 
toxicological risk assessment of furan, since a dose-response for this toxic effect is lacking. 
This is clearly shown by the large difference in BMD and the corresponding BMDL for the 
development of the cholangiocarcinomas as calculated by the ILSI expert group. However, 
the calculated BMDLs by ILSI Europe (1.28 mg/kg bw/day) and JECFA (0.96 mg/kg bw/day) 
based on hepatocellular adenomas and carcinomas in rats and mice, respectively, are close to 
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the lowest reported effect level of 1.42 mg/kg bw/day in female rats (after recalculation of the 
dose to a daily exposure) at which a 98% increase in incidence of cholangiocarcinomas was 
observed.  
 
5.3 Calculation of BMD with PROAST software and determination of 
POD 
For the present risk assessment, BMD calculations for the cholangiofibrosis and 
cholangiocarcinomas for all time points (9- and 15-months interim and 2 year) from the NTP 
study were calculated. Since there were no difference between the sexes, BMD calculations 
for the cholangiocarcinomas for all time points were combined with time as a covariate. The 
BMD for the cholangiocarcinomas from the 15-month interim study, the 2-year study and the 
combined calculation were all rejected due to no acceptable fitted curves and high confidence 
intervals caused by the lack of a dose-response, indicating large uncertainty in the 
calculations.  
The incidence of cholangiocarcinomas in rats from the 9-month interim evaluation of the 2-
year study by NTP was used to calculate a BMD and BMDL for furan as a POD for 
carcinogenicity. Although these data is based on ten animals only and is derived from a sub-
chronic time point, these are data from the most critical carcinogenic effect observed in rats. 
Initially, the BMD calculations were performed in PROAST, with sex as covariate, increasing 
the group size. However, the calculations showed that there were no difference between the 
sexes, and therefore the data for females and males could be combined, resulting in one 
overall BMDL (Table 45).  
Table 45: BMD and BMDL calculations on cholangiocarcinomas from the 9-month interim evaluation of NTP (1993), 
combining the sexes. 
End point Model Number of 
parameters 
Loglik Accept
 
BMD10 BMDL10 BMDU10 
Cholangio- 
carcinomas 
(9-month 
interim, 
sex 
combined) 
Zero 1 -54.83 - NA NA NA 
Full 8 -23.02 - NA NA NA 
One-stage 2 -25.01 yes 0.27 0.20 0.36 
Two-stage 3 -25.01 yes 0.27 0.20 0.36 
Log-logistic 3 -24.43 yes 1.04 0.46 1.5 
Weibull  3 -23.92 yes 0.71 0.22 1.28 
LogProbit 3 
-24.2 yes 1.05 0.47 1.52 
Gamma 3 -24.01 yes 0.83 0.33 1.42 
Logistic 2 -25.4 yes 1.01 0.68 1.45 
Probit 2 
-25.1 yes 0.70 NA NA 
LVM-E2 2 -25.1 yes 0.97 0.66 1.43 
LVM-H2 2 -25.57 yes 0.49 0.35 0.66 
Accept. – Acceptability 
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All models showed acceptable fit according to the PROAST program (see Appendix II, Table 
A3 and Figure A1 for more details on the BMD calculations). The calculated BMDLs for the 
accepted models differ with less than one order of magnitude, and all have acceptable 
confidence intervals (i.e. ratio BMDL10/BMDU10 < 10). The lowest BMDL10 of 0.2 mg/kg bw 
was calculated for the one-stage and two-stage models. This BMDL10 value has been re-
calculated from 5-days exposure per week to a daily exposure, giving a BMDL10 of 0.14 
mg/kg bw, and has been included in Table 46 below. 
An overview over the reported and calculated PODs for carcinogenicity of furan is given in 
Table 46. 
 
Table 46: Reported and calculated PODs for furan carcinogenicity. 
Critical effect Point of departure 
(POD) 
mg/kg bw/day 
Method Study Reference 
Cholangiocarcinomas in rats 1.42  LOAEL 2-year carcinogenicity 
study (NTP) 
NTP, 
1993 
Hepatocellular adenomas and 
carcinomas in rats 
1.28  BMDL10  2-year carcinogenicity 
study (NTP) 
Carthew 
et al., 
2010 
Hepatocellular adenomas and 
carcinomas in female mice 
0.96  BMDL10  2-year carcinogenicity 
study (Moser et al., 
2009) 
JECFA, 
2011 
Cholangiocarcinomas in rats  
(sex combined) 
0.14 BMDL10 9-month interim 
evaluation from 2-year 
carcinogenicity study 
(NTP) 
VKM, 
2012 
 
The lowest calculated or reported POD for furan from Table 46 is the BMDL10 of 0.14 mg/kg 
bw/day from the cholangiocarcinomas in rats (sex combined) from the 9-month interim 
evaluation. This BMDL10 will be used in the further risk assessment of furan. 
 
5.3.1  Correction factor  
The data on the development of cholangiocarcinomas in rats after 2 year of the NTP study 
(NTP, 1993) were not suitable for calculating a BMDL as a POD for furan toxicity, since 
there was close to 100% incidence at the lowest dose and therefore a dose-response for this 
toxic effect was lacking. As a sub-optimal solution VKM used the cholangiocarcinomas from 
the 9-month interim study (sex combined) to derive a POD, because these data showed a 
dose-response and were considered suitable for a BMDL calculation. Since the time point (9-
month) used in deriving the BMDL was shorter than a full life span (2-year) study of the rat, a 
correction factor had to be included to adjust for shorter exposure and observation time 
(Dybing et al., 1997; ECHA, 2010). The 9-month interimstudy represents a 2.66 times (24 
months/9months=2.66) shorter duration of exposure and observation compared to the full 
length study of 24 months. The combined correction factor will be 7, when taking into 
account both shorter exposure time and reduced observation time (2.66 x 2.66 = 7). 
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5.3.2  Determination of POD  
Applying a correction factor of 7 the BMDL10 of 0.14 mg/kg bw/day gave a POD of 0.02 mg 
furan/kg bw/day. This POD of 0.02 mg/kg bw/day, which was used in the risk 
characterisation, represents the most conservative POD based on the development of 
cholangiocarcinomas from the 9-month interim study, and would probably be an 
overestimation of the hazard. It is noted that the tumour incidence increased by about 2.5 to 
close to 100% from 9 to 24 months (Table 44). 
 
6 Risk characterisation  
In rodents, the liver is the main target organ for furan toxicity (see sections on general toxicity 
and carcinogenicity). Carcinogenicity studies with oral furan exposure have revealed 
significant dose-dependent increase in the combined incidence of hepatocellular adenomas 
and carcinomas in male and female B6C3F1 mice (NTP, 1993; Moser et al., 2009) and in 
male F344/N rats (NTP, 1993). Moreover, high incidences (approximately 86-100%) of 
cholangiocarcinomas were reported in F344/N rats of both sexes after 2 years of oral 
exposure, even at the lowest furan dose tested (NTP, 1993). In addition, an increased 
incidence of mononuclear cell leukaemia was observed in male and female rats at the two top 
doses, where the incidence at the top dose exceeded the historical control ranges. 
Furthermore, liver non-neoplastic lesion incidences were abundant in both B6C3F1 mice and 
F344/N rats at all tested furan doses in the 2-year experiments (NTP, 1993; Moser et al., 
2009). In the 90-day study in rats by Gill et al. (2010), biliary tract hyperplasia and 
cholangiofibrosis were observed which are related to the development of 
cholangiocarcinomas in rats reported by NTP (NTP, 1993). 
Available in vivo data with furan indicate that a reactive metabolite, most likely BDA, is 
formed and that this metabolite can react with DNA and induce mutations. To VKM’s 
knowledge, no in vivo studies on genotoxicity of BDA have been performed, but BDA was 
found genotoxic in several in vitro tests. VKM therefore considers that genotoxic mechanisms 
in furan-induced carcinogenesis cannot be excluded. Since a threshold cannot be identified, 
the substance was assessed as a genotoxic carcinogen.  
The development of cholangiocarcinomas (sex combined) from the 9-month interim study of 
NTP (1993) was used to calculate a POD of 0.02 mg/kg bw/day, which has been chosen in the 
risk characterisation for calculating margin of exposure (MOE) for the different age groups. 
The MOE is the ratio between the calculated POD from the critical toxicity in animal studies 
and the calculated human intake. A MOE will be calculated for the most important exposure 
data for all age groups. The lower the MOE is, the higher the possible risk for negative health 
effects will be. EFSA concluded that for a genotoxic compound, a guidance MOE of 10 000 
or higher if it is based on the BMDL10 from an animal study would be of low concern from a 
public health point of view (EFSA, 2005). However, the risk assessors should take into 
account the quality of the hazard characterisation and intake data and the uncertainties 
inherent in the data used in the interpretation of the calculated MOE. It should also be noted 
that in this guidance MOE, safety factors are included. 
 
6.1 Margin of exposure calculations for 6-month-old infants 
The exposure calculations for 6-month-old infants show that the major contribution to the 
furan exposure comes from jarred baby food (Table 11). When the furan exposure was 
calculated for the consumers of jarred baby food, the mean and high (95 percentile) furan 
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exposure was 0.18 µg/kg bw/day and 0.45 µg/kg bw/day, respectively. This will give MOEs 
of 111 and 44 for the two respective exposure calculations (Table 47). For 6-month-old 
consumers of jarred baby food, with an additional contribution from infant formula, milk 
products and commercial powder-based porridge, the respective mean and high furan 
exposures were calculated to 0.26 and 0.58 µg/kg bw/day, with corresponding MOE-values of 
77 and 34 (Table 47). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in 6-month-old infants. The mean 
and high furan exposures among all participants were calculated to 0.17 and 0.51 µg/kg 
bw/day, giving respective MOE-values of 118 and 39 (Table 47).  
The calculated furan exposure among the consumers of jarred baby food with an additional 
contribution from all relevant food categories is not far from the population average in 6-
month-olds (see section 3.1.11).  
The calculated mean and high (95 percentile) furan exposures among 6 month-old non-
breastfed consumers of jarred baby food and other relevant food categories were found to be 
0.35 and 0.65 µg/kg bw/day (Table 12), with corresponding MOEs of 400 and 215, 
respectively. These MOEs for non-breastfed infants are in the same range as for consumers of 
jarred baby food with an additional contribution from infant formula, milk products and 
commercial powder-based porridge among all participants (Table 47).  
 
Table 47: Margin of exposure (MOE) for furan in 6-month-old infants for consumers of jarred baby food (n=1220), 
for consumers of jarred baby food with an additional contribution from infant formula, milk products and 
commercial powder-based porridge (n=1220) and for average furan exposure in all participants (n=1986) (see Table 
11).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean exposure 
MOE  
High exposure 
Consumers of jarred baby food 0.18 0.45 111 44 
Consumers of jarred baby food with an 
additional contribution from infant 
formula, milk products and commercial 
porridge 
0.26 0.58 77 34 
Average furan exposure from jarred 
baby food, milk products, infant formula 
and commercial powder-based porridge 
in all participants 
0.17 0.51 118 39 
 
 
6.2 Margin of exposure calculations for 12-month-old infants 
The exposure calculations for 12-month-old infants show that the major contribution to the 
furan exposure comes from jarred baby food (Table 17). When the furan exposure was 
calculated for consumers of jarred baby food, the mean and high (95 percentile) furan 
exposures were 0.56 µg/kg bw/day and 1.30 µg/kg bw/day, respectively. This will give MOEs 
of 36 and 15 for the two respective exposure calculations (Table 48). For 12-month-old 
consumers of jarred baby food, with an additional contribution from infant formula, milk 
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products and commercial powder-based porridge, the respective mean and high furan 
exposures were calculated to 0.69 and 1.51 µg/kg bw/day, with corresponding MOEs of 29 
and 13 (Table 48). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in 12-month-old infants. The mean 
and high furan exposures among all participants were calculated to 0.62 and 1.43 µg/kg 
bw/day, giving respective MOE-values of 32 and 14 (Table 48).  
The calculated furan exposure among the consumers of jarred baby food with an additional 
contribution from all relevant food categories is not far from the population average in 12-
month-olds (see section 3.1.11).  
The calculated furan exposure among 12-month-old non-breastfed infants (Table 18) did not 
differ considerably from the abovementioned results, and are therefore covered by the 
calculated MOEs (Table 48). 
 
Table 48: Margin of exposure (MOE) for furan in 12-month-old infants for consumers of jarred baby food (n=1436), 
for consumers of jarred baby food with an additional contribution from infant formula, milk products and 
commercial powder-based porridge (n=1436) and for average furan exposure in all participants (n=1635) (see Table 
17).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean 
exposure 
MOE  
High 
exposure 
Consumers of jarred baby food 0.56 1.30 36 15 
Consumers of jarred baby food with an 
additional contribution from infant 
formula, milk products and commercial 
powder-based porridge 
0.69 1.51 29 13 
Average furan exposure from jarred baby 
food, milk products, infant formula and 
commercial powder-based porridge in all 
participants 
0.62 1.43 32 14 
 
 
6.3 Margin of exposure calculations for 24-month-old children 
The exposure calculations for 24-month-old children show that the major contribution to the 
furan exposure comes from jarred baby food (Table 21). When the furan exposure was 
calculated for consumers of jarred baby food, the mean and high (95 percentile) furan 
exposures were 0.18 µg/kg bw/day and 0.64 µg/kg bw/day, respectively. This will give MOEs 
of 111 and 31 for the two respective exposure calculations (Table 49). For 24-month-old 
consumers of jarred baby food, with an additional contribution from other relevant food 
categories, the respective mean and high furan exposures were calculated to 0.25 and 0.77 
µg/kg bw/day, with corresponding MOEs of 80 and 26 (Table 49). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in 24-month-old children. The mean 
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and high furan exposures among all participants were calculated to 0.10 and 0.41 µg/kg 
bw/day, giving respective MOE-values of 200 and 49 (Table 49).  
The calculated furan exposure among the consumers of jarred baby food with an additional 
contribution from all relevant food categories was found to be higher than the population 
average in 24-month-old children (see section 3.1.11). 
 
Table 49: Margin of exposure (MOE) for furan in 24-month-old children for consumers of jarred baby food (n=420), 
for consumers of jarred baby food with an additional contribution from canned and jarred vegetables, canned fruits, 
milk products, jarred tomato sauces, all breakfast cereals, chocolate and sweets, snacks, and commercial powder-
based porridge (n=420) and for average furan exposure in all participants (n=1674) (see Table 21).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean 
exposure 
MOE  
High 
exposure 
Consumers of jarred baby food 0.18 0.64 111 31 
Consumers of jarred baby food with an 
additional contribution from canned and 
jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, all 
breakfast cereals, chocolate and sweets, 
snacks, and commercial powder-based 
porridge 
0.25 0.77 80 26 
Average furan exposure from jarred baby 
food, canned and jarred vegetables, canned 
fruits, milk products, jarred tomato sauces, 
all breakfast cereals, chocolate and sweets, 
snacks, and commercial powder-based 
porridge in all participants  
0.10 0.41 200 49 
 
 
6.4 Margin of exposure calculations for 4-year-old children 
The exposure calculations for 4-year-old children show that the major contribution to the 
furan exposure comes from breakfast cereals (Table 23). When the furan exposure was 
calculated for 4-year-olds consumers of breakfast cereals, the mean and high (95 percentile) 
furan exposures were 0.03 and 0.11 µg/kg bw/day, respectively. This will give MOEs of 667 
and 182 for the two respective exposure calculations (Table 50). For 4-year-old children that 
consume breakfast cereals, with an additional contribution from other relevant food 
categories, the respective mean and high furan exposures were calculated to 0.08 and 0.26 
µg/kg bw/day, with corresponding MOEs of 250 and 77 (Table 50). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in 4-year-old children. The 
respective mean and high furan exposures among all participants were calculated to 0.07 and 
0.25 µg/kg bw/day, giving MOEs of 286 and 80 (Table 50).  
The calculated furan exposure among the consumers of breakfast cereals with an additional 
contribution from all relevant food categories is in the same order of magnitude as the 
population average in 4-year-olds (see section 3.1.11).  
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Table 50: Margin of exposure (MOE) for furan in 4-year-old children for consumers of breakfast cereals (n=182), for 
consumers of breakfast cereals with an additional contribution from canned and jarred vegetables, canned fruits, 
milk products, jarred tomato sauces, sweet breakfast cereals, chocolate and sweets, and snacks (n=182) and for 
average furan exposure in all participants (n=391) (see Table 23).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean 
exposure 
MOE  
High 
exposure 
Consumers of breakfast cereals 0.03 0.11 667 182 
Consumers of breakfast cereals with an 
additional contribution from canned and 
jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, sweet 
breakfast cereals, chocolate and sweets, 
and snacks 
0.08 0.26 250 77 
Average furan exposure from breakfast 
cereals,  canned and jarred vegetables, 
canned fruits, milk products, jarred 
tomato sauces, sweet breakfast cereals, 
chocolate and sweets, and snacks in all 
participants 
0.07 0.25 286 80 
 
 
6.5 Margin of exposure calculations for 9-year-old children 
The exposure calculations for 9-year-old children show that the major contribution to the 
furan exposure comes from breakfast cereals (Table 25). When the furan exposure was 
calculated for 9-year-old consumers of breakfast cereals, the mean and high (95 percentile) 
furan exposures were calculated to 0.02 and 0.09 µg/kg bw/day, respectively. This will give 
MOEs of 1000 and 222 for the two respective exposure calculations (Table 51). For 9-year-
old consumers of breakfast cereals with an additional contribution from other relevant food 
categories, the respective mean and high furan exposures were calculated to 0.06 and 0.17 
µg/kg bw/day, with corresponding MOEs of 333 and 118 (Table 51). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in 9-year-old children. The mean 
and high furan exposures among all participants were calculated to 0.06 and 0.20 µg/kg 
bw/day, giving respective MOE-values of 333 and 100 (Table 51).  
The calculations show that the furan exposure among the consumers of breakfast cereals with 
an additional contribution from all relevant food categories and the population average in 9-
year-old children is in the same range (see section 3.1.11).  
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Table 51: Margin of exposure (MOE) for furan in 9-year-old children for consumers of breakfast cereals (n=323), for 
consumers of breakfast cereals with an additional contribution from canned and jarred vegetables, canned fruits, 
milk products, jarred tomato sauces, sweet breakfast cereals, chocolate and sweets, and snacks (n=323) and for 
average furan exposure in all participants (n=810) (see Table 25).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean 
exposure 
MOE  
High 
exposure 
Consumers of breakfast cereals 0.02 0.09 1000 222 
Consumers of breakfast cereals with an 
additional contribution from canned and 
jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, sweet 
breakfast cereals, chocolate and sweets, 
and snacks 
0.06 0.17 333 118 
Average furan exposure from breakfast 
cereals, canned and jarred vegetables, 
canned fruits, milk products, jarred 
tomato sauces, sweet breakfast cereals, 
chocolate and sweets, and snacks in all 
participants 
0.06 0.20 333 100 
 
 
6.6 Margin of exposure calculations for 13-year-old adolescents 
The exposure calculations for 13-year-old adolescents show that the major contribution to the 
furan exposure comes from breakfast cereals (Table 27). When the furan exposure was 
calculated for 13-year-old consumers of breakfast cereals, the mean and high (95 percentile) 
furan exposures were calculated to 0.01 and 0.05 µg/kg bw/day, respectively. This will give 
MOEs of 2000 and 400 for the two respective exposure calculations (Table 52). For 13-year-
old consumers of breakfast cereals with an additional contribution from other relevant food 
categories, the respective mean and high furan exposures were calculated to 0.05 and 0.16 
µg/kg bw/day, with corresponding MOEs of 400 and 125 (Table 52). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in 13-year-old adolescents. The 
mean and high furan exposures among all participants were calculated to 0.04 and 0.14 µg/kg 
bw/day, giving respective MOE-values of 500 and 143 (Table 52).  
The calculations show that the furan exposure among the consumers of breakfast cereals with 
an additional contribution from all relevant food categories is not considerably different from 
the population average in 13-year-old adolescents (see section 3.1.11).  
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Table 52: Margin of exposure (MOE) for furan in 13-year-old adolescents for consumers of breakfast cereals (n=285), 
for consumers of breakfast cereals with an additional contribution from canned and jarred vegetables, canned fruits, 
milk products, jarred tomato sauces, sweet breakfast cereals, chocolate and sweets, and snacks (n=285) and for 
average furan exposure in all participants (n=1005) (see Table 27).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean 
exposure 
MOE  
High 
exposure 
Consumers of breakfast cereals only 0.01 0.05 2000 400 
Consumers of breakfast cereals with an 
additional contribution from canned and 
jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, sweet 
breakfast cereals, chocolate and sweets, 
snacks, and coffee 
 
 
 
0.05 
 
 
 
0.16 
 
 
 
400 
 
 
 
125 
Average furan exposure from breakfast 
cereals, canned and jarred vegetables, 
canned fruits, milk products, jarred 
tomato sauces, sweet breakfast cereals, 
chocolate and sweets, snacks, and coffee in 
all participants 
 
 
 
0.04 
 
 
 
0.14 
 
 
 
500 
 
 
 
143 
 
 
6.7 Margin of exposure calculations for adults aged 18-70 years 
The exposure calculations for adults aged 18-70 years show that the major contribution to the 
furan exposure comes from coffee (coffee roasted ground) (Table 29). When the furan 
exposure was calculated for adults that drink coffee (coffee roasted ground), the mean and 
high furan exposure were calculated to 0.33 µg/kg bw/day and 0.81 µg/kg bw/day, 
respectively. This will give MOEs of 61 and 25 for the two respective exposure calculations 
(Table 53). For adults that drink coffee (coffee roasted ground) with an additional 
contribution from consumption of other relevant food categories, the respective mean and 
high furan exposures were calculated to 0.34 and 0.82 µg/kg bw/day, with corresponding 
MOEs of 59 and 24 (Table 53). 
Furan consumption from all relevant food categories among all participants, gives a 
population average for the mean and high furan exposure in adults aged 18-70 years. The 
mean and high furan exposures in all participants were calculated to 0.27 and 0.77 µg/kg 
bw/day, giving respective MOE-values of 74 and 26 (Table 53).  
The calculated furan exposure for adults shows that the major furan exposure comes from 
coffee (coffee roasted ground and instant coffee) and that the contribution from other food 
categories is limited. The calculations show that the furan exposure among the consumers of 
coffee roasted ground with an additional contribution from all relevant food categories is in 
the same range as the population average in adults (see section 3.1.11).  
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Table 53: Margin of exposure (MOE) for furan in adults aged 18-70 years for consumers of coffee roasted ground 
(n=1398), for consumers of coffee roasted ground with an additional contribution from canned and jarred vegetables, 
canned fruits, milk products, jarred tomato sauces, all breakfast cereals, chocolate and sweets, snacks and instant 
coffee (n=1398) and for average furan exposure in all participants (n=1787) (see Table 29).  
 Mean furan 
exposure 
µg/kg bw/day 
High furan 
exposure (95 
percentile) 
µg/kg bw/day 
MOE 
Mean 
exposure 
MOE  
High 
exposure 
Consumers of coffee roasted ground 0.33 0.81 61 25 
Consumers of coffee roasted ground with 
an additional contribution from canned 
and jarred vegetables, canned fruits, milk 
products, jarred tomato sauces, all 
breakfast cereals, chocolate and sweets,  
snacks, and instant coffee 
0.34 0.82 
 
 
59 
 
 
24 
Average furan exposure from coffee 
roasted ground,  canned and jarred 
vegetables, canned fruits, milk products, 
jarred tomato sauces, all breakfast cereals, 
chocolate and sweets,  snacks, and instant 
coffee in all participants 
0.27 0.77 74 26 
 
 
6.8 Comments to the MOE 
For 6-, 12- and 24-month-old children, the main source of furan exposure is jarred baby food. 
For 4-, 9- and 13-year-old children, the major food source to the furan exposure is breakfast 
cereals. In adults, the major contributor to furan exposure is coffee. The highest furan 
exposure was calculated for 12-month-old infants and ranged from 0.62 to 1.51 µg/kg bw/day. 
In adults the furan exposure ranged from 0.27 to 0.82 µg/kg bw/day.  
For mean exposure among infants, children and adolescents, the MOE-values ranged from 29 
in 12-month-infants to 2000 in the 13-year-old adolescents. Among high consumers, the 
MOE-values ranged from 13 to 400. In adults, the corresponding MOE-values ranged from 59 
to 74 for mean exposure and from 24 to 26 for high exposure. 
VKM considers that the current exposure to furan in all age groups, particularly among 
infants and children, is of health concern. 
 
7 Uncertainty 
7.1 Furan contents in food 
The limit of detection (LOD) and limit of quantification (LOQ) reported for all matrixes 
tested were 2 and 5 µg/kg respectively. The measurement uncertainty at furan concentrations 
lower than 20 µg/kg was 80%, while at concentrations higher than 20 µg/kg the measurement 
uncertainty was 50%. Considering the given uncertainties in the analyses, the furan 
concentrations reported in the national monitoring data are presented with too many digits. 
However, VKM has chosen to use the furan concentrations as they were reported by the 
laboratory to ease the tracing of the results used in this opinion back to the original data 
source.  
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Mean middle bound furan concentrations from the Norwegian monitoring data were used in 
the exposure calculations in this opinion. Mean middle bound furan values were also used for 
the two different breakfast cereals and the food category snacks and crisps from the DTU 
report, while all furan values used from the EFSA furan database were based on the means of 
upper bound values. The approach of using mean upper bound values will most likely lead to 
an overestimate of the exposure, while using mean lower bound most likely results in an 
underestimate of the exposure. VKM therefore decided to use the mean middle bound values 
for the national monitoring data, to obtain the most realistic estimate of the exposure.  
The Norwegian monitoring data present both furan data for foods analysed as purchased and 
for furan concentrations in foods after heat treatment (Tables 1 and 3-5). Furan contents in 
identical food products analysed as purchased and after heat-treatment are of the same order 
of magnitude, except for a few products. Only furan contents of food categories analysed as 
purchased were used in the calculations in this opinion.  
There is lack of data on furan contents for many foods. The food categories used for furan 
calculations were based on results for relevant foods and food groups with high furan content 
previously reported in the literature. Thus, the present calculations of furan exposures in the 
various age groups may be underestimated.  
In the literature, different furan contents for approximately the same types of foods are 
reported. Coffee is a major contributor to furan exposure in Norwegian adults. However, 
Norwegian furan analyses for coffee were not available and therefore furan values from the 
EFSA database were used to calculate the furan exposure from consumption of coffee. This 
may not be representative for Norwegian blends and preparation methods for coffee. It is not 
known if this fact would lead to an overestimation or an underestimation at present.  
 
7.2 Dietary exposure assessment 
Every dietary assessment is connected with uncertainty. A description of the most important 
uncertainties and assumptions in the dietary exposure calculations is described below.  
Three concepts are fundamental to understanding the limitations of dietary assessment: 
habitual consumption, validity and precision (Livingstone and Black, 2003).  
The habitual consumption of an individual is the person’s consumption averaged over a 
prolonged period of time, such as weeks and months rather than days. However, this is a 
largely hypothetical concept; the consumption period covered in a dietary assessment is a 
compromise between desired goal and feasibility. In the Norwegian dietary surveys the time 
period covered are 14-days among the 1- and 2-year olds (Sped- and Småbarnskost 
2006/2007), four consecutive days among the 4-, 9- and 13-year-olds (UNGKOST 2000) and 
2 none-consecutive days among the adults (Norkost 3). Furan has been analysed and found in 
a relatively limited number of foods, and it is only the reported furan contents in the limited 
number of food groups/food items that are included in the exposure calculations. The food 
category with the highest furan content relevant for 4-, 9- and 13-year-olds was sweet 
breakfast cereals. The furan exposure could be overestimated for sweet breakfast cereals since 
there were only few samples and these had considerable higher furan contents than 
comparable food items in the EFSA database (EFSA, 2011). However, the high furan 
analyses reported in the DTU report were chosen rather than furan values from the EFSA 
database as cereal products in the Norwegian market were assumed to be more similar to the 
products in the Danish market. Both large within person and between person variations in 
consumption of furan-containing foods were seen in the consumption surveys. A large 
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number of repeated measurements and a comprehensive database on furan contents in 
different foods would be required to obtain an accurate estimate of individual furan exposure 
(Willett, 1998).  
In this risk assessment we report furan exposure in all participants within an age group as well 
as the exposure in consumers only with regard to food items contributing substantially to the 
overall exposure, e.g. jarred baby food in children and coffee in adults. When evaluating high 
consumers, the uncertainty associated with the 95 percentile is higher than for the mean value, 
especially among the age groups with a low number of participants. However, the overall 
finding in this report of small differences in the 95 percentile exposure between all 
participants and consumers only (Tables 30 and 31), indicates that the “worst case” exposure 
calculations are robust. 
The validity of a dietary assessment method refers to the degree to which the method actually 
measures the aspect of diet that it was designed to measure (Nelson and Margetts, 1997). 
Lack of validity is strongly associated with systematic errors (Burema et al., 1988). With 
systematic errors all respondents in a dietary study or each subgroup in a population produce 
the same type of error, like systematic under- or overestimation of intake. All the three 
different dietary assessment methods used in this risk assessment have limitations when it 
comes to validity. Results from validation studies among 9- and 13-year-olds indicate an 
underestimation of energy intake around 20% when the precoded food diary, used in 
UNGKOST 2000, is compared with energy expenditure (Andersen et al., 2005; Lillegaard 
and Andersen, 2005). The validation studies among 1- and 2-year-olds were performed on a 
previously established questionnaire, but the results showed a significantly higher energy 
intake with the FFQ than with the weighed record reference method (Andersen et al., 2003; 
Andersen et al., 2004; Andersen et al., 2009). The Norwegian 24-hour recall method used 
among adults in Norkost 3 has not been validated. However, other similar 24-hour recall 
methods have been validated and show an underestimation in energy intake of around 15% 
(Subar et al., 2003; Poslusna et al., 2009). Underestimation of energy intake indicates that not 
all foods eaten are reported, but not which foods are underreported. It has been shown that 
foods perceived as unhealthy such as fats, sweets, desserts and snacks tend to be 
underreported to a larger degree than foods perceived as healthy (Olafsdottir et al., 2006). 
However, among children and adolescents there have been studies were this selective 
underreporting was not shown (Sjøberg et al., 2003; Lillegaard and Andersen, 2005). As 
furan is found in foods perceived both as unhealthy and healthy, it is not likely that the 
misreporting would strongly bias the estimated furan exposure. However, if underreporting of 
furan containing foods is of the same magnitude as for total energy, the estimates for furan 
exposure are more likely to be under- than over reported. 
The precision of a technique is one that gives the same answer on repeated administrations 
(Livingstone and Black, 2003). Poor precision derives from large random errors in the 
techniques of dietary assessment. The effect of random errors can be reduced by increasing 
the number of observations, but cannot be entirely eliminated (Rothman, 2002).  
The questionnaire used among the 6-month-old children does not ask for portion sizes for 
jarred baby food, only for frequencies. To be able to calculate a scenario for furan the portion 
size was set to ¼ a jar (50 g). The jar sizes differ between different baby foods and different 
labels, but in these scenarios the jar size depicted in the photographic booklet for the 1- and 2-
year-old children has been used. It is likely that the 6-month-olds do not eat large portions of 
jarred baby food, since they are in a process of adaptation to solid foods. 
The questionnaires used in Spedkost 2006-2007 do not separate between commercial porridge 
with or without fruits. In the estimates presented in Table 11 and 12, a conservative approach 
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has been chosen to assume that all commercial porridge consumed is porridge with fruits. 
Porridge with fruits has been found to contain more than three times the amount of furan 
compared with porridge without fruit. 
The data collection in UNGKOST 2000 was performed in year 2000-2001, and dietary 
patterns are constantly changing. Especially among some groups of adolescents, coffee drinks 
seem to be more popular now than what the 12-year-old data suggests.  
It is unclear to which extent a low participation rate will influence the assessment of furan 
exposure. It has been shown that health conscious people are more likely to participate in a 
dietary survey. This can indicate a somewhat different dietary pattern among the participants 
than among the whole population. The direction of the uncertainty is difficult to estimate. 
The dietary exposure to furan in this opinion has been calculated relative to body weight 
(µg/kg bw/day) for all age groups. The individual consumption data taken from the dietary 
surveys should ideally be paired with data on body weights for the same individuals. 
However, this was not carried out in this exposure assessment. It was therefore decided to use 
the mean body weights for the different age groups among children and adolescents in all 
calculations. If mean body weight is combined with individual data on consumption, the 
assessment may overestimate the degree of individual variation in dietary exposure, if their 
consumption is correlated with body weight.  
 
7.3 Hazard identification and characterisation 
7.3.1 Differences between rodents and humans 
It is well known that cancer development in rodents and humans can be different, and that the 
interpretation of results from rodents to human health risk can be difficult. Normally, cancer 
development in rodents is used as an indicator test. This means that cancer development in 
any rodent organ after treatment with a chemical indicates that the chemical also can be a 
potential carcinogen in humans, if no specific conditions or strain specific knowledge indicate 
otherwise. 
VKM regards the cholangiocarcinomas to be the most critical toxicological end point from 
furan exposure in rodents. Cancer in the biliary duct is known to be a malignant cancer type in 
humans. It has been suggested that there can be a tendency to overdiagnose the 
cholangiofibrosis and adenofibrosis as cholangiocarcinoma in rats. This has only been 
reported in a textbook without further references to detailed descriptions (Greaves, 2007). 
However, similar histopathology (intestinal differentiation) of the cholangiofibrosis and 
cholangiocarcinomas has also been reported by Elmore and Sirica 1993, indication that there 
might be some difficulties in separating cholangiocarcinomas from cholangiofibrotic lesions. 
The difference between rats and humans may contribute to an overestimation of the human 
risk from furan exposure in rats. Cholangiocarcinomas are normally not observed in untreated 
rats, and are not a frequent tumour in rats after chemical exposure. In addition, some 
cholangiocarcinomas in rats have been found to be malignant when transferred to recipient 
rats (Maronpot et al., 1991). The cholangiocarcinomas have been characterised by an 
intestinal cell differentiation, which has been suggested as a risk factor in the development of 
cholangiocarcinomas in the biliary tract of humans (Elmore and Sirica 1993). 
Rat and humans differs in the respect that rats do not have gallbladders, while humans have. It 
is not known what impact this difference will have on the toxicity of furan or whether it will 
affect the development of cholangiocarcinomas.  
 
Vitenskapskomiteen for mattrygghet (VKM) 10/404-2 final 
 
91 
 
7.3.1 Differences between children and adults 
Human hepatic CYP2E1 expression varies during human fetal liver development and in the 
early postnatal stage, but already in 90 days old infants the activity level was comparable to 
that in children and adults (Johnsrud et al., 2003). CYP2E1 demonstrates genetic 
polymorphism affecting the noncoding region of the gene, which may influence the 
transcription and expression of the gene (Chang and Kam, 1999). It has been shown for e.g. 
trichloroethylene that metabolism was altered with less than 2% under extreme values of 
CYP2E1 expression and activity (Lipscomb et al., 2003). It is unlikely that CYP2E1 
variations could considerably alter furan metabolism, and they would probably not contribute 
considerably to the uncertainty in the risk assessment of furan. 
It is expected that children can be more susceptible to genotoxic carcinogens than adults. 
Quantification analyses support the conclusion that there can be greater susceptibility for the 
development of tumours as a result of exposure to chemicals acting through a mutagenic 
mode of action, when the exposure occur in early life stage as compared with later life stages. 
Animal experiments starting exposure at week 6-7 will not take the increased susceptibility of 
children into account. This will contribute to en underestimation of the risk of furan exposure 
in children. 
 
7.3.3 Limitations in data used for POD calculations 
The most critical toxicological effect observed at the lowest furan dose (2 mg/kg bw/day) was 
the development of cholangiocarcinomas in male and female rats. The data on the 
development of cholangiocarcinomas in rats after 2 year of the NTP study (NTP, 1993) were 
not suitable for calculating a BMDL as a POD for furan toxicity, since there was close to 
100% incidence at the lowest dose and therefore a dose-response for this toxic effect was 
lacking. As a sub-optimal solution VKM used the cholangiocarcinomas from the 9-month 
interim study (sex combined) to derive a POD, because these data showed a dose-response 
and were suitable for a BMDL calculation. Since the time point used in deriving the BMDL 
(9-months) is shorter than the full life span (2-year study) of the rat, a correction factor was 
used (see section 5.3.1). When taking into account both shorter exposure time and reduced 
observation time the correction factor is 7 and a POD of 0.02 mg/kg bw/day is derived. This 
would represent the most conservative POD based on the development of 
cholangiocarcinomas from the 9-month interim study. 
 
7.4 Summary of uncertainties 
Evaluations of the overall effect of identified uncertainties are presented in Tables 54 and 55, 
highlighting the main sources of uncertainty and indicating whether the respective source of 
uncertainty might have led to an over- or underestimation of the exposure and/or the resulting 
risk (EFSA, 2006b). 
 
Table 54: Qualitative evaluation of influences of uncertainties on the assessment of furan exposure 
Source of uncertainty Direction  
Dietary exposure assessment  
Different dietary assessment methods +/- 
Measurement uncertainty in the furan contents analysed +/- 
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Source of uncertainty Direction  
Mean upper bound furan values used for foods from the EFSA furan database + 
Furan content in sweet breakfast cereals + 
Sped- and småbarnskost 2006/2007  
Portions of jarred baby food among 6-month-olds +/- 
Use of 95 percentile +/- 
FFQ time span is 14 days +/- 
Porridge powder with fruits + 
Ungkost 2000  
Study conducted in 2000-2001 
- Possible changes in the food patterns can have occurred 
 
+/- 
Use of 95 percentile 
- The number of participants among 4-year-olds is only 391 
 
+/- 
Participation rate among 4-year-olds +/- 
Four registration days +/- 
Norkost 3, Adults   
Participation rate +/- 
Two registration days +/- 
Qualitative evaluation of overall effect of identified uncertainties: +  
+: uncertainty likely to cause over-estimation of exposure 
-: uncertainty likely to cause under-estimation of exposure 
 
VKM concluded that the furan exposure presented in this opinion can be considered realistic 
for each age group, despite of the limitations in assessing the food consumption and the 
uncertainties related to estimating the furan exposure outlined above. The exposure estimates 
are based on Norwegian food consumption data and primarily on furan concentrations for 
Norwegian food samples.  
The similarities in histopathology between cholangiofibrosis and cholangiocarcinomas in rats 
with a possible over-diagnosis of the cholangiocarcinomas, may contribute to an 
overestimation of the human risk from furan exposure (see Table 55). As a sub-optimal 
solution, VKM used the cholangiocarcinomas from the 9-month interim study (sex 
combined), including a correction factor of 7, to derive a POD. This procedure will probably 
result in an overestimation of the risk related to furan exposure in humans. It is however noted 
that by comparing tumour incidence at 9 and 24 months this is increased by a factor of about 
2.5 (Table 44).  
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Table 55: Qualitative evaluation of influences of uncertainties on evaluation of hazard in the risk assessment of furan  
Source of uncertainty Direction  
Diagnosis of cholangiocarcinomas in rats + 
Use of the 9-months cholangiocarcinomas including a correction 
factor for calculation of POD 
+ 
The lack of biliary bladder in rats +/- 
Children are probably more susceptible to genotoxic carcinogens - 
Qualitative evaluation of overall effect of identified uncertainties: + 
+: uncertainty likely to cause over-estimation of hazard 
-: uncertainty likely to cause under-estimation of hazard 
 
Data gaps 
• The only available 2-year carcinogenicity study in rats (NTP, 1993) is not suitable for 
deriving a POD, since the incidence of cholangiocarcinomas was already 100% at the 
lowest dose. A new 2-year study in rats with a selection of doses that provides a dose-
response in cholangiocarcinomas is needed in order to perform an improved risk 
assessment of furan to humans. VKM is aware of an on-going 2-year carcinogenicity 
study in rats with exposure to low doses of furan performed by the FDA. The present risk 
assessment on furan may need to be updated when data from this study become available. 
• In vivo studies on genotoxicity of BDA, the main metabolite of furan, should be 
performed since genotoxicity has been found in several in vitro tests. Such in vivo studies 
may also contribute to elucidate the mechanism behind the in vivo genotoxicity of furan. 
• A small number of samples and food types has been analysed for furan contents. In 
addition data on furan concentrations in Norwegian coffee do not exist. This contributes to 
the uncertainties in the exposure calculations for furan. Since coffee is a major source of 
furan exposure in adults, new data on the furan concentrations in Norwegian coffee would 
improve the risk assessment for adults. 
• A comprehensive and continually updated national furan database is necessary for 
estimating the overall exposure of furan through diet. Furan concentrations in both 
processed and heated foods are warranted. 
• Further research and more data are needed on the presence of furan in home-cooked 
foods. 
• More data is needed to understand under-/over-reporting of food consumption in dietary 
surveys. 
• Further research is needed to get more accurate portion size estimations in the dietary 
surveys. 
• Further research is needed to evaluate the impact of variations in number of registration 
days in the dietary surveys.  
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Conclusions  
The liver is the main target organ for furan toxicity both in mice and rats, but the rat is the 
most sensitive species. A dose-dependent increase in hepatocellular adenomas and 
carcinomas was observed in mice and rats, and an increase in the incidence of 
cholangiocarcinomas was observed in rat liver. Cholangiocarcinomas in male and female rats 
are the most sensitive toxicological end point observed in rodents. On the basis of the 
available data, VKM considers that rat cholangiocarcinomas may be relevant for human risk 
from furan.  
• Available in vivo data with furan indicate that a reactive metabolite, most likely BDA, is 
formed and that this metabolite can react with DNA and induce mutations. To VKM’s 
knowledge, no in vivo studies on genotoxicity of BDA have been performed, but BDA 
was found genotoxic in several in vitro tests. VKM therefore considers that genotoxic 
mechanisms in furan-induced carcinogenesis cannot be excluded. Since a threshold cannot 
be identified, the substance was assessed as a genotoxic carcinogen.  
• VKM used the Margin of Exposure (MOE) approach in this risk assessment. The 
suitability of different studies on cholangiocarcinomas for dose-response modelling was 
considered. The 9-month interim evaluation of a 2-year study from NTP (1993) was 
chosen because it demonstrates a dose-response relationship. From this study, a point of 
departure of 0.02 mg/kg bw/day was chosen, based on a benchmark dose lower bound 
(BMDL10) of 0.14 mg furan/kg bw/day and a correction factor of 7 to account for reduced 
dosing and observation time.  
• For 6-, 12- and 24-month-old children, the main source of furan exposure is jarred baby 
food. For 4-, 9- and 13-year-old children, the major food source to the furan exposure is 
breakfast cereals. In adults, the major contribution to the furan exposure is coffee. The 
highest furan exposure was calculated for 12-month-old infants and ranged from 0.62-
1.51 µg/kg bw/day. In adults the furan exposure ranged from 0.27-0.82 µg/kg bw/day.  
• For mean exposure among infants, children and adolescents, the MOE-values ranged from 
29 in 12-month-infants to 2000 in the 13-year-old adolescents. Among high consumers in 
these groups, the MOE-values ranged from 13 to 400. In adults, the corresponding MOE-
values ranged from 59 to 74 for mean furan exposure and from 24 to 26 for high exposure. 
• It should be noted that the risk assessment of furan contains notable uncertainties and 
limitations, such as: 
o the use of the 9-month interim study in rats including a correction factor of 7 to 
derive a point of departure, instead of the full life-time study (2-year study) of the 
rat, is likely to overestimates the hazard.   
o a possible over-diagnosis of the cholangiocarcinomas, due to the similarities in 
histopathology between cholangiofibrosis and cholangiocarcinomas in rats may 
overestimate the hazard.  
o limitations in assessing food consumption and uncertainties related to estimating 
the furan exposure.  
VKM considers that the current exposure to furan in all age groups, particularly among 
infants and children, is of health concern. 
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Appendices 
 
Appendix I 
 
DIETARY EXPOSURE TO FURAN FROM JARRED BABY FOOD IN 6-MONTH-
OLD NON-BREASTFED INFANTS (SPEDKOST 2006) 
Table A1 shows the consumption of different subcategories jarred baby food and exposure to 
furan 6 month-old non-breastfed infants. The mean and 95 percentile consumptions of jarred 
baby food are calculated based on the frequency of consumption reported in the dietary 
survey and the amount of baby food assumed to be consumed per meal (1/4 jar = ca 50 g) 
(Øverby et al., 2009).   
The furan exposures have been calculated based on the mean furan contents in the different 
subcategories of jarred baby food analysed as purchased (see Table 1 and 6) and on the mean 
and 95 percentile consumptions shown in Table A1. A calculation of the furan exposure from 
the total of jarred baby food consumed has also been included, based on the individual 
consumption data reported for 6-month-old non-breastfed infants. All values in Table A1 are 
given for consumers only among the non-breastfed participants (n=397) in the dietary survey. 
 
 
Table A1: Consumption of different subcategories jarred baby food and exposure to furan in 6-month-old non-
breastfed infants (n=397). Values for consumers only within each subcategory are given. 
  Frequency of 
consumption, 
times/day 
Amount 
consumed, 
g 
Consumption, 
g/day 
Furan 
exposure,  
µg/kg bw/daya 
Baby food 
subcategory  
Number of 
consumers  
(% of 397) 
Mean 
(SD) 
95 
percen-
tile  
1/4 jar of 
baby food 
Mean 
(SD) 
95 
percen
-tile  
Mean  95 
percen
-tile  
Meat and 
vegetables 
214 (54) 0.8 (0.3) 1.0 50 39 (17) 50 0.19 0.24 
Vegetables  138 (35) 0.6 (0.4) 1.0 50 32 (18) 50 0.13 0.20 
Fish and 
vegetables 
48 (12) 0.6 (0.3) 1.0 50 28 (16) 50 0.11 -c 
Fruitsb 274 (69) 0.9 (0.6) 2.0 50 46 (30) 100 0.05 0.10 
Total jarred 
baby food 
331 (83) 1.6 (0.9) 3.3 50 80 (45) 165 0.23 0.49 
a Calculated based on the mean body weight of 8.0 kg reported for 6-month-old infants (see Table 7). 
b Include berries but not juice. 
c Few consumers (0.38 µg/kg bw/day) 
 
The results in Table A1 should be compared with the furan exposures shown for all 
participants in the dietary survey in Table 8. 
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DIETARY EXPOSURE TO FURAN FROM JARRED BABY FOOD IN 12-MONTH-
OLD NON-BREASTFED INFANTS (SPEDKOST 2007) 
Table A2 shows the consumption of different subcategories jarred baby food and exposure to 
furan in 12-month-old non-breastfed infants. The furan exposures have been calculated based 
on the mean furan contents in jarred baby food analysed as purchased (see Table 1 and 6) and 
on the mean and 95 percentile consumption of the different subcategories of jarred baby food 
reported in the dietary survey. A calculation of the furan exposure from the total of jarred 
baby food consumed has also been included, based on the individual consumption data 
reported for 12-month-old non-breastfed infants. All values in Table A2 are given for 
consumers only among the non-breastfed participants (n=881) in the dietary survey. 
 
Table A2: Consumption of different subcategories jarred baby food and exposure to furan in 12-month-old non-
breastfed infants (n=881). Values for consumers only within each subcategory are given. 
  Consumption, 
 g/day 
Furan exposure,  
µg/kg bw/daya 
Baby food subcategory Number of consumers 
(% of 881) 
Mean (SD) 95 
percentile 
Mean 95 
percentile 
Meat and vegetables 659 (75) 115 (91) 277 0.45 1.08 
Fish and vegetables 351 (40) 54 (30) 118 0.17 0.37 
Cereal based 143 (16) 54 (33) 139 0.32 0.80 
Vegetables 75 (9) 56 (40) 195  0.18 0.62 
Fruits 608 (69) 81 (77) 218 0.07 0.18 
Total jarred baby food 777 (88) 201 (158) 473 0.58 1.33 
a Calculated based on the mean body weight of 9.9 kg reported for 12-month-old infants (see Table 7). 
b Includes berries but not juice. 
 
The results in Table A2 should be compared with the furan exposures shown for all 
participants in the dietary survey in Table 13. 
 
Appendix II  
 
Table A3: BMD and BMDL calculations on cholangiocarcinomas from the 9-month interim evaluation of NTP (1993), combining the sexes (all parameters shown from the calculation 
in Proast software) 
------------------------------------------------------       
 cholangiofibroses_carcinomas , response :     
model covar npar loglik accept BMD BMDL BMDU level 
null NA 1 -54.83 -- NA NA NA -- 
full NA 8 -23.02 -- NA NA NA -- 
one-stage -- 2 -25.01 yes 0.265 0.198 0.358 f 
two-stage -- 3 -25.01 yes 0.265 0.198 0.358 f 
log-logist -- 3 -24.43 yes 1.04 0.455 1.5 f 
Weibull -- 3 -23.92 yes 0.713 0.216 1.28 f 
log-prob -- 3 -24.2 yes 1.05 0.468 1.52 f 
gamma -- 3 -24.01 yes 0.834 0.326 1.42 f 
logistic -- 2 -25.4 yes 1.01 0.68 1.45 f 
probit -- 2 -25.1 yes 0.704 NA NA f 
LVM-E2  2 -25.1 yes 0.97 0.655 1.43 f 
LVM-H2  2 -25.57 yes 0.484 0.349 0.663 f 
BMR: 0.1 extra risk      
P-value GoF: 0.05       
constraint: no        
------------------------------------------------------       
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Figure A1: Plot of BMD calculations on cholangiocarcinomas from the 9-month interim evaluation of NTP (1993), combining the sexes. 
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Appendix III 
CALCULATION OF T25 
The T25 approach is defined as the chronic dose rate (usually expressed in units of mg per kg 
bodyweight per day) which will give tumours at a specific tissue site in 25% of the animals 
after correction for spontaneous incidence and within the standard life time of the species 
(Dybing et al., 1997). In cases where the exposure/observation times are different from the 
standard lifespan of 24 months, the T25 value is corrected. The T25 method (Dybing et al., 
1997, Sanner et al., 2001) are used within EU in setting specific concentration limits for 
carcinogens in preparations (EC, 1999) and recently as a basis for calculation of Lifetime 
Cancer Risk and for quantitative hazard assessment of non-threshold carcinogens in several 
regulatory areas e.g. ECHA (2010), SCHER/SCCP/SCENIHR (2009) and SCCS (2010).  
In the case of furan, the tumour frequency after 24 months was close to 100% (NTP, 1993). In 
such cases the T25 will be uncertain and the “true” T25 will probably be lower than the 
estimated T25 after 24 months. It is, however, possible to use the 9 and 15 months interim 
study in the calculation. The calculated T25 in the interim studies has to be divided by a factor 
“d” (Dybing et al., 1997; EC, 1999; ECHA, 2010; Carcinogen Potency Database, 2011). 
d = (24 months / exposure time) x (24 months / observation time) 
This imply that the uncorrected T25 after 9 months is divided with ([24/9] x [24/9]) = 7.11 
and the uncorrected T25 after 15 months is divided with ([24/15] x [24/15]) = 2.56. The 
results of the calculation of T25 are shown in Table A4. As expected, T25 after 24 months is 
much higher both for females and males than the T25 values calculated after 9 months and 15 
months. The average exposure value after 9 and 15 months gives T25 = 0.14 mg/kg bw/day.  
Table A4: T25 calculation on cholangiocarcinomas from the 9-, 15- and 24-month evaluation of NTP (1993).  
The exposure doses have been calculated as the daily exposure. 
Observation 
time/exposure time 
(months) 
Females T25 Females 
Uncorrected 
mg/kg bw/d 
T25 Females 
Corrected a 
mg/kg bw/d Control 1.4  
mg/kg bw 
2.9  
mg/kg bw 
5.7  
mg/kg bw 
9 0/10 
(0%) 
4/10 
(40%) 
9/10 
(90%) 
10/10 
(100%) 0.89 0.13 
15 0/9 
(0%) 
9/10 
(90%) 
9/9 
(100%) 
7/7 
(100%) 0.40 0.16 
24 0/50 
(0%) 
49/50 
(98%) 
50/50 
(100%) 
48/50 
(96%) 0.36 - 
Observation 
time/exposure time 
(months) 
Males T25 Males 
Uncorrected 
mg/kg bw/d 
T25 Males 
Corrected a 
mg/kg bw/d Control 1.4  
mg/kg bw 
2.9  
mg/kg bw 
5.7  
mg/kg bw 
9 0/10 
(0%) 
5/10 
(50%) 
7/10 
(70%) 
10/10 
(100%) 0.71 0.10 
15 0/9 
(0%) 
7/9 
(78%) 
9/9 
(100%) 
6/6 
(100%) 0.46 0.18 
24 0/50 
(0%) 
43/50 
(86%) 
48/50 
(96%) 
49/50 
(98%) 0.42 - 
a T25 is corrected for observation/exposure time and is divided with ([24/9] x [24/9]) = 7.11 after 9 months, and with ([24/15] x [24/15]) = 
2.56 after 15 month. 
